General Information of Drug (ID: DM4KI7O)

Drug Name
Zidovudine Drug Info
Synonyms
zidovudine; Azidothymidine; 30516-87-1; 3'-Azido-3'-deoxythymidine; Retrovir; AZT; Zidovudinum; Compound S; Thymidine, 3'-azido-3'-deoxy-; ZIDOVUDINE [AZT]; zidovudin; BW A509U; Zidovudinum [Latin]; Zidovudina [Spanish]; BWA509U; DRG-0004; 3'-Azido-2',3'-Dideoxythymidine; ZDV; UNII-4B9XT59T7S; 3'-Deoxy-3'-azidothymidine; CCRIS 105; Aztec; BW-A509U; BW-A-509U; HSDB 6515; 3'-Azido-3'-deoxythymidine (AIDS); CHEMBL129; NSC 602670; BW-A 509U; MLS000028548; 4B9XT59T7S; AZT; Antiviral; Azidodeoxythymidine; ZVD; Zidovudin; Zidovudina; AZT Antiviral; AZT TRANSPLACENTAL CARCINOGENESIS STUDY; Antiviral AZT; Cpd S; Racemic Liposomal AZT; Zidovudine EP III; BWA 509U; K7 [P Ti2 W10 O40]; AZT & EPO; AZT & HPA; AZT & Lymphoblastoid Interferon; AZT & SST; AZT & rsT4; AZT & sCD4; AZT & srCD4; AZT (Antiviral); AZT+PRO 140; AZT, Antiviral; Apo-Zidovudine; BWA-509U; Intron A & AZT; Novo-Azt; Propolis+AZT; Retrovir (TN); Retrovir(TM); Retrovis (TN); Zidovudine+PRO 140; AZT & Colony-stimulating factor 2; AZT & Concanavalin A (ConA); AZT & GM-CSF; AZT & IFN-alpha; AZT & IL-1; AZT & IL-2; AZT & IL-6; AZT & Li & EPO; AZT & NP (from PHCA or HSA); AZT & PM-19; DS-4152 & AZT; Liposomal AZT-SN-1; Liposomal AZT-SN-3; PC-SOD+AZT;RIFN-beta seron & AZT; AZT & CD4(178)-PE 40; AZT & Li & GM-CSF; AZT & Li & IL-1; AZT & Li & IL-6; AZT & rIFNalpha2; Racemic-dipalmitoylglycerophospho-AZT (in a lipid vesicle); Zidovudine (JAN/USP/INN); Zidovudine [USAN:INN:BAN:JAN]; AZT & rsCD4 & rIFNalphaA; SN-1-dipalmitoylglycerophospho-AZT (in a lipid vesicle); SN-3-dipalmitoylglycerophospho-AZT (in a lipid vesicle); AZT & Interferon-alpha-2; Met-SDF-1beta & AZT; Met-SDF-1beta & Zidovudine; Interferon AD + 3'-azido-3'-deoxythymidine; 1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)thymine; 3′-Azido-3′-deoxythymidine; 3' Azido 2',3' Dideoxythymidine; 3' Azido 3' deoxythymidine; 3'-Azido-3'-deoxythymidine & Concanavalin A; 3'-Azido-3'-deoxythymidine & Erythropoietin; 3'-Azido-3'-deoxythymidine & Heteropolyoxotungstate PM-19; 3'-Azido-3'-deoxythymidine & Interleukin-1; 3'-Azido-3'-deoxythymidine & Interleukin-2; 3'-Azido-3'-deoxythymidine & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lithium & Erythropoietin; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-1; 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-6; 3'-Azido-3'-deoxythymidine & Lymphoblastoid Interferon; 3'-Azido-3'-deoxythymidine & Sho-Saiko-To; 3'-Azido-3'deoxythymidine & Interferon-alpha; 3'-Azidothymidine; 3'-azido-3'-deoxythymidine, AZT; 3-Azido-3-deoxythymidine; Dendrigen; CTCE-0422
Indication
Disease Entry ICD 11 Status REF
Human immunodeficiency virus infection 1C62 Approved [1]
Diarrhea ME05.1 Investigative [2]
Nephropathy GC2Z Investigative [2]
Virus infection 1A24-1D9Z Investigative [3]
Therapeutic Class
Anti-HIV Agents
Cross-matching ID
PubChem CID
35370
ChEBI ID
CHEBI:10110
CAS Number
CAS 30516-87-1
TTD Drug ID
DM4KI7O
VARIDT Drug ID
DR00296
INTEDE Drug ID
DR1729
ACDINA Drug ID
D00739

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
DTP
DME
DOT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
Patented Agent(s)
Preclinical Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Nevirapine DM6HX9B Human immunodeficiency virus infection 1C62 Approved [21]
Zalcitabine DMH7MUV Human immunodeficiency virus infection 1C62 Approved [22]
Tenofovir DM1IS6U Chronic hepatitis B virus infection Approved [5]
Lamivudine DMI347A Chronic HBV infection 1E51.0Z Approved [23]
Abacavir DMMN36E Human immunodeficiency virus infection 1C62 Approved [24]
Delavirdine DM3NF5G Human immunodeficiency virus infection 1C62 Approved [23]
Efavirenz DMC0GSJ Human immunodeficiency virus infection 1C62 Approved [23]
Rilpivirine DMJ0QOW Human immunodeficiency virus infection 1C62 Approved [25]
Etravirine DMGV8QU Human immunodeficiency virus-1 infection 1C62 Approved [26]
MK-1439 DM215WE Human immunodeficiency virus infection 1C62 Approved [27]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ponatinib DMYGJQO Acute lymphoblastic leukaemia 2A85 Approved [28]
Intedanib DMSTA36 Colorectal cancer 2B91.Z Approved [29]
Midostaurin DMI6E0R Acute myeloid leukaemia 2A60 Approved [30]
Gilteritinib DMTI0ZO Acute myeloid leukaemia 2A60 Approved [27]
Pexidartinib DMS2J0Z Tenosynovial giant cell tumour 2F7B Approved [31]
Pacritinib DM1T6ZN Myelofibrosis 2A20.2 Approved [4]
Quizartinib DM8Y4JS Acute myeloid leukaemia 2A60 Approved [32]
Lestaurtinib DMQ2AIJ Acute myeloid leukaemia 2A60 Approved (orphan drug) [33]
Famitinib DMSFWT7 Solid tumour/cancer 2A00-2F9Z Phase 2 [34]
BMS-690514 DMX302C Chronic pain MG30 Phase 2 [35]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Transported By P-glycoprotein 1 (ABCB1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Amoxicillin DMUYNEI Acute otitis media AB00 Approved [7]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [36]
Methotrexate DM2TEOL Anterior urethra cancer Approved [8]
Folic Acid DMEMBJC Colorectal carcinoma Approved [37]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [8]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [8]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [38]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [8]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [39]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [40]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [41]
Methotrexate DM2TEOL Anterior urethra cancer Approved [42]
Folic Acid DMEMBJC Colorectal carcinoma Approved [43]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [44]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [45]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [46]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [47]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [46]
Sulfasalazine DMICA9H Irritable bowel syndrome DD91.0 Approved [48]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [49]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [50]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [51]
Dinoprostone DMTYOPD Medical abortion JA00.1Z Approved [52]
Erythromycin DM4K7GQ Acne vulgaris ED80 Approved [53]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [54]
Aciclovir DMYLOVR Genital herpes 1A94 Approved [55]
Ranitidine DM0GUSX Gastric ulcer DA60 Approved [56]
Entecavir DM7VTQO Hepatitis B virus infection 1E51.0 Approved [57]
Theophylline DMRJFN9 Bronchitis CA20 Approved [53]
Tetracycline DMZA017 Acne vulgaris ED80 Approved [58]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dinoprostone DMTYOPD Medical abortion JA00.1Z Approved [59]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [60]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [61]
Oxaliplatin DMQNWRD Adenocarcinoma 2D40 Approved [62]
Verapamil DMA7PEW Angina pectoris BA40 Approved [63]
Sorafenib DMS8IFC Adenocarcinoma 2D40 Approved [64]
Quinine DMSWYF5 Malaria 1F40-1F45 Approved [65]
Dopamine DMPGUCF Acromegaly 5A60.0 Approved [66]
Propranolol DM79NTF Angina pectoris BA40 Approved [67]
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [7]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [68]
Folic Acid DMEMBJC Colorectal carcinoma Approved [69]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [70]
Dinoprostone DMTYOPD Medical abortion JA00.1Z Approved [71]
Prasterone DM67VKL Chronic obstructive pulmonary disease CA22 Approved [72]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [73]
Mercaptopurine DMTM2IK Acute lymphoblastic leukaemia 2A85 Approved [74]
Glutathione DMAHMT9 Human immunodeficiency virus infection 1C62 Approved [75]
Ganciclovir DM1MBYQ Cytomegalovirus infection 1D82 Approved [7]
Cefazolin DMPDYFR Bacteremia 1A73 Approved [76]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Amoxicillin DMUYNEI Acute otitis media AB00 Approved [77]
Methotrexate DM2TEOL Anterior urethra cancer Approved [78]
Dinoprostone DMTYOPD Medical abortion JA00.1Z Approved [52]
Aciclovir DMYLOVR Genital herpes 1A94 Approved [6]
Ganciclovir DM1MBYQ Cytomegalovirus infection 1D82 Approved [6]
Cefazolin DMPDYFR Bacteremia 1A73 Approved [79]
Olmesartan medoxomil DMWBHRY High blood pressure BA00 Approved [80]
Zalcitabine DMH7MUV Human immunodeficiency virus infection 1C62 Approved [81]
FLUORESCEIN DMQTFAO Ocular disease 1F00.1Z Approved [82]
Tenofovir DM1IS6U Chronic hepatitis B virus infection Approved [83]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [84]
Dinoprostone DMTYOPD Medical abortion JA00.1Z Approved [52]
Prasterone DM67VKL Chronic obstructive pulmonary disease CA22 Approved [85]
Pravastatin DM6A0X7 Adult acute monocytic leukemia Approved [86]
L-Tryptophan DMIBH7M Depression 6A70-6A7Z Approved [87]
Mercaptopurine DMTM2IK Acute lymphoblastic leukaemia 2A85 Approved [88]
PITAVASTATIN CALCIUM DM1UJO0 Dyslipidemia 5C80-5C81 Approved [89]
Rosuvastatin DMMIQ7G Arteriosclerosis BD40 Approved [90]
Cilostazol DMZMSCT Intermittent claudication BD40.00 Approved [91]
Aciclovir DMYLOVR Genital herpes 1A94 Approved [92]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [93]
Dinoprostone DMTYOPD Medical abortion JA00.1Z Approved [52]
L-Glutamic Acid DM4PUDW Schizophrenia 6A20 Approved [94]
Pravastatin DM6A0X7 Adult acute monocytic leukemia Approved [95]
Tetracycline DMZA017 Acne vulgaris ED80 Approved [58]
Bumetanide DMRV7H0 Congestive heart failure BD10 Approved [96]
Estrone sulfate DMVBIZL Atrophic vaginitis GA30.2 Approved [97]
Levocetirizine DMQYLGP Allergic rhinitis CA08.0 Approved [98]
PGF2alpha DM4XAU7 Solid tumour/cancer 2A00-2F9Z Clinical trial [52]
uric acid DMA1MKT Discovery agent N.A. Investigative [99]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Metabolized By Cytochrome P450 3A4 (CYP3A4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [100]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [101]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [102]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [103]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [104]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [105]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [106]
Prasterone DM67VKL Chronic obstructive pulmonary disease CA22 Approved [101]
Verapamil DMA7PEW Angina pectoris BA40 Approved [107]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [108]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [109]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [110]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [111]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [112]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [113]
Mycophenolate mofetil DMPQAGE Hepatosplenic T-cell lymphoma Approved [114]
Metronidazole DMTIVEN Abscess Approved [115]
Propofol DMB4OLE Anaesthesia 9A78.6 Approved [116]
Ethanol DMDRQZU Chronic pain MG30 Approved [117]
Atorvastatin DMF28YC Acute coronary syndrome BA41 Approved [118]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Metabolized By Cytochrome P450 2A6 (CYP2A6)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [119]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [11]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [120]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [104]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [121]
Metronidazole DMTIVEN Abscess Approved [122]
Propofol DMB4OLE Anaesthesia 9A78.6 Approved [123]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [124]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [11]
Lidocaine DML4ZOT Anaesthesia 9A78.6 Approved [11]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Metabolized By Cytochrome P450 2C8 (CYP2C8)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [119]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [125]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [125]
Verapamil DMA7PEW Angina pectoris BA40 Approved [126]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [127]
Sorafenib DMS8IFC Adenocarcinoma 2D40 Approved [128]
Quinine DMSWYF5 Malaria 1F40-1F45 Approved [125]
Mycophenolate mofetil DMPQAGE Hepatosplenic T-cell lymphoma Approved [129]
Propofol DMB4OLE Anaesthesia 9A78.6 Approved [123]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [130]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Metabolized By Cytochrome P450 2C9 (CYP2C9)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Progesterone DMUY35B Amenorrhea GA20.0 Approved [131]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [132]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [133]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [11]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [134]
Verapamil DMA7PEW Angina pectoris BA40 Approved [135]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [136]
Estrone DM5T6US Acne vulgaris ED80 Approved [137]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [138]
Pravastatin DM6A0X7 Adult acute monocytic leukemia Approved [139]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Metabolized By Mephenytoin 4-hydroxylase (CYP2C19)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Amoxicillin DMUYNEI Acute otitis media AB00 Approved [140]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [131]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [141]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [142]
Verapamil DMA7PEW Angina pectoris BA40 Approved [143]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [144]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [138]
Quinine DMSWYF5 Malaria 1F40-1F45 Approved [145]
Propofol DMB4OLE Anaesthesia 9A78.6 Approved [123]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [11]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [146]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [107]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [147]
Mycophenolate mofetil DMPQAGE Hepatosplenic T-cell lymphoma Approved [129]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [107]
PITAVASTATIN CALCIUM DM1UJO0 Dyslipidemia 5C80-5C81 Approved [148]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [149]
Ezetimibe DM7A8TW Atherosclerosis BD40 Approved [150]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [151]
Losartan DM72JXH Diabetic kidney disease GB61.Z Approved [107]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Aspirin DM672AH Acute coronary syndrome BA41 Approved [152]
Methotrexate DM2TEOL Anterior urethra cancer Approved [153]
Paclitaxel DMLB81S Breast carcinoma Approved [51]
Allopurinol DMLPAOB Gout FA25 Approved [51]
Bumetanide DMRV7H0 Congestive heart failure BD10 Approved [51]
Dinoprostone DMTYOPD Medical abortion JA00.1Z Approved [51]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [51]
Tetracycline DMZA017 Acne vulgaris ED80 Approved [51]
Ranitidine DM0GUSX Gastric ulcer DA60 Approved [56]
Salicyclic acid DM2F8XZ Acne vulgaris ED80 Approved [152]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [154]
Quercetin DM3NC4M Obesity 5B81 Approved [155]
Glutathione DMAHMT9 Human immunodeficiency virus infection 1C62 Approved [156]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [157]
Nefazodone DM4ZS8M Major depressive disorder 6A70.3 Approved [158]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [159]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [160]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [162]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Testosterone DM7HUNW Hot flushes GA30 Approved [164]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [164]
Gefitinib DM15F0X Colon adenocarcinoma Approved [165]
Sunitinib DMCBJSR Acute undifferentiated leukemia Approved [166]
Rosuvastatin DMMIQ7G Arteriosclerosis BD40 Approved [167]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [168]
Methotrexate DM2TEOL Anterior urethra cancer Approved [169]
Quercetin DM3NC4M Obesity 5B81 Approved [155]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [170]
Folic Acid DMEMBJC Colorectal carcinoma Approved [171]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Flupentixol DM0DJ9O Schizophrenia 6A20 Approved [172]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [173]
Crizotinib DM4F29C Non-small-cell lung cancer 2C25.Y Approved [174]
Lamotrigine DM8SXYG Bipolar disorder 6A60 Approved [175]
Cepharanthine DM9Y5JB N. A. N. A. Approved [176]
Itraconazole DMCR1MV Aspergillosis 1F20 Approved [177]
Clozapine DMFC71L Schizophrenia 6A20 Approved [178]
Midostaurin DMI6E0R Acute myeloid leukaemia 2A60 Approved [179]
Trifluoperazine DMKBYWI Anxiety Approved [180]
Olanzapine DMPFN6Y Bipolar depression Approved [178]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [181]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Zalcitabine DMH7MUV Human immunodeficiency virus infection 1C62 Approved [183]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [185]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [186]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [187]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [189]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Erythropoietin (EPO)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [190]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [191]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Hydrocortisone DMGEMB7 Acne vulgaris ED80 Approved [193]
Fenoterol DMIP3ZV Asthma CA23 Approved [194]
Vitamin A DMJ2AH4 Night blindness 9D45 Approved [195]
Enalapril DMNFUZR Congestive heart failure BD10 Approved [196]
Hydroxyurea DMOQVU9 Chronic myelogenous leukaemia 2A20.0 Approved [197]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Floxuridine DM04LR2 Colorectal cancer 2B91.Z Approved [198]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [199]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [200]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [201]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [202]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [203]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [204]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [205]
Testosterone DM7HUNW Hot flushes GA30 Approved [206]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [206]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [207]
Methotrexate DM2TEOL Anterior urethra cancer Approved [208]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [209]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [210]
Paclitaxel DMLB81S Breast carcinoma Approved [211]
Floxuridine DM04LR2 Colorectal cancer 2B91.Z Approved [212]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [213]
Mechlorethamine DM0CVXA Chronic myelogenous leukaemia 2A20.0 Approved [214]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [215]
Flucytosine DM13VTW Cryptococcal meningitis Approved [216]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [217]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [218]
Gefitinib DM15F0X Colon adenocarcinoma Approved [219]
Talazoparib DM1KS78 Breast cancer 2C60-2C65 Approved [220]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [199]
Etretinate DM2CZFA Keratosis ED56 Approved [221]
Prednisone DM2HG4X Acute asthma CA23 Approved [222]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [223]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [224]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [225]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [226]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [226]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [186]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [161]
Urethane DM7NSI0 N. A. N. A. Phase 4 [228]
OTX-015 DMI8RG1 Acute myeloid leukaemia 2A60 Phase 1/2 [229]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [208]
Fructose DM43AN2 Vomiting MD90 Approved [230]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [157]
Testosterone DM7HUNW Hot flushes GA30 Approved [231]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [232]
Folic Acid DMEMBJC Colorectal carcinoma Approved [233]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [234]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [235]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [236]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [238]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Milchsaure DM462BT Pruritus EC90 Investigative [239]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [240]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [241]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [242]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [243]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [238]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Fenretinide DMRD5SP Macular degeneration 9B78.3 Phase 3 [244]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [245]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [246]
Gefitinib DM15F0X Colon adenocarcinoma Approved [247]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [248]
Selenium DM25CGV N. A. N. A. Approved [249]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [250]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [251]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [252]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [253]
Testosterone DM7HUNW Hot flushes GA30 Approved [206]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [254]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [199]
Methotrexate DM2TEOL Anterior urethra cancer Approved [255]
Quercetin DM3NC4M Obesity 5B81 Approved [256]
Furazolidone DM3P6V7 Diarrhea ME05.1 Approved [257]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [202]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [157]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [258]
Liothyronine DM6IR3P Congenital hypothyroidism Approved [259]
Olaparib DM8QB1D Ovarian cancer 2C73 Approved [260]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [226]
Methotrexate DM2TEOL Anterior urethra cancer Approved [208]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [261]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [262]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [263]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [240]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [264]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [265]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [203]
Panobinostat DM58WKG Chronic graft versus host disease Approved [266]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
Palbociclib DMD7L94 Breast cancer 2C60-2C65 Approved [267]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [268]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [234]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [269]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [270]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [271]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [272]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [273]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [181]
Liothyronine DM6IR3P Congenital hypothyroidism Approved [274]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [265]
Leflunomide DMR8ONJ Arthritis FA20 Approved [275]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [276]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [277]
Liothyronine DM6IR3P Congenital hypothyroidism Approved [278]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [279]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [234]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein SLC31A2 (SLC31A2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [280]
Methotrexate DM2TEOL Anterior urethra cancer Approved [281]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [261]
Testosterone DM7HUNW Hot flushes GA30 Approved [206]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [206]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [282]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [234]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [235]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [280]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Paclitaxel DMLB81S Breast carcinoma Approved [283]
Methotrexate DM2TEOL Anterior urethra cancer Approved [284]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [285]
Calcipotriol DM03CP7 Psoriasis EA90 Approved [286]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [287]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [288]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [276]
Prednisone DM2HG4X Acute asthma CA23 Approved [289]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [290]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [291]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [154]
Pemetrexed DMMX2E6 Central nervous system lymphoma 2B33.5 Approved [292]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [70]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [288]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [293]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [294]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [295]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [160]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [268]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [157]
Panobinostat DM58WKG Chronic graft versus host disease Approved [266]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [296]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Testosterone enanthate DMB6871 N. A. N. A. Approved [297]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
Indomethacin DMSC4A7 Bursitis Approved [298]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [186]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [299]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [242]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [300]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Urethane DM7NSI0 N. A. N. A. Phase 4 [228]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [301]
chloropicrin DMSGBQA Discovery agent N.A. Investigative [302]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [262]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [303]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [304]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [305]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [272]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [306]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [307]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [308]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [309]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [238]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [300]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
DTI-015 DMXZRW0 Brain cancer 2A00 Approved [310]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [272]
Testosterone DM7HUNW Hot flushes GA30 Approved [206]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [206]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [265]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [265]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [232]
Ifosfamide DMCT3I8 Adult central nervous system germ cell tumor Approved [265]
Fenofibrate DMFKXDY Coronary atherosclerosis Approved [311]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [306]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [243]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [312]
Mitoxantrone DMM39BF Acute myelogenous leukaemia 2A41 Approved [313]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [314]
THAPSIGARGIN DMDMQIE N. A. N. A. Preclinical [315]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [316]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [317]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [276]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [202]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [261]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [273]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [318]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [319]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [296]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [306]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [320]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [279]
Leflunomide DMR8ONJ Arthritis FA20 Approved [275]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [241]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [235]
Melphalan DMOLNHF Hematologic disease 3C0Z Approved [321]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Indomethacin DMSC4A7 Bursitis Approved [298]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [186]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [240]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [308]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [276]
Cocaine DMSOX7I Anaesthesia 9A78.6 Approved [322]
Arsenic DMTL2Y1 N. A. N. A. Approved [323]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [324]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [305]
Vinblastine DM5TVS3 Advanced cancer 2A00-2F9Z Approved [313]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [325]
3R14S-OCHRATOXIN A DM2KEW6 Discovery agent N.A. Investigative [326]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [327]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [272]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [279]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [235]
Dopamine DMPGUCF Acromegaly 5A60.0 Approved [328]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [329]
Arsenic DMTL2Y1 N. A. N. A. Approved [330]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [331]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Dihydroartemisinin DMBXVMZ Malaria 1F40-1F45 Approved [332]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [333]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [308]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [243]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
PEITC DMOMN31 Prostate cancer 2C82.0 Phase 2 [334]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [325]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [314]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Levacecarnine hci DMJBOCR Cognitive impairment 6D71 Approved [335]
Verapamil DMA7PEW Angina pectoris BA40 Approved [336]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [157]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [311]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [337]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [338]
Arsenic DMTL2Y1 N. A. N. A. Approved [339]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [276]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [263]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [340]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [265]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [341]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [265]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [242]
Ethanol DMDRQZU Chronic pain MG30 Approved [342]
Fenofibrate DMFKXDY Coronary atherosclerosis Approved [265]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [272]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [306]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [242]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [308]
Ethinyl Estradiol DMODJ40 Acne vulgaris ED80 Approved [343]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [236]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [243]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [300]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Fenretinide DMRD5SP Macular degeneration 9B78.3 Phase 3 [244]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Benzbromarone DMC3YUA Gout FA25 Approved [344]
Verapamil DMA7PEW Angina pectoris BA40 Approved [344]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [311]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [345]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [263]
Adenosine triphosphate DM79F6G Malnutrition 5B50-5B71 Approved [346]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [311]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [320]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [347]
Testosterone DM7HUNW Hot flushes GA30 Approved [348]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Hydrocortisone DMGEMB7 Acne vulgaris ED80 Approved [348]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [234]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [269]
Bortezomib DMNO38U Leukemia Approved [349]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [287]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [317]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [350]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [306]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [351]
Folic Acid DMEMBJC Colorectal carcinoma Approved [233]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [352]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [353]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Floxuridine DM04LR2 Colorectal cancer 2B91.Z Approved [354]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [254]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [355]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [240]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [253]
Testosterone DM7HUNW Hot flushes GA30 Approved [206]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [206]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Capsaicin DMGMF6V Back pain ME84.Z Approved [356]
Mitomycin DMH0ZJE Breast cancer 2C60-2C65 Approved [357]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [254]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [358]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [224]
Methotrexate DM2TEOL Anterior urethra cancer Approved [153]
Quercetin DM3NC4M Obesity 5B81 Approved [359]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [360]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [361]
Testosterone DM7HUNW Hot flushes GA30 Approved [206]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [265]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [206]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cytochrome b (CYTB)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [362]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [232]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Urethane DM7NSI0 N. A. N. A. Phase 4 [228]
Fialuridine DMCIGRB Hepatitis B virus infection 1E51.0 Phase 2 [363]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [364]
THAPSIGARGIN DMDMQIE N. A. N. A. Preclinical [315]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [327]
Ethidium DMMEQUR Discovery agent N.A. Investigative [365]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [366]
Quercetin DM3NC4M Obesity 5B81 Approved [367]
Clarithromycin DM4M1SG Acute maxillary sinusitis Approved [368]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [369]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [370]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Chloramphenicol DMFXEWT Bacterial infection 1A00-1C4Z Approved [368]
Menthol DMG2KW7 Back pain ME84.Z Approved [371]
Didanosine DMI2QPE Human immunodeficiency virus infection 1C62 Approved [372]
Josamycin DMKJ8LB Bacterial infection 1A00-1C4Z Approved [368]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [369]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [232]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Zalcitabine DMH7MUV Human immunodeficiency virus infection 1C62 Approved [373]
Ethinyl Estradiol DMODJ40 Acne vulgaris ED80 Approved [374]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Adenosine triphosphate DM79F6G Malnutrition 5B50-5B71 Approved [375]
Gemcitabine DMSE3I7 Anterior urethra cancer Approved [375]
Resveratrol DM3RWXL Giant cell arteritis 4A44.2 Phase 3 [376]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [377]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Thioguanine DM7NKEV Acute lymphocytic leukaemia 2B33.3 Approved [378]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [379]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [200]
Methotrexate DM2TEOL Anterior urethra cancer Approved [208]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [380]
Fructose DM43AN2 Vomiting MD90 Approved [381]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [157]
Testosterone DM7HUNW Hot flushes GA30 Approved [206]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [206]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [241]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Adenosine deaminase (ADA)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [317]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [277]
Panobinostat DM58WKG Chronic graft versus host disease Approved [266]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [306]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [382]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [234]
Corticotropin DMP9TWZ Cushing disease 5A70 Approved [383]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [384]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By ATP synthase subunit a (ATP6)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [362]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [385]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [279]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [232]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Ethinyl Estradiol DMODJ40 Acne vulgaris ED80 Approved [374]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [243]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [386]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Urethane DM7NSI0 N. A. N. A. Phase 4 [228]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Tumor necrosis factor (TNF)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Indomethacin DMSC4A7 Bursitis Approved [387]
Amphotericin B DMTAJQE Acne vulgaris ED80 Approved [388]
Fructose DM43AN2 Vomiting MD90 Approved [166]
Ketoprofen DMRKXPT Bursitis Approved [166]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [389]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [390]
Baclofen DM0QV1J Multiple sclerosis 8A40 Approved [391]
Gefitinib DM15F0X Colon adenocarcinoma Approved [392]
Ganciclovir DM1MBYQ Cytomegalovirus infection 1D82 Approved [393]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [394]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Interferon alpha-1/13 (IFNA1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [272]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [395]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [396]
PMID28870136-Compound-48 DMPIM9L N. A. N. A. Patented [397]
QUERCITRIN DM1DH96 Discovery agent N.A. Investigative [398]
Drug(s) Affected By Interferon gamma (IFNG)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Amphotericin B DMTAJQE Acne vulgaris ED80 Approved [399]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [400]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [401]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [402]
Methotrexate DM2TEOL Anterior urethra cancer Approved [208]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [403]
Quercetin DM3NC4M Obesity 5B81 Approved [404]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [405]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [406]
Isoniazid DM5JVS3 Latent tuberculosis infection Approved [407]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Interleukin-1 alpha (IL1A)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [408]
Primidone DM0WX6I Epilepsy 8A60-8A68 Approved [409]
Fexofenadine DM17ONX Allergic rhinitis CA08.0 Approved [409]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [394]
Clavulanate DM2FGRT Bacteremia 1A73 Approved [409]
Methotrexate DM2TEOL Anterior urethra cancer Approved [208]
Quercetin DM3NC4M Obesity 5B81 Approved [256]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [409]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [380]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [272]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Interleukin-1 beta (IL1B)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [410]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [411]
Gefitinib DM15F0X Colon adenocarcinoma Approved [412]
Fexofenadine DM17ONX Allergic rhinitis CA08.0 Approved [409]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [413]
Lumiracoxib DM1S4AG Chronic renal failure GB61.Z Approved [409]
Imiquimod DM1TMA3 Alopecia areata ED70.2 Approved [414]
Selenium DM25CGV N. A. N. A. Approved [415]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [416]
Spironolactone DM2AQ5N Chronic heart failure BD1Z Approved [417]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [153]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [403]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [418]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [419]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [420]
Propofol DMB4OLE Anaesthesia 9A78.6 Approved [421]
Atorvastatin DMF28YC Acute coronary syndrome BA41 Approved [422]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Folic Acid DMEMBJC Colorectal carcinoma Approved [233]
Clozapine DMFC71L Schizophrenia 6A20 Approved [423]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [424]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [425]
Allopurinol DMLPAOB Gout FA25 Approved [426]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [427]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [428]
Amoxicillin DMUYNEI Acute otitis media AB00 Approved [429]
Abacavir DMMN36E Human immunodeficiency virus infection 1C62 Approved [430]
Flucloxacillin DMNUWST Bacterial infection 1A00-1C4Z Approved [431]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [432]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Albumin (ALB)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [186]
Sulfamethoxazole DMB08GE Acute otitis media AB00 Approved [166]
Tolbutamide DM02AWV Advanced cancer 2A00-2F9Z Approved [433]
Diazepam DM08E9O Alcohol withdrawal Approved [434]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [435]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [436]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [437]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [438]
Methotrexate DM2TEOL Anterior urethra cancer Approved [439]
Quercetin DM3NC4M Obesity 5B81 Approved [440]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [366]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [232]
Chloramphenicol DMFXEWT Bacterial infection 1A00-1C4Z Approved [365]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [243]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Capsaicin DMGMF6V Back pain ME84.Z Approved [441]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [166]
Haloperidol DM96SE0 Delirium Approved [166]
Thiothixene DMDINC4 Schizophrenia 6A20 Approved [166]
Resveratrol DM3RWXL Giant cell arteritis 4A44.2 Phase 3 [442]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [369]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [232]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [243]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
THAPSIGARGIN DMDMQIE N. A. N. A. Preclinical [315]
3R14S-OCHRATOXIN A DM2KEW6 Discovery agent N.A. Investigative [443]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [327]
methyl p-hydroxybenzoate DMO58UW Discovery agent N.A. Investigative [444]
paraquat DMR8O3X Discovery agent N.A. Investigative [445]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [446]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [279]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [232]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Cholecalciferol DMGU74E Adult acute monocytic leukemia Approved [447]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [448]
Arsenic DMTL2Y1 N. A. N. A. Approved [449]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Urethane DM7NSI0 N. A. N. A. Phase 4 [228]
CERC-801 DM3SZ7P N. A. N. A. Phase 2 [450]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Nefazodone DM4ZS8M Major depressive disorder 6A70.3 Approved [451]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [369]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [232]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
INX-189 DMSTJ6Q Hepatitis C virus infection 1E51.1 Phase 2 [452]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [364]
THAPSIGARGIN DMDMQIE N. A. N. A. Preclinical [315]
3R14S-OCHRATOXIN A DM2KEW6 Discovery agent N.A. Investigative [443]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [327]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [453]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [454]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [276]
Selenium DM25CGV N. A. N. A. Approved [320]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [455]
Methotrexate DM2TEOL Anterior urethra cancer Approved [208]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [202]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [157]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [456]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [457]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [425]
Allopurinol DMLPAOB Gout FA25 Approved [458]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [459]
Clavulanate DM2FGRT Bacteremia 1A73 Approved [432]
Ticlopidine DMO946V Acute coronary syndrome BA41 Approved [460]
Amoxicillin DMUYNEI Acute otitis media AB00 Approved [432]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [272]
Erythromycin DM4K7GQ Acne vulgaris ED80 Approved [429]
Bupropion DM5PCS7 Depression 6A70-6A7Z Approved [429]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [241]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Folic Acid DMEMBJC Colorectal carcinoma Approved [233]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [234]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [329]
Arsenic DMTL2Y1 N. A. N. A. Approved [461]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [325]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [462]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [463]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [464]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [465]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [466]
Penicillamine DM40EF6 Cystinuria 5C60.2 Approved [467]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [360]
Pyrazinamide DM4IF32 Meningeal tuberculosis Approved [468]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [469]
Bupropion DM5PCS7 Depression 6A70-6A7Z Approved [470]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Interleukin-6 (IL6)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [471]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [472]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [408]
Pantothenic acid DM091H2 Vitamin deficiency 5B55-5B71 Approved [473]
Indinavir DM0T3YH Human immunodeficiency virus infection 1C62 Approved [20]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [411]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [394]
Imiquimod DM1TMA3 Alopecia areata ED70.2 Approved [414]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [474]
Methotrexate DM2TEOL Anterior urethra cancer Approved [471]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Endothelin-1 (EDN1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Bosentan DMIOGBU Pulmonary arterial hypertension BB01.0 Approved [475]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [241]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [476]
Methotrexate DM2TEOL Anterior urethra cancer Approved [477]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [478]
Quercetin DM3NC4M Obesity 5B81 Approved [479]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [277]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [480]
Lisinopril DMUOK4C Chronic heart failure BD1Z Approved [481]
Panobinostat DM58WKG Chronic graft versus host disease Approved [266]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Lipoprotein lipase (LPL)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Paclitaxel DMLB81S Breast carcinoma Approved [166]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [454]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [394]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [482]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [157]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [483]
Nevirapine DM6HX9B Human immunodeficiency virus infection 1C62 Approved [484]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [485]
Efavirenz DMC0GSJ Human immunodeficiency virus infection 1C62 Approved [484]
Benzbromarone DMC3YUA Gout FA25 Approved [486]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Aspirin DM672AH Acute coronary syndrome BA41 Approved [319]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [305]
Urethane DM7NSI0 N. A. N. A. Phase 4 [228]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [487]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [488]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [325]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [314]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [320]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [271]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [202]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [489]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [273]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [489]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [279]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [265]
Leflunomide DMR8ONJ Arthritis FA20 Approved [275]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By P3 protein (SLC10A3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [242]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [276]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [353]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [490]
Urethane DM7NSI0 N. A. N. A. Phase 4 [228]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [325]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [314]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [366]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [491]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Cocaine DMSOX7I Anaesthesia 9A78.6 Approved [492]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [309]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [238]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [300]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [325]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sevoflurane DMC9O43 Anaesthesia 9A78.6 Approved [493]
Docetaxel DMDI269 Advanced cancer 2A00-2F9Z Approved [494]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [495]
Gemcitabine DMSE3I7 Anterior urethra cancer Approved [496]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [166]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [408]
Verapamil DMA7PEW Angina pectoris BA40 Approved [497]
Mechlorethamine DM0CVXA Chronic myelogenous leukaemia 2A20.0 Approved [498]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [390]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [499]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [272]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [262]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [242]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [234]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [500]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [238]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [300]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [501]
Coprexa DMA0WEK Neurological disorder 6B60 Phase 3 [502]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [464]
Etretinate DM2CZFA Keratosis ED56 Approved [503]
Methotrexate DM2TEOL Anterior urethra cancer Approved [153]
Quercetin DM3NC4M Obesity 5B81 Approved [504]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [380]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [505]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [262]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [273]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [506]
Stavudine DM6DEK9 Human immunodeficiency virus infection 1C62 Approved [15]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [507]
2-deoxyglucose DMIAHVU Solid tumour/cancer 2A00-2F9Z Approved [508]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [509]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [510]
Ofloxacin DM0VQN3 Acute gonococcal cervicitis Approved [511]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [293]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [511]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [261]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [295]
Aluminium DM6ECN9 Hyperhidrosis EE00 Approved [512]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
2-deoxyglucose DMIAHVU Solid tumour/cancer 2A00-2F9Z Approved [513]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [287]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [514]
Citalopram DM2G9AE Acute coronary syndrome BA41 Approved [515]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [514]
Methotrexate DM2TEOL Anterior urethra cancer Approved [153]
Thioridazine DM35M8J Schizophrenia 6A20 Approved [514]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Fluoxetine DM3PD2C Bipolar depression Approved [514]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [516]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By C-C motif chemokine 2 (CCL2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Indinavir DM0T3YH Human immunodeficiency virus infection 1C62 Approved [20]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [454]
Gefitinib DM15F0X Colon adenocarcinoma Approved [517]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [394]
Imiquimod DM1TMA3 Alopecia areata ED70.2 Approved [518]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [519]
TECFIDERA DM2OVDT Multiple sclerosis 8A40 Approved [520]
Methotrexate DM2TEOL Anterior urethra cancer Approved [208]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [521]
Quercetin DM3NC4M Obesity 5B81 Approved [522]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [320]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [523]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [524]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [262]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [279]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [306]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [242]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [525]
Fructose DM43AN2 Vomiting MD90 Approved [230]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [526]
Testosterone DM7HUNW Hot flushes GA30 Approved [206]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [206]
Haloperidol DM96SE0 Delirium Approved [527]
Leflunomide DMR8ONJ Arthritis FA20 Approved [275]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [528]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [529]
Mirtazapine DML53ZJ Depression 6A70-6A7Z Approved [527]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [530]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [531]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [360]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [530]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Ursodeoxycholic acid DMCUT21 Cholelithiasis DC11 Approved [532]
Fenofibrate DMFKXDY Coronary atherosclerosis Approved [533]
Capsaicin DMGMF6V Back pain ME84.Z Approved [534]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [535]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By N-chimaerin (CHN1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [241]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [234]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [427]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [536]
Urethane DM7NSI0 N. A. N. A. Phase 4 [228]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [325]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [317]
COUMESTROL DM40TBU Discovery agent N.A. Investigative [299]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [351]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [320]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [238]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [300]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [242]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [325]
3R14S-OCHRATOXIN A DM2KEW6 Discovery agent N.A. Investigative [537]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [316]
AHPN DM8G6O4 Discovery agent N.A. Investigative [538]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [539]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [540]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Aclarubicin DMLFZHD Acute myeloid leukaemia 2A60 Approved [541]
Pomalidomide DMTGBAX Plasma cell myeloma 2A83.1 Approved [542]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [543]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [544]
phorbol 12-myristate 13-acetate DMJWD62 Acute myeloid leukaemia 2A60 Phase 2 [545]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [546]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [325]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Histone H2AX (H2AX)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [547]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [548]
Selenium DM25CGV N. A. N. A. Approved [320]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [549]
Etretinate DM2CZFA Keratosis ED56 Approved [550]
Methotrexate DM2TEOL Anterior urethra cancer Approved [551]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [552]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [553]
Lapatinib DM3BH1Y Breast cancer 2C60-2C65 Approved [554]
Quercetin DM3NC4M Obesity 5B81 Approved [555]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [556]
Selenium DM25CGV N. A. N. A. Approved [320]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [262]
Panobinostat DM58WKG Chronic graft versus host disease Approved [266]
Testosterone DM7HUNW Hot flushes GA30 Approved [231]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [306]
Testosterone enanthate DMB6871 N. A. N. A. Approved [297]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [320]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [557]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [306]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [238]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [300]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [507]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [558]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [272]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [295]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [279]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [162]
Paclitaxel DMLB81S Breast carcinoma Approved [559]
Arsenic DMTL2Y1 N. A. N. A. Approved [461]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [324]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cyclin-A2 (CCNA2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [560]
Mechlorethamine DM0CVXA Chronic myelogenous leukaemia 2A20.0 Approved [561]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [288]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [199]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [562]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [563]
Methotrexate DM2TEOL Anterior urethra cancer Approved [564]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [565]
Lapatinib DM3BH1Y Breast cancer 2C60-2C65 Approved [566]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [262]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [240]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Capsaicin DMGMF6V Back pain ME84.Z Approved [567]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [309]
Vinblastine DM5TVS3 Advanced cancer 2A00-2F9Z Approved [313]
Arsenic DMTL2Y1 N. A. N. A. Approved [568]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [313]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [569]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [523]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [570]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [279]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Fenofibrate DMFKXDY Coronary atherosclerosis Approved [571]
Menthol DMG2KW7 Back pain ME84.Z Approved [371]
Arsenic DMTL2Y1 N. A. N. A. Approved [461]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [276]
Selenium DM25CGV N. A. N. A. Approved [320]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [296]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Gentamicin DMKINJO Bacteremia 1A73 Approved [572]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [573]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Amphetamine DMSZQAK Attention deficit hyperactivity disorder 6A05.Z Approved [574]
Norepinephrine DMOUC09 Alopecia ED70 Approved [575]
Selenium DM25CGV N. A. N. A. Approved [320]
Dextroamphetamine DMMIHVP Attention deficit hyperactivity disorder 6A05.Z Approved [576]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Cocaine DMSOX7I Anaesthesia 9A78.6 Approved [574]
DTI-015 DMXZRW0 Brain cancer 2A00 Approved [310]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [490]
Nortriptyline DM4KDYJ Depression 6A70-6A7Z Approved [577]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [578]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [320]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [235]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [579]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [243]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [580]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [490]
Milchsaure DM462BT Pruritus EC90 Investigative [239]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [320]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [272]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [262]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [491]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [234]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [324]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [300]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Indomethacin DMSC4A7 Bursitis Approved [581]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [582]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [499]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [583]
Gefitinib DM15F0X Colon adenocarcinoma Approved [584]
Talazoparib DM1KS78 Breast cancer 2C60-2C65 Approved [220]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [585]
Selenium DM25CGV N. A. N. A. Approved [320]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [586]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [587]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [276]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [588]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [308]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [186]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [238]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [589]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [254]
Gefitinib DM15F0X Colon adenocarcinoma Approved [590]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [591]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [202]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [272]
Leflunomide DMR8ONJ Arthritis FA20 Approved [275]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [306]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Clozapine DMFC71L Schizophrenia 6A20 Approved [510]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [366]
Quercetin DM3NC4M Obesity 5B81 Approved [592]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [262]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [240]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [306]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Tramadol DMRQD04 Osteoarthritis FA00-FA05 Approved [593]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [324]
Resveratrol DM3RWXL Giant cell arteritis 4A44.2 Phase 3 [442]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [471]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [311]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [471]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [594]
Testosterone DM7HUNW Hot flushes GA30 Approved [348]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [595]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [162]
Fenofibrate DMFKXDY Coronary atherosclerosis Approved [311]
Hydrocortisone DMGEMB7 Acne vulgaris ED80 Approved [348]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Nitric oxide synthase 3 (NOS3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [596]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [597]
Bosentan DMIOGBU Pulmonary arterial hypertension BB01.0 Approved [166]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [598]
Methotrexate DM2TEOL Anterior urethra cancer Approved [153]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [599]
Quercetin DM3NC4M Obesity 5B81 Approved [600]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [601]
Fructose DM43AN2 Vomiting MD90 Approved [602]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [603]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [308]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [329]
Arsenic DMTL2Y1 N. A. N. A. Approved [604]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [324]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [238]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
DTI-015 DMXZRW0 Brain cancer 2A00 Approved [310]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [605]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [272]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Benzatropine DMF7EXL Parkinsonian disorder Approved [510]
Clozapine DMFC71L Schizophrenia 6A20 Approved [510]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Cocaine DMSOX7I Anaesthesia 9A78.6 Approved [322]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [309]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [293]
Selenium DM25CGV N. A. N. A. Approved [606]
Methotrexate DM2TEOL Anterior urethra cancer Approved [477]
Quercetin DM3NC4M Obesity 5B81 Approved [359]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [607]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [608]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [588]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [241]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
Ethanol DMDRQZU Chronic pain MG30 Approved [609]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [276]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [186]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [325]
COUMARIN DM0N8ZM Discovery agent N.A. Investigative [462]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [317]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [351]
Manganese DMKT129 N. A. N. A. Investigative [610]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [611]
Folic Acid DMEMBJC Colorectal carcinoma Approved [612]
Methotrexate DM2TEOL Anterior urethra cancer Approved [154]
Quercetin DM3NC4M Obesity 5B81 Approved [613]
Docetaxel DMDI269 Advanced cancer 2A00-2F9Z Approved [614]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [615]
Epirubicin DMPDW6T Solid tumour/cancer 2A00-2F9Z Approved [616]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [617]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [618]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [618]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [208]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [329]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [324]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Urethane DM7NSI0 N. A. N. A. Phase 4 [228]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [488]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [314]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [619]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [620]
Triacetin DM0AEPG Onychomycosis EE12.1 Approved [621]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [463]
Bepridil DM0RKS4 Chronic/stable angina BA40.1 Approved [622]
Indinavir DM0T3YH Human immunodeficiency virus infection 1C62 Approved [623]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [199]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [624]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [625]
Methotrexate DM2TEOL Anterior urethra cancer Approved [564]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [272]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [279]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [626]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [305]
DTI-015 DMXZRW0 Brain cancer 2A00 Approved [310]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [627]
Liothyronine DM6IR3P Congenital hypothyroidism Approved [628]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Stavudine DM6DEK9 Human immunodeficiency virus infection 1C62 Approved [15]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [485]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Efavirenz DMC0GSJ Human immunodeficiency virus infection 1C62 Approved [629]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [630]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [234]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [579]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [276]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [309]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [153]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [262]
Testosterone DM7HUNW Hot flushes GA30 Approved [206]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [206]
Morniflumate DM9UTDE Otitis media AA80-AB0Z Approved [631]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Folic Acid DMEMBJC Colorectal carcinoma Approved [233]
Capecitabine DMTS85L Adenocarcinoma 2D40 Approved [632]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [161]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Leptin (LEP)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Indinavir DM0T3YH Human immunodeficiency virus infection 1C62 Approved [20]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [394]
Ramipril DM2R68E Acute heart failure BD10-BD13 Approved [633]
Quercetin DM3NC4M Obesity 5B81 Approved [634]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [635]
Stavudine DM6DEK9 Human immunodeficiency virus infection 1C62 Approved [20]
Nevirapine DM6HX9B Human immunodeficiency virus infection 1C62 Approved [484]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [636]
Amlodipine DMBDAZV Angina pectoris BA40 Approved [637]
Efavirenz DMC0GSJ Human immunodeficiency virus infection 1C62 Approved [484]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Caspase-3 (CASP3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sevoflurane DMC9O43 Anaesthesia 9A78.6 Approved [638]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [639]
Lovastatin DM9OZWQ Arteriosclerosis BD40 Approved [640]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [210]
Docetaxel DMDI269 Advanced cancer 2A00-2F9Z Approved [641]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [642]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [643]
Mannitol DMSCDY9 Bronchiectasis CA24 Approved [644]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [645]
Aprepitant DM053KT Depression 6A70-6A7Z Approved [646]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [254]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [293]
Prednisone DM2HG4X Acute asthma CA23 Approved [222]
Thioridazine DM35M8J Schizophrenia 6A20 Approved [647]
Quercetin DM3NC4M Obesity 5B81 Approved [256]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [648]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [649]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [650]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [651]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [320]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [157]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [296]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [333]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [276]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [652]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [653]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [272]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [273]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [265]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [265]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [265]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
Motexafin gadolinium DMEJKRF Brain cancer 2A00 Approved [273]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [654]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [655]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [656]
Gefitinib DM15F0X Colon adenocarcinoma Approved [392]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [657]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [658]
Quercetin DM3NC4M Obesity 5B81 Approved [256]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [659]
Vinblastine DM5TVS3 Advanced cancer 2A00-2F9Z Approved [658]
Ethacrynic acid DM60QMR Edema MG29 Approved [660]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [661]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [317]
Gefitinib DM15F0X Colon adenocarcinoma Approved [662]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [663]
Epinephrine DM3KJBC Acute asthma CA23 Approved [664]
Quercetin DM3NC4M Obesity 5B81 Approved [665]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [380]
Fructose DM43AN2 Vomiting MD90 Approved [381]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [666]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [667]
Vinblastine DM5TVS3 Advanced cancer 2A00-2F9Z Approved [668]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [276]
Selenium DM25CGV N. A. N. A. Approved [320]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [157]
Panobinostat DM58WKG Chronic graft versus host disease Approved [266]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [295]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Ampicillin DMHWE7P Acute epiglottitis Approved [192]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [268]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [306]
Dihydroartemisinin DMBXVMZ Malaria 1F40-1F45 Approved [332]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [232]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [276]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Josamycin DMKJ8LB Bacterial infection 1A00-1C4Z Approved [368]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [325]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [263]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [483]
Leflunomide DMR8ONJ Arthritis FA20 Approved [275]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Sodium chloride DMM3950 Skin burns ME65.0 Approved [669]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [579]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [161]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [162]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [670]
GSK683699 DMTW79H Inflammatory bowel disease DD72 Phase 2 [671]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [325]
Milchsaure DM462BT Pruritus EC90 Investigative [239]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [262]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [303]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [308]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Cocaine DMSOX7I Anaesthesia 9A78.6 Approved [492]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [243]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
THAPSIGARGIN DMDMQIE N. A. N. A. Preclinical [315]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Fatty acid synthase (FASN)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Lindane DMB8CNL Infestations of lice and scabies 1G00.Z Approved [672]
Selenium DM25CGV N. A. N. A. Approved [320]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [436]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [623]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [673]
Quercetin DM3NC4M Obesity 5B81 Approved [674]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [201]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [675]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [594]
Crizotinib DM4F29C Non-small-cell lung cancer 2C25.Y Approved [676]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [320]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [234]
Paclitaxel DMLB81S Breast carcinoma Approved [677]
Arsenic DMTL2Y1 N. A. N. A. Approved [323]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [238]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [299]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Sulfate transporter (SLC26A2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [464]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [277]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [263]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [306]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [351]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [579]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [276]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [678]
Testosterone DM7HUNW Hot flushes GA30 Approved [206]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [206]
Leflunomide DMR8ONJ Arthritis FA20 Approved [275]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [268]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [329]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [186]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [453]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [510]
Selenium DM25CGV N. A. N. A. Approved [320]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [201]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [360]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [234]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [235]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [556]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [181]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [296]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [306]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Ethanol DMDRQZU Chronic pain MG30 Approved [679]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [268]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [235]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [680]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [276]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [594]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [594]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [273]
Panobinostat DM58WKG Chronic graft versus host disease Approved [266]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [271]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [681]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [306]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Arsenic DMTL2Y1 N. A. N. A. Approved [461]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [166]
Urethane DM7NSI0 N. A. N. A. Phase 4 [228]
Sulforaphane DMQY3L0 Skin disease EA00-EM0Z Investigative [682]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [293]
Selenium DM25CGV N. A. N. A. Approved [320]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [295]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [232]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Indomethacin DMSC4A7 Bursitis Approved [298]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [309]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [162]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [329]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [238]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
THAPSIGARGIN DMDMQIE N. A. N. A. Preclinical [315]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [235]
Milchsaure DM462BT Pruritus EC90 Investigative [239]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [272]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [268]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [579]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [488]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [325]
Nitrobenzanthrone DMN6L70 N. A. N. A. Investigative [683]
3-iodothyronamine DM3L0F8 Discovery agent N.A. Investigative [684]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [272]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [579]
Delphinidin DMS2WIN Cardiovascular disease BA00-BE2Z Phase 2 [685]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [325]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [314]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [351]
Sulforaphane DMQY3L0 Skin disease EA00-EM0Z Investigative [682]
⏷ Show the Full List of 9 Drug(s)
Drug(s) Affected By Hemoglobin subunit beta (HBB)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [686]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [295]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [687]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Voxelotor DMCS6M5 Sickle-cell disorder 3A51 Approved [688]
Ibrutinib DMHZCPO Mantle cell lymphoma 2A85.5 Approved [689]
Flucloxacillin DMNUWST Bacterial infection 1A00-1C4Z Approved [690]
Capecitabine DMTS85L Adenocarcinoma 2D40 Approved [632]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [691]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [692]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein BTG2 (BTG2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [199]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [224]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [277]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [693]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [694]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [295]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [361]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [369]
Testosterone DM7HUNW Hot flushes GA30 Approved [206]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [579]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [695]
QUERCITRIN DM1DH96 Discovery agent N.A. Investigative [398]
⏷ Show the Full List of 7 Drug(s)
Drug(s) Affected By Vigilin (HDLBP)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [320]
Quercetin DM3NC4M Obesity 5B81 Approved [462]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [157]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [266]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [166]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [410]
Flucytosine DM13VTW Cryptococcal meningitis Approved [216]
Ganciclovir DM1MBYQ Cytomegalovirus infection 1D82 Approved [216]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [696]
Methotrexate DM2TEOL Anterior urethra cancer Approved [477]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [697]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [273]
Amifostine DM5FL14 Mucositis CA00 Approved [698]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [295]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [699]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [591]
Selenium DM25CGV N. A. N. A. Approved [320]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [360]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [262]
Panobinostat DM58WKG Chronic graft versus host disease Approved [266]
Isoniazid DM5JVS3 Latent tuberculosis infection Approved [700]
Estrone DM5T6US Acne vulgaris ED80 Approved [699]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [265]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [272]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [262]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Bortezomib DMNO38U Leukemia Approved [349]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [309]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Ethanol DMDRQZU Chronic pain MG30 Approved [166]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Epinephrine DM3KJBC Acute asthma CA23 Approved [701]
Adenosine triphosphate DM79F6G Malnutrition 5B50-5B71 Approved [701]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [232]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [702]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [235]
Vitamin B3 DMQVRZH Chronic renal failure GB61.Z Approved [703]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [579]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
CS-038 DM67P0F Type-2 diabetes 5A11 Phase 3 [702]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [314]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Phosphate DMUXQG7 Constipation DD91.1 Approved [704]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [272]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [263]
Testosterone DM7HUNW Hot flushes GA30 Approved [231]
Leflunomide DMR8ONJ Arthritis FA20 Approved [275]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [276]
Arsenic DMTL2Y1 N. A. N. A. Approved [461]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [705]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [293]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [623]
Quercetin DM3NC4M Obesity 5B81 Approved [507]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [201]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [261]
Crizotinib DM4F29C Non-small-cell lung cancer 2C25.Y Approved [676]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [262]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [706]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [707]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Caspase-8 (CASP8)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Lovastatin DM9OZWQ Arteriosclerosis BD40 Approved [708]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [709]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [710]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [410]
Gefitinib DM15F0X Colon adenocarcinoma Approved [662]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [711]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [712]
Selenium DM25CGV N. A. N. A. Approved [320]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [713]
Methotrexate DM2TEOL Anterior urethra cancer Approved [208]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [287]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [272]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [262]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [273]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [714]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [715]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [306]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Motexafin gadolinium DMEJKRF Brain cancer 2A00 Approved [273]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Adiponectin (ADIPOQ)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Indinavir DM0T3YH Human immunodeficiency virus infection 1C62 Approved [20]
Ritonavir DMU764S Human immunodeficiency virus infection 1C62 Approved [20]
Ramipril DM2R68E Acute heart failure BD10-BD13 Approved [716]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [717]
Cilazapril DM4V6JA Congestive heart failure BD10 Approved [718]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [719]
Stavudine DM6DEK9 Human immunodeficiency virus infection 1C62 Approved [20]
Nevirapine DM6HX9B Human immunodeficiency virus infection 1C62 Approved [484]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [720]
Testosterone DM7HUNW Hot flushes GA30 Approved [721]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [276]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [277]
Leflunomide DMR8ONJ Arthritis FA20 Approved [275]
Aclarubicin DMLFZHD Acute myeloid leukaemia 2A60 Approved [541]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [384]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [384]
Pomalidomide DMTGBAX Plasma cell myeloma 2A83.1 Approved [542]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [722]
Urethane DM7NSI0 N. A. N. A. Phase 4 [228]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [723]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [240]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [306]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [309]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [724]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [305]
Fenretinide DMRD5SP Macular degeneration 9B78.3 Phase 3 [244]
ME-344 DM6JN19 Breast cancer 2C60-2C65 Phase 1/2 [725]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Paclitaxel DMLB81S Breast carcinoma Approved [283]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [263]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [306]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [242]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [726]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [314]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [727]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [306]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [728]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [619]
methyl p-hydroxybenzoate DMO58UW Discovery agent N.A. Investigative [444]
⏷ Show the Full List of 6 Drug(s)
Drug(s) Affected By Heme A synthase COX15 (COX15)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [240]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Paclitaxel DMLB81S Breast carcinoma Approved [677]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [186]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [304]
Warfarin DMJYCVW Atrial fibrillation BC81.3 Approved [729]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [325]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [490]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [730]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [325]
Milchsaure DM462BT Pruritus EC90 Investigative [239]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [477]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [731]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [279]
Testosterone DM7HUNW Hot flushes GA30 Approved [231]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [265]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [265]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [333]
Ifosfamide DMCT3I8 Adult central nervous system germ cell tumor Approved [265]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [306]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
Cholecalciferol DMGU74E Adult acute monocytic leukemia Approved [732]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [382]
Bortezomib DMNO38U Leukemia Approved [349]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Arsenic DMTL2Y1 N. A. N. A. Approved [461]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [299]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [325]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [192]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [201]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [733]
Testosterone DM7HUNW Hot flushes GA30 Approved [231]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [306]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [384]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [186]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [490]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Salicyclic acid DM2F8XZ Acne vulgaris ED80 Approved [152]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [152]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [263]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [152]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [152]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [311]
Mefenamic acid DMK7HFI Dysmenorrhea GA34.3 Approved [152]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [276]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [261]
Panobinostat DM58WKG Chronic graft versus host disease Approved [266]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [241]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [579]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [353]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [490]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [272]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [734]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
Ampicillin DMHWE7P Acute epiglottitis Approved [192]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [234]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [235]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [352]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [347]
Testosterone DM7HUNW Hot flushes GA30 Approved [231]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Testosterone enanthate DMB6871 N. A. N. A. Approved [297]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [234]
Bortezomib DMNO38U Leukemia Approved [349]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [579]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [320]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [261]
Testosterone DM7HUNW Hot flushes GA30 Approved [231]
Testosterone enanthate DMB6871 N. A. N. A. Approved [297]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Paclitaxel DMLB81S Breast carcinoma Approved [283]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [579]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [427]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [325]
Drug(s) Affected By Zinc transporter 7 (SLC30A7)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [269]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [579]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [186]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [304]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [735]
3R14S-OCHRATOXIN A DM2KEW6 Discovery agent N.A. Investigative [736]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [287]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [272]
Testosterone DM7HUNW Hot flushes GA30 Approved [231]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [206]
Leflunomide DMR8ONJ Arthritis FA20 Approved [275]
Testosterone enanthate DMB6871 N. A. N. A. Approved [297]
Cholecalciferol DMGU74E Adult acute monocytic leukemia Approved [732]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [579]
Vandetanib DMRICNP Solid tumour/cancer 2A00-2F9Z Approved [737]
Gemcitabine DMSE3I7 Anterior urethra cancer Approved [738]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [276]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [242]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [653]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [739]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [740]
Urethane DM7NSI0 N. A. N. A. Phase 4 [228]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [325]
Milchsaure DM462BT Pruritus EC90 Investigative [239]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Arsenic DMTL2Y1 N. A. N. A. Approved [461]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [304]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [741]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [726]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [325]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [314]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Phosphate DMUXQG7 Constipation DD91.1 Approved [704]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [276]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [678]
Leflunomide DMR8ONJ Arthritis FA20 Approved [275]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [742]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [654]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [234]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [743]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [272]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [235]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [324]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [266]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [744]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [325]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [327]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [745]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [192]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [746]
Succinic acid DMDWICP Malnutrition 5B50-5B71 Approved [747]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [384]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [384]
Arsenic DMTL2Y1 N. A. N. A. Approved [748]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [242]
GSK2110183 DMZHB37 leukaemia 2A60-2B33 Phase 2 [749]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dinoprostone DMTYOPD Medical abortion JA00.1Z Approved [750]
Methotrexate DM2TEOL Anterior urethra cancer Approved [208]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [157]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [742]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [311]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [268]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [751]
Arsenic DMTL2Y1 N. A. N. A. Approved [752]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [753]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [300]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Gefitinib DM15F0X Colon adenocarcinoma Approved [429]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [429]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [272]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [754]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [429]
Bupropion DM5PCS7 Depression 6A70-6A7Z Approved [429]
Repaglinide DM5SXUV Diabetic complication 5A2Y Approved [429]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [240]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Testosterone enanthate DMB6871 N. A. N. A. Approved [297]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Folic Acid DMEMBJC Colorectal carcinoma Approved [233]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [186]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [161]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [755]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [490]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [735]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [272]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [234]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [329]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [186]
Urethane DM7NSI0 N. A. N. A. Phase 4 [228]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [325]
methyl p-hydroxybenzoate DMO58UW Discovery agent N.A. Investigative [444]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [261]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [306]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [268]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [756]
Malathion DMXZ84M Pediculus capitis infestation 1G00.0 Approved [757]
Mitoxantrone DMM39BF Acute myelogenous leukaemia 2A41 Approved [313]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [276]
Selenium DM25CGV N. A. N. A. Approved [320]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [350]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [262]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [758]
Testosterone DM7HUNW Hot flushes GA30 Approved [206]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [206]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [192]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [272]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [279]
Testosterone DM7HUNW Hot flushes GA30 Approved [231]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [329]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [759]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [314]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [317]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [263]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [680]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [760]
Methotrexate DM2TEOL Anterior urethra cancer Approved [761]
Pemetrexed DMMX2E6 Central nervous system lymphoma 2B33.5 Approved [761]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [760]
Urethane DM7NSI0 N. A. N. A. Phase 4 [228]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [487]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [271]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Fluoxetine DM3PD2C Bipolar depression Approved [762]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [273]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [263]
Leflunomide DMR8ONJ Arthritis FA20 Approved [275]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [306]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Motexafin gadolinium DMEJKRF Brain cancer 2A00 Approved [273]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [379]
Selenium DM25CGV N. A. N. A. Approved [320]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [234]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [579]
Arsenic DMTL2Y1 N. A. N. A. Approved [461]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [320]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [311]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Propofol DMB4OLE Anaesthesia 9A78.6 Approved [763]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [311]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [161]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Folic Acid DMEMBJC Colorectal carcinoma Approved [233]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [234]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [579]
Arsenic DMTL2Y1 N. A. N. A. Approved [461]
DTI-015 DMXZRW0 Brain cancer 2A00 Approved [310]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [764]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [325]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [314]
acetaldehyde DMJFKG4 Discovery agent N.A. Investigative [765]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [293]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [295]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [341]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [766]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [234]
Indomethacin DMSC4A7 Bursitis Approved [767]
Arsenic DMTL2Y1 N. A. N. A. Approved [461]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [353]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [768]
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [769]
Adenosine DMM2NSK Paroxysmal supraventricular tachycardia BC81.Z Approved [770]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [261]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [263]
Testosterone DM7HUNW Hot flushes GA30 Approved [206]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [206]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [192]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [266]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [746]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [615]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [353]
Urethane DM7NSI0 N. A. N. A. Phase 4 [228]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [304]
PDX-101 DM6OC53 Plasma cell myeloma 2A83.1 Phase 2 [304]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [161]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [314]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [771]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [742]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [276]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [325]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [314]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Leflunomide DMR8ONJ Arthritis FA20 Approved [275]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [265]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [265]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [265]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [265]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [265]
Fructose DM43AN2 Vomiting MD90 Approved [772]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [325]
D-glucose DMMG2TO Discovery agent N.A. Investigative [772]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [261]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [579]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [353]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [773]
Stavudine DM6DEK9 Human immunodeficiency virus infection 1C62 Approved [773]
Zalcitabine DMH7MUV Human immunodeficiency virus infection 1C62 Approved [773]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [276]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Panobinostat DM58WKG Chronic graft versus host disease Approved [266]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
Ethanol DMDRQZU Chronic pain MG30 Approved [774]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [579]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [276]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [304]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Levacecarnine hci DMJBOCR Cognitive impairment 6D71 Approved [775]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [202]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [350]
Leflunomide DMR8ONJ Arthritis FA20 Approved [275]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [268]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [743]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [337]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [427]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [268]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [309]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [325]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [314]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [351]
OXYQUINOLINE DMZVS9Y Discovery agent N.A. Investigative [192]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [353]
Urethane DM7NSI0 N. A. N. A. Phase 4 [228]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [325]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [483]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [268]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [490]
Daunorubicin DMQUSBT Acute monocytic leukemia Approved [776]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [776]
ANW-32821 DMMJOZD N. A. N. A. Phase 2 [777]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [730]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [778]
Milchsaure DM462BT Pruritus EC90 Investigative [239]
Sulforaphane DMQY3L0 Skin disease EA00-EM0Z Investigative [682]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [157]
Panobinostat DM58WKG Chronic graft versus host disease Approved [266]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [483]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
Folic Acid DMEMBJC Colorectal carcinoma Approved [779]
Gallium nitrate DMF9O6B Hypercalcaemia 5B91.0 Approved [780]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [268]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [654]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [265]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [265]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Ifosfamide DMCT3I8 Adult central nervous system germ cell tumor Approved [265]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [579]
Arsenic DMTL2Y1 N. A. N. A. Approved [461]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [653]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Urethane DM7NSI0 N. A. N. A. Phase 4 [228]
Resveratrol DM3RWXL Giant cell arteritis 4A44.2 Phase 3 [781]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Panobinostat DM58WKG Chronic graft versus host disease Approved [266]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [333]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [384]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [384]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [490]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [266]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [325]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [351]
acetaldehyde DMJFKG4 Discovery agent N.A. Investigative [765]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [782]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [783]
Stavudine DM6DEK9 Human immunodeficiency virus infection 1C62 Approved [15]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Hesperetin DMKER83 High blood cholesterol level 5C80.00 Approved [784]
Chloroquine DMSI5CB Malaria 1F40-1F45 Approved [783]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [785]
Urethane DM7NSI0 N. A. N. A. Phase 4 [228]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [320]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [272]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Testosterone enanthate DMB6871 N. A. N. A. Approved [297]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [579]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [186]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [242]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [276]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [273]
Testosterone DM7HUNW Hot flushes GA30 Approved [786]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [715]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [333]
Motexafin gadolinium DMEJKRF Brain cancer 2A00 Approved [273]
Arsenic DMTL2Y1 N. A. N. A. Approved [461]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [161]
PMID28870136-Compound-48 DMPIM9L N. A. N. A. Patented [556]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [320]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [325]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [619]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [317]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [276]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Testosterone DM7HUNW Hot flushes GA30 Approved [231]
Leflunomide DMR8ONJ Arthritis FA20 Approved [275]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [306]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [234]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [329]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [201]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [202]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [261]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [234]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [579]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [309]
Urethane DM7NSI0 N. A. N. A. Phase 4 [228]
GSK2110183 DMZHB37 leukaemia 2A60-2B33 Phase 2 [749]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [276]
Methotrexate DM2TEOL Anterior urethra cancer Approved [153]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [272]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [766]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [242]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Arsenic DMTL2Y1 N. A. N. A. Approved [461]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [353]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [787]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [325]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [263]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [279]
Leflunomide DMR8ONJ Arthritis FA20 Approved [275]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [306]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Ursodeoxycholic acid DMCUT21 Cholelithiasis DC11 Approved [788]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [349]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [743]
Arsenic DMTL2Y1 N. A. N. A. Approved [461]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [186]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [754]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [306]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [234]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [235]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [754]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [329]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Urethane DM7NSI0 N. A. N. A. Phase 4 [228]
Epigallocatechin gallate DMCGWBJ Hepatic fibrosis DB93.0 Phase 3 [789]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [686]
Selenium DM25CGV N. A. N. A. Approved [320]
Methotrexate DM2TEOL Anterior urethra cancer Approved [471]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [272]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [295]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [296]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
Ethanol DMDRQZU Chronic pain MG30 Approved [774]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [471]
Prednisolone DMQ8FR2 Acute adrenal insufficiency Approved [471]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [276]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [272]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [273]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [347]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [715]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Motexafin gadolinium DMEJKRF Brain cancer 2A00 Approved [273]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [276]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [272]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [341]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Folic Acid DMEMBJC Colorectal carcinoma Approved [779]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Arsenic DMTL2Y1 N. A. N. A. Approved [790]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [186]
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [536]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [261]
Leflunomide DMR8ONJ Arthritis FA20 Approved [275]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [791]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [299]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
Resveratrol DM3RWXL Giant cell arteritis 4A44.2 Phase 3 [781]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [792]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [695]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [408]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [271]
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [793]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [262]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [273]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [734]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [279]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [296]
Leflunomide DMR8ONJ Arthritis FA20 Approved [275]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [192]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [272]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [240]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Folic Acid DMEMBJC Colorectal carcinoma Approved [233]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [309]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [266]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [488]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Interleukin-3 (IL3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [208]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [794]
Ethanol DMDRQZU Chronic pain MG30 Approved [794]
Menthol DMG2KW7 Back pain ME84.Z Approved [795]
Betamethasone Valerate DMMIAXO Dermatological disease DA24.Y Approved [796]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [797]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [427]
Tacrolimus DMZ7XNQ Graft-versus-host disease 4B24 Approved [796]
Famotidine DMRL3AB Gastric ulcer DA60 Approved [166]
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [166]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Ursodeoxycholic acid DMCUT21 Cholelithiasis DC11 Approved [798]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Dopamine DMPGUCF Acromegaly 5A60.0 Approved [328]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [276]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [309]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [188]
DNCB DMDTVYC Immune System disease 4A01-4B41 Phase 2 [799]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [186]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [300]
Zalcitabine DMH7MUV Human immunodeficiency virus infection 1C62 Approved [166]
Didanosine DMI2QPE Human immunodeficiency virus infection 1C62 Approved [166]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [300]
INX-189 DMSTJ6Q Hepatitis C virus infection 1E51.1 Phase 2 [452]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [325]
QUERCITRIN DM1DH96 Discovery agent N.A. Investigative [398]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [208]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [360]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [271]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [341]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Zalcitabine DMH7MUV Human immunodeficiency virus infection 1C62 Approved [166]
Didanosine DMI2QPE Human immunodeficiency virus infection 1C62 Approved [166]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [325]
PMID28870136-Compound-48 DMPIM9L N. A. N. A. Patented [800]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By p21 protein (HRAS)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Digoxin DMQCTIH Arrhythmia BC9Z Approved [166]
Indomethacin DMSC4A7 Bursitis Approved [166]
NVP-LAQ824 DM8JWNA Mood disorder 6A60-6E23 Phase 3 [166]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Zalcitabine DMH7MUV Human immunodeficiency virus infection 1C62 Approved [801]
Nefazodone DM4ZS8M Major depressive disorder 6A70.3 Approved [451]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [802]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [279]
Tofacitinib DMBS370 Rheumatoid arthritis FA20 Approved [803]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [370]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Chloramphenicol DMFXEWT Bacterial infection 1A00-1C4Z Approved [804]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [805]
Nicotinamide DMUPE07 Acne vulgaris ED80 Approved [802]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Thymidylate kinase (DTYMK)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [202]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [272]
Testosterone DM7HUNW Hot flushes GA30 Approved [206]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [206]
Leflunomide DMR8ONJ Arthritis FA20 Approved [275]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [266]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [185]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [806]
Isoniazid DM5JVS3 Latent tuberculosis infection Approved [807]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [808]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [241]
Lindane DMB8CNL Infestations of lice and scabies 1G00.Z Approved [809]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [162]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Arsenic DMTL2Y1 N. A. N. A. Approved [449]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [237]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [810]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [811]
SPI-1005 DM6XFHS Reperfusion injury ND56.Z Approved [812]
Methotrexate DM2TEOL Anterior urethra cancer Approved [153]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [295]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [182]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [813]
Mitotane DMU1GX0 Adrenocortical carcinoma 2D11.Z Approved [814]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [815]
Zalcitabine DMH7MUV Human immunodeficiency virus infection 1C62 Approved [166]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [510]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [758]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [279]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [163]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [349]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [234]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [184]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [329]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Uridine DMQTREB Depression 6A70-6A7Z Approved [816]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [161]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [227]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [311]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [186]
Adenosine DMM2NSK Paroxysmal supraventricular tachycardia BC81.Z Approved [817]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [818]
Azacitidine DMTA5OE Acute myelogenous leukaemia 2A41 Approved [818]
DEOXYCYTIDINE DMYE5LJ Acute myeloid leukaemia 2A60 Approved [816]
Urethane DM7NSI0 N. A. N. A. Phase 4 [228]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Fms-like tyrosine kinase 3 (FLT-3) TTGJCWZ FLT3_HUMAN Binder [4]
Human immunodeficiency virus Reverse transcriptase (HIV RT) TT84ETX POL_HV1B1 Inhibitor [5]

Drug Transporter (DTP)
DTP Name DTP ID UniProt ID MOA REF
Organic anion transporter 2 (SLC22A7) DT0OC1Q S22A7_HUMAN Substrate [6]
Organic anion transporter 4 (SLC22A11) DT06JWZ S22AB_HUMAN Substrate [6]
Multidrug resistance-associated protein 4 (ABCC4) DTCSGPB MRP4_HUMAN Substrate [7]
Organic cation transporter 1 (SLC22A1) DTT79CX S22A1_HUMAN Substrate [7]
Breast cancer resistance protein (ABCG2) DTI7UX6 ABCG2_HUMAN Substrate [8]
Organic anion transporter 1 (SLC22A6) DTQ23VB S22A6_HUMAN Substrate [6]
Organic anion transporter 3 (SLC22A8) DTVP67E S22A8_HUMAN Substrate [6]
P-glycoprotein 1 (ABCB1) DTUGYRD MDR1_HUMAN Substrate [9]

Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID MOA REF
Cytochrome P450 3A4 (CYP3A4) DE4LYSA CP3A4_HUMAN Substrate [10]
Cytochrome P450 2C9 (CYP2C9) DE5IED8 CP2C9_HUMAN Substrate [11]
UDP-glucuronosyltransferase 1A1 (UGT1A1) DEYGVN4 UD11_HUMAN Substrate [12]
Mephenytoin 4-hydroxylase (CYP2C19) DEGTFWK CP2CJ_HUMAN Substrate [11]
Cytochrome P450 2A6 (CYP2A6) DEJVYAZ CP2A6_HUMAN Substrate [11]
Cytochrome P450 2C8 (CYP2C8) DES5XRU CP2C8_HUMAN Substrate [11]
UDP-glucuronosyltransferase 2B7 (UGT2B7) Main DME DEB3CV1 UD2B7_HUMAN Substrate [13]

Drug Off-Target (DOT)
DOT Name DOT ID UniProt ID Interaction REF
11-beta-hydroxysteroid dehydrogenase 1 (HSD11B1) OTO7FJA9 DHI1_HUMAN Gene/Protein Processing [14]
60 kDa heat shock protein, mitochondrial (HSPD1) OTTO1Y11 CH60_HUMAN Gene/Protein Processing [15]
ABC-type oligopeptide transporter ABCB9 (ABCB9) OTSOBOL5 ABCB9_HUMAN Gene/Protein Processing [16]
Acetyl-CoA carboxylase 1 (ACACA) OT5CQPZY ACACA_HUMAN Gene/Protein Processing [14]
Acetyl-CoA carboxylase 2 (ACACB) OT96UIP1 ACACB_HUMAN Gene/Protein Processing [14]
Acyl carrier protein, mitochondrial (NDUFAB1) OTF906UR ACPM_HUMAN Gene/Protein Processing [17]
Adenine phosphoribosyltransferase (APRT) OT5ZUKVF APT_HUMAN Gene/Protein Processing [18]
Adenosine 3'-phospho 5'-phosphosulfate transporter 2 (SLC35B3) OTBDPI8I S35B3_HUMAN Gene/Protein Processing [16]
Adenosine deaminase (ADA) OTOX2872 ADA_HUMAN Gene/Protein Processing [19]
Adiponectin (ADIPOQ) OTNX23LE ADIPO_HUMAN Gene/Protein Processing [20]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4825).
2 Zidovudine FDA Label
3 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
4 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1807).
5 Antiviral drugs in current clinical use. J Clin Virol. 2004 Jun;30(2):115-33.
6 Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. J Pharmacol Exp Ther. 2002 Mar;300(3):918-24.
7 Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm Res. 2013 Apr;30(4):996-1007.
8 Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 2016 Jan 1;370(1):153-64.
9 The transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further research. Antiviral Res. 2009 May;82(2):A99-109.
10 The metabolism of zidovudine by human liver microsomes in vitro: formation of 3'-amino-3'-deoxythymidine. Biochem Pharmacol. 1994 Jul 19;48(2):267-76.
11 Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev. 2002 Feb-May;34(1-2):83-448.
12 Interindividual variability in pharmacokinetics of generic nucleoside reverse transcriptase inhibitors in TB/HIV-coinfected Ghanaian patients: UGT2B7*1c is associated with faster zidovudine clearance and glucuronidation. J Clin Pharmacol. 2009 Sep;49(9):1079-90.
13 Determination of UDP-glucuronosyltransferase UGT2B7 activity in human liver microsomes by ultra-performance liquid chromatography with MS detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Jul 1;870(1):84-90.
14 Adipocyte differentiation, mitochondrial gene expression and fat distribution: differences between zidovudine and tenofovir after 6 months. Antivir Ther. 2009;14(8):1089-100. doi: 10.3851/IMP1457.
15 Lon protease and eiF2 are involved in acute, but not prolonged, antiretroviral induced stress response in HepG2 cells. Chem Biol Interact. 2016 May 25;252:82-6. doi: 10.1016/j.cbi.2016.03.021. Epub 2016 Apr 1.
16 Differential gene expression in human hepatocyte cell lines exposed to the antiretroviral agent zidovudine. Arch Toxicol. 2014 Mar;88(3):609-23. doi: 10.1007/s00204-013-1169-3. Epub 2013 Nov 30.
17 Morphological and molecular course of mitochondrial pathology in cultured human cells exposed long-term to Zidovudine. Environ Mol Mutagen. 2007 Apr-May;48(3-4):179-89. doi: 10.1002/em.20245.
18 Mutagenicity and loss of heterozygosity at the APRT locus in human lymphoblastoid cells exposed to 3'-azido-3'-deoxythymidine. Mutagenesis. 2000 Sep;15(5):405-10. doi: 10.1093/mutage/15.5.405.
19 Enhancement of erythrocytic adenosine deaminase following treatment of AIDS-related complex/AIDS patients with zidovudine. AIDS. 1990 Aug;4(8):799-802. doi: 10.1097/00002030-199008000-00012.
20 Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages. Antivir Ther. 2007;12(4):489-500.
21 HIV-1 reverse transcriptase complex with DNA and nevirapine reveals non-nucleoside inhibition mechanism.Nat Struct Mol Biol.2012 Jan 22;19(2):253-9.
22 A peptide inhibitor of HIV-1 reverse transcriptase using alpha,beta-dehydro residues: a structure-based computer model. J Biomol Struct Dyn. 1998 Oct;16(2):347-54.
23 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
24 Quadruple nucleos(t)ide reverse transcriptase inhibitors-only regimen of tenofovir plus zidovudine/lamivudine/abacavir in heavily pre-treated HIV-1 infected patients: salvage therapy or backbone only Curr HIV Res. 2009 May;7(3):320-6.
25 Emerging antiviral drugs. Expert Opin Emerg Drugs. 2008 Sep;13(3):393-416.
26 2008 FDA drug approvals. Nat Rev Drug Discov. 2009 Feb;8(2):93-6.
27 2018 FDA drug approvals.Nat Rev Drug Discov. 2019 Feb;18(2):85-89.
28 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
29 2014 FDA drug approvals. Nat Rev Drug Discov. 2015 Feb;14(2):77-81.
30 A comparison of physicochemical property profiles of marketed oral drugs and orally bioavailable anti-cancer protein kinase inhibitors in clinical development. Curr Top Med Chem. 2007;7(14):1408-22.
31 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2019
32 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
33 Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with ... Blood. 2008 Jun 15;111(12):5663-71.
34 Metabolism and bioactivation of famitinib, a novel inhibitor of receptor tyrosine kinase, in cancer patients. Br J Pharmacol. 2013 Apr;168(7):1687-706.
35 Preclinical pharmacokinetics and in vitro metabolism of BMS-690514, a potent inhibitor of EGFR and VEGFR2. J Pharm Sci. 2010 Aug;99(8):3579-93.
36 MDR1 (ABCB1) G1199A (Ser400Asn) polymorphism alters transepithelial permeability and sensitivity to anticancer agents. Cancer Chemother Pharmacol. 2009 Jun;64(1):183-8.
37 Folate transporter expression decreases in the human placenta throughout pregnancy and in pre-eclampsia. Pregnancy Hypertens. 2012 Apr;2(2):123-31.
38 Comparative studies on in vitro methods for evaluating in vivo function of MDR1 P-glycoprotein. Pharm Res. 2001 Dec;18(12):1660-8.
39 Antiestrogens and steroid hormones: substrates of the human P-glycoprotein. Biochem Pharmacol. 1994 Jul 19;48(2):287-92.
40 Association of genetic polymorphisms in the influx transporter SLCO1B3 and the efflux transporter ABCB1 with imatinib pharmacokinetics in patients with chronic myeloid leukemia. Ther Drug Monit. 2011 Apr;33(2):244-50.
41 Doxorubicin transport by RALBP1 and ABCG2 in lung and breast cancer. Int J Oncol. 2007 Mar;30(3):717-25.
42 Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter. Cancer Res. 2003 Sep 1;63(17):5538-43.
43 The effect of low pH on breast cancer resistance protein (ABCG2)-mediated transport of methotrexate, 7-hydroxymethotrexate, methotrexate diglutamate, folic acid, mitoxantrone, topotecan, and resveratrol in in vitro drug transport models. Mol Pharmacol. 2007 Jan;71(1):240-9.
44 Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer. Cancer Chemother Pharmacol. 2009 May;63(6):1103-10.
45 Inhibiting the function of ABCB1 and ABCG2 by the EGFR tyrosine kinase inhibitor AG1478. Biochem Pharmacol. 2009 Mar 1;77(5):781-93.
46 Sterol transport by the human breast cancer resistance protein (ABCG2) expressed in Lactococcus lactis. J Biol Chem. 2003 Jun 6;278(23):20645-51.
47 The phytoestrogen genistein enhances multidrug resistance in breast cancer cell lines by translational regulation of ABC transporters. Cancer Lett. 2016 Jun 28;376(1):165-72.
48 Curcumin inhibits the activity of ABCG2/BCRP1, a multidrug resistance-linked ABC drug transporter in mice. Pharm Res. 2009 Feb;26(2):480-7.
49 Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump. Blood. 2004 Nov 1;104(9):2940-2.
50 Transport of organic anions across the basolateral membrane of proximal tubule cells. Rev Physiol Biochem Pharmacol. 2003;146:95-158.
51 Transport mechanism and substrate specificity of human organic anion transporter 2 (hOat2 [SLC22A7]). J Pharm Pharmacol. 2005 May;57(5):573-8.
52 Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins. J Pharmacol Exp Ther. 2002 Apr;301(1):293-8.
53 Possible involvement of organic anion transporter 2 on the interaction of theophylline with erythromycin in the human liver. Drug Metab Dispos. 2005 May;33(5):619-22.
54 Identification of multispecific organic anion transporter 2 expressed predominantly in the liver. FEBS Lett. 1998 Jun 12;429(2):179-82.
55 Organic anion transporter 2 (SLC22A7) is a facilitative transporter of cGMP. Mol Pharmacol. 2008 Apr;73(4):1151-8.
56 A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters. J Pharmacol Exp Ther. 2005 Oct;315(1):337-45.
57 Human organic anion transporter 2 is an entecavir, but not tenofovir, transporter. Drug Metab Pharmacokinet. 2017 Feb;32(1):116-119.
58 Human organic anion transporters mediate the transport of tetracycline. Jpn J Pharmacol. 2002 Jan;88(1):69-76.
59 Are organic cation transporters capable of transporting prostaglandins? Naunyn Schmiedebergs Arch Pharmacol. 2005 Aug;372(2):125-30.
60 Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family). J Pharmacol Exp Ther. 2006 Nov;319(2):879-86.
61 Pharmacologic markers and predictors of responses to imatinib therapy in patients with chronic myeloid leukemia. Leuk Lymphoma. 2008 Apr;49(4):639-42.
62 Organic cation transporters are determinants of oxaliplatin cytotoxicity. Cancer Res. 2006 Sep 1;66(17):8847-57.
63 Implications of genetic polymorphisms in drug transporters for pharmacotherapy. Cancer Lett. 2006 Mar 8;234(1):4-33.
64 Upregulation of histone acetylation reverses organic anion transporter 2 repression and enhances 5-fluorouracil sensitivity in hepatocellular carcinoma
65 Comparison of type I and type II organic cation transport by organic cation transporters and organic anion-transporting polypeptides. J Pharmacol Exp Ther. 2001 Jul;298(1):110-5.
66 Organic cation transporters and their pharmacokinetic and pharmacodynamic consequences. Drug Metab Pharmacokinet. 2008;23(4):243-53.
67 Influx Transport of Cationic Drug at the Blood-Retinal Barrier: Impact on the Retinal Delivery of Neuroprotectants. Biol Pharm Bull. 2017;40(8):1139-1145.
68 Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2/ABCC2- and MRP4/ABCC4-mediated methotrexate transport. J Pharmacol Exp Ther. 2007 Jan;320(1):229-35.
69 Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system. Cancer Res. 2002 Jun 1;62(11):3144-50.
70 ATP-binding cassette C transporters in human pancreatic carcinoma cell lines. Upregulation in 5-fluorouracil-resistant cells. Pancreatology. 2009;9(1-2):136-44.
71 The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9244-9.
72 Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4). Biochem J. 2003 Apr 15;371(Pt 2):361-7.
73 P-glycoprotein, but not multidrug resistance protein 4, plays a role in the systemic clearance of irinotecan and SN-38 in mice. Drug Metab Lett. 2010 Dec;4(4):195-201.
74 Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia. Blood. 2009 Aug 13;114(7):1383-6.
75 Role of glutathione in the multidrug resistance protein 4 (MRP4/ABCC4)-mediated efflux of cAMP and resistance to purine analogues. Biochem J. 2002 Feb 1;361(Pt 3):497-503.
76 Oral availability of cefadroxil depends on ABCC3 and ABCC4. Drug Metab Dispos. 2012 Mar;40(3):515-21.
77 The anti-influenza drug oseltamivir exhibits low potential to induce pharmacokinetic drug interactions via renal secretion-correlation of in vivo and in vitro studies. Drug Metab Dispos. 2002 Jan;30(1):13-9.
78 Transport of aminopterin by human organic anion transporters hOAT1 and hOAT3: Comparison with methotrexate. Drug Metab Pharmacokinet. 2010;25(2):163-9.
79 Expression levels of renal organic anion transporters (OATs) and their correlation with anionic drug excretion in patients with renal diseases. Pharm Res. 2004 Jan;21(1):61-7.
80 Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor. Drug Metab Dispos. 2007 Dec;35(12):2166-76.
81 Interaction of zalcitabine with human organic anion transporter 1. Pharmazie. 2006 May;61(5):491-2.
82 Apical expression or expression in a non polarized cell of hOAT1 inverses regulation by epidermal growth factor (EGF) as compared to basolateral hOAT1. Cell Physiol Biochem. 2004;14(3):177-86.
83 Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs. Nucleosides Nucleotides Nucleic Acids. 2001 Apr-Jul;20(4-7):641-8.
84 Methotrexate-loxoprofen interaction: involvement of human organic anion transporters hOAT1 and hOAT3. Drug Metab Pharmacokinet. 2004 Oct;19(5):369-74.
85 Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Mol Pharmacol. 2001 May;59(5):1277-86.
86 Prediction of the overall renal tubular secretion and hepatic clearance of anionic drugs and a renal drug-drug interaction involving organic anion transporter 3 in humans by in vitro uptake experiments. Drug Metab Dispos. 2011 Jun;39(6):1031-8.
87 Murine renal organic anion transporters mOAT1 and mOAT3 facilitate the transport of neuroactive tryptophan metabolites. Am J Physiol Cell Physiol. 2005 Nov;289(5):C1075-84.
88 Organic anion transporter 3 is involved in the brain-to-blood efflux transport of thiopurine nucleobase analogs. J Neurochem. 2004 Aug;90(4):931-41.
89 Transporter-mediated influx and efflux mechanisms of pitavastatin, a new inhibitor of HMG-CoA reductase. J Pharm Pharmacol. 2005 Oct;57(10):1305-11.
90 The contribution of organic anion transporters OAT1 and OAT3 to the renal uptake of rosuvastatin. J Pharmacol Exp Ther. 2007 Sep;322(3):1221-7.
91 Aspirin and probenecid inhibit organic anion transporter 3-mediated renal uptake of cilostazol and probenecid induces metabolism of cilostazol in the rat. Drug Metab Dispos. 2014 Jun;42(6):996-1007.
92 Expression of organic anion transporter 2 in the human kidney and its potential role in the tubular secretion of guanine-containing antiviral drugs. Drug Metab Dispos. 2012 Mar;40(3):617-24.
93 Characterization of methotrexate transport and its drug interactions with human organic anion transporters. J Pharmacol Exp Ther. 2002 Aug;302(2):666-71.
94 The role of the intracellular glutamate gradient in driving organic anion transporter function.
95 Inhibition of human organic anion transporter 3 mediated pravastatin transport by gemfibrozil and the metabolites in humans. Xenobiotica. 2007 Apr;37(4):416-26.
96 Interactions of human organic anion transporters with diuretics. J Pharmacol Exp Ther. 2004 Mar;308(3):1021-9.
97 Inhibitory effects of angiotensin II receptor antagonists and leukotriene receptor antagonists on the transport of human organic anion transporter 4. J Pharm Pharmacol. 2006 Nov;58(11):1499-505.
98 Cellular Uptake of Levocetirizine by Organic Anion Transporter 4. J Pharm Sci. 2017 Sep;106(9):2895-2898.
99 Involvement of uric acid transporters in alteration of serum uric acid level by angiotensin II receptor blockers. Pharm Res. 2008 Mar;25(3):639-46.
100 Expression levels and activation of a PXR variant are directly related to drug resistance in osteosarcoma cell lines. Cancer. 2007 Mar 1;109(5):957-65.
101 Contribution of human hepatic cytochrome P450 isoforms to regioselective hydroxylation of steroid hormones. Xenobiotica. 1998 Jun;28(6):539-47.
102 Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6. J Pharmacol Exp Ther. 2004 Sep;310(3):1062-75.
103 Isoform-specific regulation of cytochromes P450 expression by estradiol and progesterone. Drug Metab Dispos. 2013 Feb;41(2):263-9.
104 Metabolic interactions between acetaminophen (paracetamol) and two flavonoids, luteolin and quercetin, through in-vitro inhibition studies. J Pharm Pharmacol. 2017 Dec;69(12):1762-1772.
105 Potent mechanism-based inhibition of CYP3A4 by imatinib explains its liability to interact with CYP3A4 substrates. Br J Pharmacol. 2012 Apr;165(8):2787-98.
106 Effects of morin on the pharmacokinetics of etoposide in rats. Biopharm Drug Dispos. 2007 Apr;28(3):151-6.
107 Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675.
108 Cytochrome P450 3A4-mediated interaction of diclofenac and quinidine. Drug Metab Dispos. 2000 Sep;28(9):1043-50.
109 Functional significance of UDP-glucuronosyltransferase variants in the metabolism of active tamoxifen metabolites. Cancer Res. 2009 Mar 1;69(5):1892-900.
110 Functional characterization of human and cynomolgus monkey UDP-glucuronosyltransferase 1A1 enzymes. Life Sci. 2010 Aug 14;87(7-8):261-8.
111 Effect of UDP-glucuronosyltransferase (UGT) 1A polymorphism (rs8330 and rs10929303) on glucuronidation status of acetaminophen. Dose Response. 2017 Sep 11;15(3):1559325817723731.
112 UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for etoposide glucuronidation in human liver and intestinal microsomes: structural characterization of phenolic and alcoholic glucuronides of etoposide and estimation of enzyme kinetics. Drug Metab Dispos. 2007 Mar;35(3):371-80.
113 Effect of aging on glucuronidation of valproic acid in human liver microsomes and the role of UDP-glucuronosyltransferase UGT1A4, UGT1A8, and UGT1A10. Drug Metab Dispos. 2009 Jan;37(1):229-36.
114 Characterization of rat intestinal microsomal UDP-glucuronosyltransferase activity toward mycophenolic acid. Drug Metab Dispos. 2006 Sep;34(9):1632-9.
115 Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios. Drug Metab Dispos. 2004 Nov;32(11):1201-8.
116 Substrate-dependent modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1) by propofol in recombinant human UGT1A1 and human liver microsomes. Basic Clin Pharmacol Toxicol. 2007 Sep;101(3):211-4.
117 Identification and preliminary characterization of UDP-glucuronosyltransferases catalyzing formation of ethyl glucuronide. Anal Bioanal Chem. 2014 Apr;406(9-10):2325-32.
118 Atorvastatin glucuronidation is minimally and nonselectively inhibited by the fibrates gemfibrozil, fenofibrate, and fenofibric acid. Drug Metab Dispos. 2007 Aug;35(8):1315-24.
119 Roles of cytochromes P450 1A2, 2A6, and 2C8 in 5-fluorouracil formation from tegafur, an anticancer prodrug, in human liver microsomes. Drug Metab Dispos. 2000 Dec;28(12):1457-63.
120 Genotoxicity of tamoxifen, tamoxifen epoxide and toremifene in human lymphoblastoid cells containing human cytochrome P450s. Carcinogenesis. 1994 Jan;15(1):5-9.
121 Psychotropic drug interactions with valproate. Clin Neuropharmacol. 2005 Mar-Apr;28(2):96-101.
122 The role of human cytochrome P450 enzymes in the formation of 2-hydroxymetronidazole: CYP2A6 is the high affinity (low Km) catalyst. Drug Metab Dispos. 2013 Sep;41(9):1686-94.
123 Possible involvement of multiple human cytochrome P450 isoforms in the liver metabolism of propofol. Br J Anaesth. 1998 Jun;80(6):788-95.
124 CYP2A6- and CYP2A13-catalyzed metabolism of the nicotine delta-5'(1')iminium ion. J Pharmacol Exp Ther. 2012 Nov;343(2):307-15.
125 Role of cytochrome P450 2C8 in drug metabolism and interactions. Pharmacol Rev. 2016 Jan;68(1):168-241.
126 Differential expression and function of CYP2C isoforms in human intestine and liver. Pharmacogenetics. 2003 Sep;13(9):565-75.
127 Analysis of human cytochrome P450 2C8 substrate specificity using a substrate pharmacophore and site-directed mutants. Biochemistry. 2004 Dec 14;43(49):15379-92.
128 Interaction of sorafenib and cytochrome P450 isoenzymes in patients with advanced melanoma: a phase I/II pharmacokinetic interaction study. Cancer Chemother Pharmacol. 2011 Nov;68(5):1111-8.
129 PharmGKB summary: mycophenolic acid pathway. Pharmacogenet Genomics. 2014 Jan;24(1):73-9.
130 Influence of CYP2C8 polymorphisms on the hydroxylation metabolism of paclitaxel, repaglinide and ibuprofen enantiomers in vitro. Biopharm Drug Dispos. 2013 Jul;34(5):278-87.
131 Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes. Arch Biochem Biophys. 1997 Oct 1;346(1):161-9.
132 Tamoxifen inhibits cytochrome P450 2C9 activity in breast cancer patients. J Chemother. 2006 Aug;18(4):421-4.
133 Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology. 2003 Aug;144(8):3382-98.
134 Drug-drug interactions with imatinib: an observational study. Medicine (Baltimore). 2016 Oct;95(40):e5076.
135 Drug interactions with calcium channel blockers: possible involvement of metabolite-intermediate complexation with CYP3A. Drug Metab Dispos. 2000 Feb;28(2):125-30.
136 New insights into the structural features and functional relevance of human cytochrome P450 2C9. Part I. Curr Drug Metab. 2009 Dec;10(10):1075-126.
137 A potential role for the estrogen-metabolizing cytochrome P450 enzymes in human breast carcinogenesis. Breast Cancer Res Treat. 2003 Dec;82(3):191-7.
138 A mechanistic approach to antiepileptic drug interactions. Ann Pharmacother. 1998 May;32(5):554-63.
139 In vitro comparative inhibition profiles of major human drug metabolising cytochrome P450 isozymes (CYP2C9, CYP2D6 and CYP3A4) by HMG-CoA reductase inhibitors. Eur J Clin Pharmacol. 1996;50(3):209-15.
140 High-dose rabeprazole/amoxicillin therapy as the second-line regimen after failure to eradicate H. pylori by triple therapy with the usual doses of a proton pump inhibitor, clarithromycin and amoxicillin. Hepatogastroenterology. 2003 Nov-Dec;50(54):2274-8.
141 Cytochrome P450 pharmacogenetics and cancer. Oncogene. 2006 Mar 13;25(11):1679-91.
142 CYP2C19*17 is associated with decreased breast cancer risk. Breast Cancer Res Treat. 2009 May;115(2):391-6.
143 Cytochromes of the P450 2C subfamily are the major enzymes involved in the O-demethylation of verapamil in humans. Naunyn Schmiedebergs Arch Pharmacol. 1995 Dec;353(1):116-21.
144 Diclofenac and its derivatives as tools for studying human cytochromes P450 active sites: particular efficiency and regioselectivity of P450 2Cs. Biochemistry. 1999 Oct 26;38(43):14264-70.
145 Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology. 2001 Feb;120(2):525-33.
146 Metabolism and transport of tamoxifen in relation to its effectiveness: new perspectives on an ongoing controversy. Future Oncol. 2014 Jan;10(1):107-22.
147 Pharmacokinetic and pharmacodynamic interaction of lorazepam and valproic acid in relation to UGT2B7 genetic polymorphism in healthy subjects. Clin Pharmacol Ther. 2008 Apr;83(4):595-600.
148 Pitavastatin: a review in hypercholesterolemia. Am J Cardiovasc Drugs. 2017 Apr;17(2):157-168.
149 Troglitazone glucuronidation in human liver and intestine microsomes: high catalytic activity of UGT1A8 and UGT1A10. Drug Metab Dispos. 2002 Dec;30(12):1462-9.
150 Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions. Clin Pharmacokinet. 2005;44(5):467-94.
151 Pharmacogenomics of statins: understanding susceptibility to adverse effects. Pharmgenomics Pers Med. 2016 Oct 3;9:97-106.
152 Interactions of human organic anion transporters and human organic cation transporters with nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther. 2002 Nov;303(2):534-9.
153 Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium. Arthritis Rheumatol. 2014 Jan;66(1):15-23.
154 Methotrexate normalizes up-regulated folate pathway genes in rheumatoid arthritis. Arthritis Rheum. 2013 Nov;65(11):2791-802.
155 Activation of beta-catenin signalling by GSK-3 inhibition increases p-glycoprotein expression in brain endothelial cells. J Neurochem. 2008 Aug;106(4):1855-65. doi: 10.1111/j.1471-4159.2008.05537.x. Epub 2008 Jul 4.
156 Selenium-dependent and -independent transport of arsenic by the human multidrug resistance protein 2 (MRP2/ABCC2): implications for the mutual detoxification of arsenic and selenium. Carcinogenesis. 2010 Aug;31(8):1450-5. doi: 10.1093/carcin/bgq125. Epub 2010 Jun 27.
157 Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure. Toxicol Sci. 2011 Dec;124(2):370-7.
158 Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury. Arch Toxicol. 2020 Apr;94(4):1151-1172. doi: 10.1007/s00204-020-02691-9. Epub 2020 Mar 10.
159 Hematopoietic stem cell differentiation affects expression and function of MRP4 (ABCC4), a transport protein for signaling molecules and drugs. Int J Cancer. 2009 May 15;124(10):2303-11. doi: 10.1002/ijc.24207.
160 Prolonged use of aspirin alters human and rat intestinal cells and thereby limits the absorption of clopidogrel. Clin Pharmacol Ther. 2011 Oct;90(4):612-9. doi: 10.1038/clpt.2011.163. Epub 2011 Sep 7.
161 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
162 Stem cell transcriptome responses and corresponding biomarkers that indicate the transition from adaptive responses to cytotoxicity. Chem Res Toxicol. 2017 Apr 17;30(4):905-922.
163 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
164 Localization of breast cancer resistance protein (Bcrp) in endocrine organs and inhibition of its transport activity by steroid hormones. Cell Tissue Res. 2012 Aug;349(2):551-63. doi: 10.1007/s00441-012-1417-5. Epub 2012 May 13.
165 Pharmacogenetics of ABCG2 and adverse reactions to gefitinib. J Natl Cancer Inst. 2006 Dec 6;98(23):1739-42.
166 ADReCS-Target: target profiles for aiding drug safety research and application. Nucleic Acids Res. 2018 Jan 4;46(D1):D911-D917. doi: 10.1093/nar/gkx899.
167 ABCG2 polymorphism is associated with the low-density lipoprotein cholesterol response to rosuvastatin. Clin Pharmacol Ther. 2010 May;87(5):558-62.
168 Ciprofloxacin mediates cancer stem cell phenotypes in lung cancer cells through caveolin-1-dependent mechanism. Chem Biol Interact. 2016 Apr 25;250:1-11.
169 Proteomic identification of differentially expressed proteins associated with the multiple drug resistance in methotrexate-resistant human breast cancer cells. Int J Oncol. 2014 Jul;45(1):448-58.
170 Chronic imatinib mesylate exposure leads to reduced intracellular drug accumulation by induction of the ABCG2 (BCRP) and ABCB1 (MDR1) drug transport pumps. Cancer Biol Ther. 2005 Jul;4(7):747-52.
171 Folate deprivation induces BCRP (ABCG2) expression and mitoxantrone resistance in Caco-2 cells. Int J Cancer. 2008 Oct 1;123(7):1712-20.
172 Characteristics of P388/VMDRC.04, a simple, sensitive model for studying P-glycoprotein antagonists. Cancer Res. 1994 Feb 1;54(3):730-7.
173 Michaelis-Menten kinetic analysis of drugs of abuse to estimate their affinity to human P-glycoprotein. Toxicol Lett. 2013 Feb 27;217(2):137-42. doi: 10.1016/j.toxlet.2012.12.012. Epub 2012 Dec 27.
174 Editor's Highlight: PlacentalDisposition and Effects of Crizotinib: An Ex Vivo Study in the Isolated Dual-Side Perfused Human Cotyledon. Toxicol Sci. 2017 Jun 1;157(2):500-509. doi: 10.1093/toxsci/kfx063.
175 Functional evaluation of polymorphisms in the human ABCB1 gene and the impact on clinical responses of antiepileptic drugs. Pharmacogenet Genomics. 2008 May;18(5):390-402. doi: 10.1097/FPC.0b013e3282f85e36.
176 Cepharanthine potently enhances the sensitivity of anticancer agents in K562 cells. Cancer Sci. 2005 Jun;96(6):372-6. doi: 10.1111/j.1349-7006.2005.00057.x.
177 Clinical pharmacokinetic monitoring of itraconazole is warranted in only a subset of patients. Ther Drug Monit. 2005 Jun;27(3):322-33. doi: 10.1097/01.ftd.0000150135.22645.ea.
178 Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein. Psychopharmacology (Berl). 2006 Sep;187(4):415-23. doi: 10.1007/s00213-006-0437-9. Epub 2006 Jun 30.
179 Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro. Haematologica. 2002 Feb;87(2):167-76.
180 Characterization of the ATPase activity of the Mr 170,000 to 180,000 membrane glycoprotein (P-glycoprotein) associated with multidrug resistance in K562/ADM cells. Cancer Res. 1988 Sep 1;48(17):4926-32.
181 Keratinocyte-derived IL-36gama plays a role in hydroquinone-induced chemical leukoderma through inhibition of melanogenesis in human epidermal melanocytes. Arch Toxicol. 2019 Aug;93(8):2307-2320.
182 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
183 2', 3'-Dideoxycytidine represses thymidine kinases 1 and 2 expression in T-lymphoid cells. Life Sci. 2004 Jan 2;74(7):835-42. doi: 10.1016/j.lfs.2003.07.023.
184 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
185 Drug-induced endoplasmic reticulum and oxidative stress responses independently sensitize toward TNF-mediated hepatotoxicity. Toxicol Sci. 2014 Jul;140(1):144-59. doi: 10.1093/toxsci/kfu072. Epub 2014 Apr 20.
186 Gene expression analysis of precision-cut human liver slices indicates stable expression of ADME-Tox related genes. Toxicol Appl Pharmacol. 2011 May 15;253(1):57-69.
187 Expression profiling of nucleotide metabolism-related genes in human breast cancer cells after treatment with 5-fluorouracil. Cancer Invest. 2009 Jun;27(5):561-7.
188 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
189 Arabinosylcytosine downregulates thymidine kinase and induces cross-resistance to zidovudine in T-lymphoid cells. Biochem Biophys Res Commun. 2003 Aug 1;307(3):564-8. doi: 10.1016/s0006-291x(03)01232-4.
190 Role of hydrogen peroxide in hypoxia-induced erythropoietin production. Biochem J. 1994 Oct 15;303 ( Pt 2)(Pt 2):507-10. doi: 10.1042/bj3030507.
191 Normal erythropoietin response in chronic hepatitis C patients with ribavirin-induced anaemia. Antivir Ther. 2003 Feb;8(1):57-63.
192 Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.
193 Role of erythropoietin in cortisol-induced hypertension. J Hum Hypertens. 2000 Mar;14(3):195-8. doi: 10.1038/sj.jhh.1000959.
194 Fenoterol but not dobutamine increases erythropoietin production in humans. Clin Pharmacol Ther. 1997 Jun;61(6):669-76. doi: 10.1016/S0009-9236(97)90102-8.
195 Vitamin A supplementation in children with poor vitamin A and iron status increases erythropoietin and hemoglobin concentrations without changing total body iron. Am J Clin Nutr. 2006 Sep;84(3):580-6. doi: 10.1093/ajcn/84.3.580.
196 Worsening of anemia by angiotensin converting enzyme inhibitors and its prevention by antiestrogenic steroid in chronic hemodialysis patients. J Cardiovasc Pharmacol. 1989;13 Suppl 3:S27-30. doi: 10.1097/00005344-198900133-00007.
197 Relationship of erythropoietin, fetal hemoglobin, and hydroxyurea treatment to tricuspid regurgitation velocity in children with sickle cell disease. Blood. 2009 Nov 19;114(21):4639-44. doi: 10.1182/blood-2009-04-218040. Epub 2009 Sep 1.
198 Fluorodeoxyuridine modulates cellular expression of the DNA base excision repair enzyme uracil-DNA glycosylase. Cancer Res. 2006 Sep 1;66(17):8829-37. doi: 10.1158/0008-5472.CAN-06-0540.
199 Gene expression after treatment with hydrogen peroxide, menadione, or t-butyl hydroperoxide in breast cancer cells. Cancer Res. 2002 Nov 1;62(21):6246-54.
200 Delivery method, target gene structure, and growth properties of target cells impact mutagenic responses to reactive nitrogen and oxygen species. Chem Res Toxicol. 2012 Apr 16;25(4):873-83. doi: 10.1021/tx2004882. Epub 2012 Feb 21.
201 Pharmacotoxicology of clinically-relevant concentrations of obeticholic acid in an organotypic human hepatocyte system. Toxicol In Vitro. 2017 Mar;39:93-103.
202 Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells. World J Gastroenterol. 2009 Jan 21;15(3):310-20.
203 Effect of retinoic acid on gene expression in human conjunctival epithelium: secretory phospholipase A2 mediates retinoic acid induction of MUC16. Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4050-61.
204 Development of an integrated assay in human TK6 cells to permit comprehensive genotoxicity analysis in vitro. Mutat Res Genet Toxicol Environ Mutagen. 2020 Jan;849:503129. doi: 10.1016/j.mrgentox.2019.503129. Epub 2019 Dec 27.
205 E2F1 downregulation by arsenic trioxide in lung adenocarcinoma. Int J Oncol. 2014 Nov;45(5):2033-43. doi: 10.3892/ijo.2014.2609. Epub 2014 Aug 19.
206 Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer. 2011 May 18;10:58.
207 p53-R175H mutant gains new function in regulation of doxorubicin-induced apoptosis. Int J Cancer. 2005 Apr 10;114(3):331-6. doi: 10.1002/ijc.20818.
208 The contribution of methotrexate exposure and host factors on transcriptional variance in human liver. Toxicol Sci. 2007 Jun;97(2):582-94.
209 Quantitative analysis of gene expression changes in response to genotoxic compounds. Toxicol In Vitro. 2017 Mar;39:15-28. doi: 10.1016/j.tiv.2016.11.004. Epub 2016 Nov 5.
210 Induction of apoptosis by cidofovir in human papillomavirus (HPV)-positive cells. Oncol Res. 2000;12(9-10):397-408. doi: 10.3727/096504001108747855.
211 Gallic acid potentiates the apoptotic effect of paclitaxel and carboplatin via overexpression of Bax and P53 on the MCF-7 human breast cancer cell line. J Biochem Mol Toxicol. 2021 Feb;35(2):e22638. doi: 10.1002/jbt.22638. Epub 2020 Oct 1.
212 Regulation of human dUTPase gene expression and p53-mediated transcriptional repression in response to oxaliplatin-induced DNA damage. Nucleic Acids Res. 2009 Jan;37(1):78-95. doi: 10.1093/nar/gkn910. Epub 2008 Nov 16.
213 Role of miRNA in the regulation of cannabidiol-mediated apoptosis in neuroblastoma cells. Oncotarget. 2019 Jan 1;10(1):45-59. doi: 10.18632/oncotarget.26534. eCollection 2019 Jan 1.
214 Nitrogen Mustard Alkylates and Cross-Links p53 in Human Keratinocytes. Chem Res Toxicol. 2022 Apr 18;35(4):636-650. doi: 10.1021/acs.chemrestox.1c00420. Epub 2022 Mar 21.
215 Fulvestrant induces resistance by modulating GPER and CDK6 expression: implication of methyltransferases, deacetylases and the hSWI/SNF chromatin remodelling complex. Br J Cancer. 2013 Nov 12;109(10):2751-62. doi: 10.1038/bjc.2013.583. Epub 2013 Oct 29.
216 Mechanisms of thymidine kinase/ganciclovir and cytosine deaminase/ 5-fluorocytosine suicide gene therapy-induced cell death in glioma cells. Oncogene. 2005 Feb 10;24(7):1231-43. doi: 10.1038/sj.onc.1208290.
217 Cannabidiol Activates Neuronal Precursor Genes in Human Gingival Mesenchymal Stromal Cells. J Cell Biochem. 2017 Jun;118(6):1531-1546. doi: 10.1002/jcb.25815. Epub 2016 Dec 29.
218 Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor. Cancer Res. 2002 Aug 1;62(15):4419-26.
219 Leptomycin B reduces primary and acquired resistance of gefitinib in lung cancer cells. Toxicol Appl Pharmacol. 2017 Nov 15;335:16-27. doi: 10.1016/j.taap.2017.09.017. Epub 2017 Sep 21.
220 BMN 673 (talazoparib): A potent PARP inhibitor for triple negative breast cancer with different genetic profile. J Biochem Mol Toxicol. 2019 May;33(5):e22286. doi: 10.1002/jbt.22286. Epub 2019 Jan 23.
221 Bexarotene activates the p53/p73 pathway in human cutaneous T-cell lymphoma. Br J Dermatol. 2009 Mar;160(3):519-26. doi: 10.1111/j.1365-2133.2008.08931.x. Epub 2008 Nov 25.
222 Glucocorticoids induce G1 arrest of lymphoblastic cells through retinoblastoma protein Rb1 dephosphorylation in childhood acute lymphoblastic leukemia in vivo. Cancer Biol Ther. 2004 May;3(5):470-6. doi: 10.4161/cbt.3.5.838. Epub 2004 May 9.
223 Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line. Clin Cancer Res. 2000 Mar;6(3):891-900.
224 Utilization of CDKN1A/p21 gene for class discrimination of DNA damage-induced clastogenicity. Toxicology. 2014 Jan 6;315:8-16. doi: 10.1016/j.tox.2013.10.009. Epub 2013 Nov 6.
225 p21(WAF1/cip1) is an important determinant of intestinal cell response to sulindac in vitro and in vivo. Cancer Res. 2001 Aug 15;61(16):6297-302.
226 Time series analysis of oxidative stress response patterns in HepG2: a toxicogenomics approach. Toxicology. 2013 Apr 5;306:24-34.
227 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
228 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
229 Comprehensive transcriptome profiling of BET inhibitor-treated HepG2 cells. PLoS One. 2022 Apr 29;17(4):e0266966. doi: 10.1371/journal.pone.0266966. eCollection 2022.
230 Effects of four-week high-fructose diet on gene expression in skeletal muscle of healthy men. Diabetes Metab. 2008 Feb;34(1):82-5. doi: 10.1016/j.diabet.2007.08.004. Epub 2007 Dec 11.
231 The exosome-like vesicles derived from androgen exposed-prostate stromal cells promote epithelial cells proliferation and epithelial-mesenchymal transition. Toxicol Appl Pharmacol. 2021 Jan 15;411:115384. doi: 10.1016/j.taap.2020.115384. Epub 2020 Dec 25.
232 Integrated 'omics analysis reveals new drug-induced mitochondrial perturbations in human hepatocytes. Toxicol Lett. 2018 Jun 1;289:1-13.
233 Folic acid supplementation dysregulates gene expression in lymphoblastoid cells--implications in nutrition. Biochem Biophys Res Commun. 2011 Sep 9;412(4):688-92. doi: 10.1016/j.bbrc.2011.08.027. Epub 2011 Aug 16.
234 Temozolomide induces activation of Wnt/-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278. doi: 10.1007/s10565-019-09502-7. Epub 2019 Nov 22.
235 Identification of mechanisms of action of bisphenol a-induced human preadipocyte differentiation by transcriptional profiling. Obesity (Silver Spring). 2014 Nov;22(11):2333-43.
236 Mechanism of cisplatin proximal tubule toxicity revealed by integrating transcriptomics, proteomics, metabolomics and biokinetics. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):117-27.
237 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
238 New insights into the mechanisms underlying 5-fluorouracil-induced intestinal toxicity based on transcriptomic and metabolomic responses in human intestinal organoids. Arch Toxicol. 2021 Aug;95(8):2691-2718. doi: 10.1007/s00204-021-03092-2. Epub 2021 Jun 20.
239 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.
240 Chronic occupational exposure to arsenic induces carcinogenic gene signaling networks and neoplastic transformation in human lung epithelial cells. Toxicol Appl Pharmacol. 2012 Jun 1;261(2):204-16.
241 Integrative "-Omics" analysis in primary human hepatocytes unravels persistent mechanisms of cyclosporine A-induced cholestasis. Chem Res Toxicol. 2016 Dec 19;29(12):2164-2174.
242 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
243 Human 3D multicellular microtissues: an upgraded model for the in vitro mechanistic investigation of inflammation-associated drug toxicity. Toxicol Lett. 2019 Sep 15;312:34-44.
244 4-HPR modulates gene expression in ovarian cells. Int J Cancer. 2006 Sep 1;119(5):1005-13. doi: 10.1002/ijc.21797.
245 Gene expression changes associated with altered growth and differentiation in benzo[a]pyrene or arsenic exposed normal human epidermal keratinocytes. J Appl Toxicol. 2008 May;28(4):491-508.
246 Effect of ellagic acid on the expression of human telomerase reverse transcriptase (hTERT) alpha+beta+ transcript in estrogen receptor-positive MCF-7 breast cancer cells. Clin Biochem. 2009 Sep;42(13-14):1358-62. doi: 10.1016/j.clinbiochem.2009.05.017. Epub 2009 Jun 6.
247 Antiproliferative effects of gefitinib are associated with suppression of E2F-1 expression and telomerase activity. Anticancer Res. 2006 Sep-Oct;26(5A):3387-91.
248 Arsenic suppresses gene expression in promyelocytic leukemia cells partly through Sp1 oxidation. Blood. 2005 Jul 1;106(1):304-10.
249 Inhibitory effects of selenium on telomerase activity and hTERT expression in cadmium-transformed 16HBE cells. Biomed Environ Sci. 2007 Aug;20(4):307-12.
250 Troglitazone suppresses telomerase activity independently of PPARgamma in estrogen-receptor negative breast cancer cells. BMC Cancer. 2010 Jul 22;10:390. doi: 10.1186/1471-2407-10-390.
251 Analysis of telomerase activity and RNA expression in a patient with acute promyelocytic leukemia treated with all-trans retinoic acid. Pediatr Blood Cancer. 2006 Apr;46(4):506-11. doi: 10.1002/pbc.20392.
252 Characterization of arsenic-induced cytogenetic alterations in acute promyelocytic leukemia cell line, NB4. Med Oncol. 2012 Jun;29(2):1209-16. doi: 10.1007/s12032-011-9946-4. Epub 2011 May 5.
253 Lunasin, a novel seed peptide, sensitizes human breast cancer MDA-MB-231 cells to aspirin-arrested cell cycle and induced apoptosis. Chem Biol Interact. 2010 Jul 30;186(2):127-34. doi: 10.1016/j.cbi.2010.04.027. Epub 2010 May 21.
254 Cannabidiol-induced transcriptomic changes and cellular senescence in human Sertoli cells. Toxicol Sci. 2023 Feb 17;191(2):227-238. doi: 10.1093/toxsci/kfac131.
255 Melanoma coordinates general and cell-specific mechanisms to promote methotrexate resistance. Exp Cell Res. 2012 Jun 10;318(10):1146-59.
256 Quercetin potentiates apoptosis by inhibiting nuclear factor-kappaB signaling in H460 lung cancer cells. Biol Pharm Bull. 2013;36(6):944-51. doi: 10.1248/bpb.b12-01004.
257 Involvement of the activation of Nrf2/HO-1, p38 MAPK signaling pathways and endoplasmic reticulum stress in furazolidone induced cytotoxicity and S phase arrest in human hepatocyte L02 cells: modulation of curcumin. Toxicol Mech Methods. 2017 Mar;27(3):165-172. doi: 10.1080/15376516.2016.1273424. Epub 2017 Jan 8.
258 ATR, PML, and CHK2 play a role in arsenic trioxide-induced apoptosis. J Biol Chem. 2006 Sep 29;281(39):28764-71. doi: 10.1074/jbc.M604392200. Epub 2006 Aug 3.
259 Identification of small molecule proliferating cell nuclear antigen (PCNA) inhibitor that disrupts interactions with PIP-box proteins and inhibits DNA replication. J Biol Chem. 2012 Apr 20;287(17):14289-300. doi: 10.1074/jbc.M112.353201. Epub 2012 Mar 1.
260 PARP inhibition restores extrinsic apoptotic sensitivity in glioblastoma. PLoS One. 2014 Dec 22;9(12):e114583. doi: 10.1371/journal.pone.0114583. eCollection 2014.
261 Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One. 2013 May 28;8(5):e63862.
262 Temporal changes in gene expression in the skin of patients treated with isotretinoin provide insight into its mechanism of action. Dermatoendocrinol. 2009 May;1(3):177-87.
263 Rifampin Regulation of Drug Transporters Gene Expression and the Association of MicroRNAs in Human Hepatocytes. Front Pharmacol. 2016 Apr 26;7:111.
264 Vitamin D3 transactivates the zinc and manganese transporter SLC30A10 via the Vitamin D receptor. J Steroid Biochem Mol Biol. 2016 Oct;163:77-87.
265 Transcriptomics hit the target: monitoring of ligand-activated and stress response pathways for chemical testing. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):7-18.
266 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
267 Cdk4/6 inhibition induces epithelial-mesenchymal transition and enhances invasiveness in pancreatic cancer cells. Mol Cancer Ther. 2012 Oct;11(10):2138-48. doi: 10.1158/1535-7163.MCT-12-0562. Epub 2012 Aug 6.
268 Interleukin-19 as a translational indicator of renal injury. Arch Toxicol. 2015 Jan;89(1):101-6.
269 Identification of biomarkers and outcomes of endocrine disruption in human ovarian cortex using In Vitro Models. Toxicology. 2023 Feb;485:153425. doi: 10.1016/j.tox.2023.153425. Epub 2023 Jan 5.
270 In vitro and in vivo irinotecan-induced changes in expression profiles of cell cycle and apoptosis-associated genes in acute myeloid leukemia cells. Mol Cancer Ther. 2005 Jun;4(6):885-900.
271 Expression profile analysis of colon cancer cells in response to sulindac or aspirin. Biochem Biophys Res Commun. 2002 Mar 29;292(2):498-512.
272 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
273 Motexafin gadolinium and zinc induce oxidative stress responses and apoptosis in B-cell lymphoma lines. Cancer Res. 2005 Dec 15;65(24):11676-88.
274 Similarities and differences between two modes of antagonism of the thyroid hormone receptor. ACS Chem Biol. 2011 Oct 21;6(10):1096-106.
275 Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells. Toxicology. 2017 Dec 1;392:11-21.
276 Global gene expression analysis reveals differences in cellular responses to hydroxyl- and superoxide anion radical-induced oxidative stress in caco-2 cells. Toxicol Sci. 2010 Apr;114(2):193-203. doi: 10.1093/toxsci/kfp309. Epub 2009 Dec 31.
277 Differential modulation of PI3-kinase/Akt pathway during all-trans retinoic acid- and Am80-induced HL-60 cell differentiation revealed by DNA microarray analysis. Biochem Pharmacol. 2004 Dec 1;68(11):2177-86.
278 Thyroid hormone responsive genes in cultured human fibroblasts. J Clin Endocrinol Metab. 2005 Feb;90(2):936-43.
279 THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders. Transl Psychiatry. 2018 Apr 25;8(1):89. doi: 10.1038/s41398-018-0137-3.
280 Regulation of copper transporter 2 expression by copper and cisplatin in human ovarian carcinoma cells. Mol Pharmacol. 2010 Jun;77(6):912-21. doi: 10.1124/mol.109.062836. Epub 2010 Mar 1.
281 Inflammation in methotrexate-induced pulmonary toxicity occurs via the p38 MAPK pathway. Toxicology. 2009 Feb 27;256(3):183-90. doi: 10.1016/j.tox.2008.11.016. Epub 2008 Nov 28.
282 A genomic approach to predict synergistic combinations for breast cancer treatment. Pharmacogenomics J. 2013 Feb;13(1):94-104. doi: 10.1038/tpj.2011.48. Epub 2011 Nov 15.
283 Evaluation of drug transporters' significance for multidrug resistance in head and neck squamous cell carcinoma. Head Neck. 2011 Jul;33(7):959-68. doi: 10.1002/hed.21559. Epub 2010 Aug 24.
284 Gene expression profiling of leukemia T-cells resistant to methotrexate and 7-hydroxymethotrexate reveals alterations that preserve intracellular levels of folate and nucleotide biosynthesis. Biochem Pharmacol. 2009 Apr 15;77(8):1410-7.
285 Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines. World J Gastroenterol. 2005 May 14;11(18):2748-53. doi: 10.3748/wjg.v11.i18.2748.
286 Adaptive homeostasis of the vitamin D-vitamin D nuclear receptor axis in 8-methoxypsoralen-induced hepatotoxicity. Toxicol Appl Pharmacol. 2019 Jan 1;362:150-158. doi: 10.1016/j.taap.2018.11.002. Epub 2018 Nov 10.
287 Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1. Redox Biol. 2020 Jan;28:101321. doi: 10.1016/j.redox.2019.101321. Epub 2019 Sep 5.
288 Estrogen regulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell proliferation and cell transformation. J Mol Endocrinol. 2004 Apr;32(2):397-414.
289 Differential regulation of the human MRP2 and MRP3 gene expression by glucocorticoids. J Steroid Biochem Mol Biol. 2005 Aug;96(3-4):229-34. doi: 10.1016/j.jsbmb.2005.03.004.
290 Induction of multidrug resistance proteins MRP1 and MRP3 and gamma-glutamylcysteine synthetase gene expression by nonsteroidal anti-inflammatory drugs in human colon cancer cells. Biochem Biophys Res Commun. 2002 Feb 8;290(5):1427-33. doi: 10.1006/bbrc.2002.6367.
291 Activation of nuclear factor-kappa B pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells. Mol Pharmacol. 2008 Aug;74(2):476-84.
292 The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites. Mol Cancer Ther. 2005 May;4(5):855-63.
293 Minimal peroxide exposure of neuronal cells induces multifaceted adaptive responses. PLoS One. 2010 Dec 17;5(12):e14352. doi: 10.1371/journal.pone.0014352.
294 Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells. Biochem Pharmacol. 2009 Mar 1;77(5):897-909.
295 Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide. Med Oncol. 2011 Dec;28(4):1225-54.
296 Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol. 2005 Nov;19(11):2685-95.
297 Transcriptional profiling of testosterone-regulated genes in the skeletal muscle of human immunodeficiency virus-infected men experiencing weight loss. J Clin Endocrinol Metab. 2007 Jul;92(7):2793-802. doi: 10.1210/jc.2006-2722. Epub 2007 Apr 17.
298 Mechanisms of indomethacin-induced alterations in the choline phospholipid metabolism of breast cancer cells. Neoplasia. 2006 Sep;8(9):758-71.
299 Pleiotropic combinatorial transcriptomes of human breast cancer cells exposed to mixtures of dietary phytoestrogens. Food Chem Toxicol. 2009 Apr;47(4):787-95.
300 Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res. 2012 Nov;22(11):2153-62.
301 Low dose of bisphenol a modulates ovarian cancer gene expression profile and promotes epithelial to mesenchymal transition via canonical Wnt pathway. Toxicol Sci. 2018 Aug 1;164(2):527-538.
302 Transcriptomic analysis of human primary bronchial epithelial cells after chloropicrin treatment. Chem Res Toxicol. 2015 Oct 19;28(10):1926-35.
303 JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells. Oncogene. 2008 Aug 28;27(37):5033-44.
304 Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol. 2017 Feb;91(2):839-864.
305 Reproducible chemical-induced changes in gene expression profiles in human hepatoma HepaRG cells under various experimental conditions. Toxicol In Vitro. 2009 Apr;23(3):466-75. doi: 10.1016/j.tiv.2008.12.018. Epub 2008 Dec 30.
306 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
307 Effects of lithium and valproic acid on gene expression and phenotypic markers in an NT2 neurosphere model of neural development. PLoS One. 2013;8(3):e58822.
308 Growth inhibition of ovarian tumor-initiating cells by niclosamide. Mol Cancer Ther. 2012 Aug;11(8):1703-12.
309 Increased mitochondrial ROS formation by acetaminophen in human hepatic cells is associated with gene expression changes suggesting disruption of the mitochondrial electron transport chain. Toxicol Lett. 2015 Apr 16;234(2):139-50.
310 Gene expression profile induced by BCNU in human glioma cell lines with differential MGMT expression. J Neurooncol. 2005 Jul;73(3):189-98.
311 Transcriptomic analysis of untreated and drug-treated differentiated HepaRG cells over a 2-week period. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):27-35.
312 Proteomic analysis of hepatic effects of phenobarbital in mice with humanized liver. Arch Toxicol. 2022 Oct;96(10):2739-2754. doi: 10.1007/s00204-022-03338-7. Epub 2022 Jul 26.
313 Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations. Int J Cancer. 2006 Apr 1;118(7):1699-712. doi: 10.1002/ijc.21570.
314 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
315 Endoplasmic reticulum stress impairs insulin signaling through mitochondrial damage in SH-SY5Y cells. Neurosignals. 2012;20(4):265-80.
316 Bisphenol A induces DSB-ATM-p53 signaling leading to cell cycle arrest, senescence, autophagy, stress response, and estrogen release in human fetal lung fibroblasts. Arch Toxicol. 2018 Apr;92(4):1453-1469.
317 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019 Oct 10;11(1):138. doi: 10.1186/s13148-019-0725-y.
318 Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3. Oncogene. 2005 Feb 3;24(6):980-91. doi: 10.1038/sj.onc.1208095.
319 Expression profile analysis of human peripheral blood mononuclear cells in response to aspirin. Arch Immunol Ther Exp (Warsz). 2005 Mar-Apr;53(2):151-8.
320 Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 4;101(5):306-20.
321 Bone marrow osteoblast damage by chemotherapeutic agents. PLoS One. 2012;7(2):e30758. doi: 10.1371/journal.pone.0030758. Epub 2012 Feb 17.
322 Proteomic analysis of the nucleus accumbens of rats with different vulnerability to cocaine addiction. Neuropharmacology. 2009 Jul;57(1):41-8. doi: 10.1016/j.neuropharm.2009.04.005. Epub 2009 Apr 22.
323 Epigenetic changes in individuals with arsenicosis. Chem Res Toxicol. 2011 Feb 18;24(2):165-7. doi: 10.1021/tx1004419. Epub 2011 Feb 4.
324 Predictive toxicology using systemic biology and liver microfluidic "on chip" approaches: application to acetaminophen injury. Toxicol Appl Pharmacol. 2012 Mar 15;259(3):270-80.
325 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
326 In vitro gene expression data supporting a DNA non-reactive genotoxic mechanism for ochratoxin A. Toxicol Appl Pharmacol. 2007 Apr 15;220(2):216-24.
327 Bisphenol A Exposure Changes the Transcriptomic and Proteomic Dynamics of Human Retinoblastoma Y79 Cells. Genes (Basel). 2021 Feb 11;12(2):264. doi: 10.3390/genes12020264.
328 Mitochondrial proteomics investigation of a cellular model of impaired dopamine homeostasis, an early step in Parkinson's disease pathogenesis. Mol Biosyst. 2014 Jun;10(6):1332-44.
329 Low doses of cisplatin induce gene alterations, cell cycle arrest, and apoptosis in human promyelocytic leukemia cells. Biomark Insights. 2016 Aug 24;11:113-21.
330 Nucleophosmin in the pathogenesis of arsenic-related bladder carcinogenesis revealed by quantitative proteomics. Toxicol Appl Pharmacol. 2010 Jan 15;242(2):126-35. doi: 10.1016/j.taap.2009.09.016. Epub 2009 Oct 7.
331 The modulatory effect of triclosan on the reversion of the activated phenotype of LX-2 hepatic stellate cells. J Biochem Mol Toxicol. 2020 Jan;34(1):e22413. doi: 10.1002/jbt.22413. Epub 2019 Nov 12.
332 Untargeted Proteomics and Systems-Based Mechanistic Investigation of Artesunate in Human Bronchial Epithelial Cells. Chem Res Toxicol. 2015 Oct 19;28(10):1903-13. doi: 10.1021/acs.chemrestox.5b00105. Epub 2015 Sep 21.
333 The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1. Toxicol Appl Pharmacol. 2009 Feb 15;235(1):124-34.
334 Identification of potential protein targets of isothiocyanates by proteomics. Chem Res Toxicol. 2011 Oct 17;24(10):1735-43. doi: 10.1021/tx2002806. Epub 2011 Aug 26.
335 Clozapine-induced reduction of l-carnitine reabsorption via inhibition/down-regulation of renal carnitine/organic cation transporter 2 contributes to liver lipid metabolic disorder in mice. Toxicol Appl Pharmacol. 2019 Jan 15;363:47-56. doi: 10.1016/j.taap.2018.11.007. Epub 2018 Nov 19.
336 Expression, localization, and function of the carnitine transporter octn2 (slc22a5) in human placenta. Drug Metab Dispos. 2005 Jan;33(1):31-7. doi: 10.1124/dmd.104.001560. Epub 2004 Oct 14.
337 Multiple drug transporters mediate the placental transport of sulpiride. Arch Toxicol. 2017 Dec;91(12):3873-3884. doi: 10.1007/s00204-017-2008-8. Epub 2017 Jun 9.
338 Urinary excretion of carnitine as a marker of proximal tubular damage associated with platin-based antineoplastic drugs. Nephrol Dial Transplant. 2010 Feb;25(2):426-33. doi: 10.1093/ndt/gfp456. Epub 2009 Sep 7.
339 Inorganic arsenic as an endocrine disruptor: modulation of the glucocorticoid receptor pathway in placental cells via CpG methylation. Chem Res Toxicol. 2019 Mar 18;32(3):493-499.
340 In vitro study of transporters involved in intestinal absorption of inorganic arsenic. Chem Res Toxicol. 2012 Feb 20;25(2):446-53. doi: 10.1021/tx200491f. Epub 2012 Jan 26.
341 Identification of vitamin D3 target genes in human breast cancer tissue. J Steroid Biochem Mol Biol. 2016 Nov;164:90-97.
342 Prenatal ethanol exposure increases maternal bile acids through placental transport pathway. Toxicology. 2021 Jun 30;458:152848. doi: 10.1016/j.tox.2021.152848. Epub 2021 Jul 2.
343 The genomic response of a human uterine endometrial adenocarcinoma cell line to 17alpha-ethynyl estradiol. Toxicol Sci. 2009 Jan;107(1):40-55.
344 Multidrug resistance protein-6 (MRP6) in human dermal fibroblasts. Comparison between cells from normal subjects and from Pseudoxanthoma elasticum patients. Matrix Biol. 2003 Nov;22(6):491-500. doi: 10.1016/j.matbio.2003.09.001.
345 Expression of the human ABCC6 gene is induced by retinoids through the retinoid X receptor. Biochem Biophys Res Commun. 2006 Dec 1;350(4):1082-7. doi: 10.1016/j.bbrc.2006.10.007. Epub 2006 Oct 10.
346 Loss of ATP-dependent transport activity in pseudoxanthoma elasticum-associated mutants of human ABCC6 (MRP6). J Biol Chem. 2002 May 10;277(19):16860-7.
347 Gene expression profile induced by arsenic trioxide in chronic lymphocytic leukemia cells reveals a central role for heme oxygenase-1 in apoptosis and regulation of matrix metalloproteinase-9. Oncotarget. 2016 Dec 13;7(50):83359-83377.
348 Testosterone stimulates adipose tissue 11beta-hydroxysteroid dehydrogenase type 1 expression in a depot-specific manner in children. J Clin Endocrinol Metab. 2010 Jul;95(7):3300-8.
349 The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxide. Exp Hematol. 2011 Jan;39(1):55-65.
350 Retinoic acid receptor alpha amplifications and retinoic acid sensitivity in breast cancers. Clin Breast Cancer. 2013 Oct;13(5):401-8.
351 From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Arch Toxicol. 2014 Jul;88(7):1451-68.
352 A transcriptomics-based in vitro assay for predicting chemical genotoxicity in vivo. Carcinogenesis. 2012 Jul;33(7):1421-9.
353 17-Estradiol Activates HSF1 via MAPK Signaling in ER-Positive Breast Cancer Cells. Cancers (Basel). 2019 Oct 11;11(10):1533. doi: 10.3390/cancers11101533.
354 Checkpoint signaling, base excision repair, and PARP promote survival of colon cancer cells treated with 5-fluorodeoxyuridine but not 5-fluorouracil. PLoS One. 2011;6(12):e28862. doi: 10.1371/journal.pone.0028862. Epub 2011 Dec 15.
355 Direct activation of ATM by resveratrol under oxidizing conditions. PLoS One. 2014 Jun 16;9(6):e97969. doi: 10.1371/journal.pone.0097969. eCollection 2014.
356 Triggering of transient receptor potential vanilloid type 1 (TRPV1) by capsaicin induces Fas/CD95-mediated apoptosis of urothelial cancer cells in an ATM-dependent manner. Carcinogenesis. 2009 Aug;30(8):1320-9. doi: 10.1093/carcin/bgp138. Epub 2009 Jun 5.
357 Repairing of N-mustard derivative BO-1055 induced DNA damage requires NER, HR, and MGMT-dependent DNA repair mechanisms. Oncotarget. 2015 Sep 22;6(28):25770-83. doi: 10.18632/oncotarget.4514.
358 mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene-expression levels. Cancer Sci. 2008 Oct;99(10):1992-2003. doi: 10.1111/j.1349-7006.2008.00955.x.
359 Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes. Clin Diagn Lab Immunol. 2004 Jan;11(1):63-9. doi: 10.1128/cdli.11.1.63-69.2004.
360 Retinoic acid-induced downmodulation of telomerase activity in human cancer cells. Exp Mol Pathol. 2005 Oct;79(2):108-17.
361 In vitro effects of aldehydes present in tobacco smoke on gene expression in human lung alveolar epithelial cells. Toxicol In Vitro. 2013 Apr;27(3):1072-81.
362 Carbon tetrachloride induced mitochondrial division, respiratory chain damage, abnormal intracellular [H(+)] and apoptosis are due to the activation of 5-HT degradation system in hepatocytes. Toxicol Appl Pharmacol. 2022 Mar 15;439:115929. doi: 10.1016/j.taap.2022.115929. Epub 2022 Feb 21.
363 Mechanisms of Chronic Fialuridine Hepatotoxicity as Revealed in Primary Human Hepatocyte Spheroids. Toxicol Sci. 2019 Oct 1;171(2):385-395. doi: 10.1093/toxsci/kfz195.
364 New insights into BaP-induced toxicity: role of major metabolites in transcriptomics and contribution to hepatocarcinogenesis. Arch Toxicol. 2016 Jun;90(6):1449-58.
365 The effect of ethidium bromide and chloramphenicol on mitochondrial biogenesis in primary human fibroblasts. Toxicol Appl Pharmacol. 2012 May 15;261(1):42-9. doi: 10.1016/j.taap.2012.03.009.
366 Tea polyphenols ameliorates neural redox imbalance and mitochondrial dysfunction via mechanisms linking the key circadian regular Bmal1. Food Chem Toxicol. 2017 Dec;110:189-199. doi: 10.1016/j.fct.2017.10.031. Epub 2017 Oct 20.
367 Quantitative proteomic analysis of HepG2 cells treated with quercetin suggests IQGAP1 involved in quercetin-induced regulation of cell proliferation and migration. OMICS. 2009 Apr;13(2):93-103. doi: 10.1089/omi.2008.0075.
368 A genome-wide analysis of targets of macrolide antibiotics in mammalian cells. J Biol Chem. 2020 Feb 14;295(7):2057-2067. doi: 10.1074/jbc.RA119.010770. Epub 2020 Jan 8.
369 Single-cell Transcriptome Mapping Identifies Common and Cell-type Specific Genes Affected by Acute Delta9-tetrahydrocannabinol in Humans. Sci Rep. 2020 Feb 26;10(1):3450. doi: 10.1038/s41598-020-59827-1.
370 Nuclear and Mitochondrial DNA Methylation Patterns Induced by Valproic Acid in Human Hepatocytes. Chem Res Toxicol. 2017 Oct 16;30(10):1847-1854. doi: 10.1021/acs.chemrestox.7b00171. Epub 2017 Sep 13.
371 Pod-based menthol and tobacco flavored e-cigarettes cause mitochondrial dysfunction in lung epithelial cells. Toxicol Lett. 2020 Oct 15;333:303-311. doi: 10.1016/j.toxlet.2020.08.003. Epub 2020 Aug 9.
372 In vitro cytotoxicity and mitochondrial toxicity of tenofovir alone and in combination with other antiretrovirals in human renal proximal tubule cells. Antimicrob Agents Chemother. 2006 Nov;50(11):3824-32. doi: 10.1128/AAC.00437-06. Epub 2006 Aug 28.
373 Small-scale immunopurification of cytochrome c oxidase for a high-throughput multiplexing analysis of enzyme activity and amount. Biotechnol Appl Biochem. 2007 Dec;48(Pt 4):167-78. doi: 10.1042/BA20060223.
374 Enhanced levels of several mitochondrial mRNA transcripts and mitochondrial superoxide production during ethinyl estradiol-induced hepatocarcinogenesis and after estrogen treatment of HepG2 cells. Carcinogenesis. 1998 Dec;19(12):2187-93. doi: 10.1093/carcin/19.12.2187.
375 An increase of cytochrome C oxidase mediated disruption of gemcitabine incorporation into DNA in a resistant KB clone. Biochem Pharmacol. 2007 Jun 15;73(12):1927-38. doi: 10.1016/j.bcp.2007.03.014. Epub 2007 Mar 20.
376 Resveratrol induces apoptosis and alters gene expression in human fibrosarcoma cells. Anticancer Res. 2015 Feb;35(2):767-74.
377 High-throughput data integration of RNA-miRNA-circRNA reveals novel insights into mechanisms of benzo[a]pyrene-induced carcinogenicity. Nucleic Acids Res. 2015 Mar 11;43(5):2525-34. doi: 10.1093/nar/gkv115. Epub 2015 Feb 17.
378 CRISPR/Cas9-mediated gene knockout screens and target identification via whole-genome sequencing uncover host genes required for picornavirus infection. J Biol Chem. 2017 Jun 23;292(25):10664-10671. doi: 10.1074/jbc.M117.782425. Epub 2017 Apr 26.
379 Pro-oxidant induced DNA damage in human lymphoblastoid cells: homeostatic mechanisms of genotoxic tolerance. Toxicol Sci. 2012 Aug;128(2):387-97. doi: 10.1093/toxsci/kfs152. Epub 2012 Apr 26.
380 Increased sensitivity for troglitazone-induced cytotoxicity using a human in vitro co-culture model. Toxicol In Vitro. 2009 Oct;23(7):1387-95.
381 Non-nutritional sweeteners effects on endothelial vascular function. Toxicol In Vitro. 2020 Feb;62:104694. doi: 10.1016/j.tiv.2019.104694. Epub 2019 Oct 23.
382 PPARgamma controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells. J Exp Med. 2006 Oct 2;203(10):2351-62.
383 Activity of adenosine deaminase in red blood cells of patients suffering from multiple sclerosis treated with adrenocorticotropic hormone. Pol J Pharmacol. 1995 Nov-Dec;47(6):525-30.
384 Acute hypersensitivity of pluripotent testicular cancer-derived embryonal carcinoma to low-dose 5-aza deoxycytidine is associated with global DNA Damage-associated p53 activation, anti-pluripotency and DNA demethylation. PLoS One. 2012;7(12):e53003. doi: 10.1371/journal.pone.0053003. Epub 2012 Dec 27.
385 Detection of gene expression alteration of myeloma cells treated with arsenic trioxide. Zhonghua Xue Ye Xue Za Zhi. 2005 Apr;26(4):209-13.
386 The identification of cellular targets of 17 estradiol using a lytic (T7) cDNA phage display approach. Toxicol In Vitro. 2011 Feb;25(1):388-93. doi: 10.1016/j.tiv.2010.10.012. Epub 2010 Oct 27.
387 Indomethacin and juglone inhibit inflammatory molecules to induce apoptosis in colon cancer cells. J Biochem Mol Toxicol. 2020 Feb;34(2):e22433. doi: 10.1002/jbt.22433. Epub 2020 Jan 9.
388 A cell impedance-based real-time in vitro assay to assess the toxicity of amphotericin B formulations. Toxicol Appl Pharmacol. 2017 Nov 1;334:18-23. doi: 10.1016/j.taap.2017.08.017. Epub 2017 Sep 1.
389 CBD Promotes Oral Ulcer Healing via Inhibiting CMPK2-Mediated Inflammasome. J Dent Res. 2022 Feb;101(2):206-215. doi: 10.1177/00220345211024528. Epub 2021 Jul 16.
390 Sertraline, an antidepressant, induces apoptosis in hepatic cells through the mitogen-activated protein kinase pathway. Toxicol Sci. 2014 Feb;137(2):404-15. doi: 10.1093/toxsci/kft254. Epub 2013 Nov 5.
391 Anti-inflammatory effects of the GABA(B) receptor agonist baclofen in allergic contact dermatitis. Exp Dermatol. 2010 Jul 1;19(7):661-6. doi: 10.1111/j.1600-0625.2010.01076.x. Epub 2010 Feb 25.
392 Frankincense myrrh attenuates hepatocellular carcinoma by regulating tumor blood vessel development through multiple epidermal growth factor receptor-mediated signaling pathways. World J Gastrointest Oncol. 2022 Feb 15;14(2):450-477. doi: 10.4251/wjgo.v14.i2.450.
393 Sulfasalazine unveils a contact-independent HSV-TK/ganciclovir gene therapy bystander effect in malignant gliomas. Int J Oncol. 2007 Jan;30(1):283-90.
394 Oxidative Stress Alters miRNA and Gene Expression Profiles in Villous First Trimester Trophoblasts. Biomed Res Int. 2015;2015:257090. doi: 10.1155/2015/257090. Epub 2015 Aug 3.
395 Influence of chemotherapeutic agents and cytokines on the expression of 5-fluorouracil-associated enzymes in human colon cancer cell lines. J Gastroenterol. 2006 Feb;41(2):140-50.
396 Interferon-alpha enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin by p53-dependent apoptosis. Acta Pharmacol Sin. 2007 Nov;28(11):1835-41. doi: 10.1111/j.1745-7254.2007.00662.x.
397 Effects of interferon-alpha monotherapy on hepatic drug metabolism in cancer patients. Br J Clin Pharmacol. 1993 Sep;36(3):229-35. doi: 10.1111/j.1365-2125.1993.tb04222.x.
398 Molecular mechanisms of quercitrin-induced apoptosis in non-small cell lung cancer. Arch Med Res. 2014 Aug;45(6):445-54.
399 Differential expression of microRNAs and their predicted targets in renal cells exposed to amphotericin B and its complex with copper (II) ions. Toxicol Mech Methods. 2017 Sep;27(7):537-543. doi: 10.1080/15376516.2017.1333554. Epub 2017 Jun 8.
400 Regulatory role of nitric oxide on monocyte-derived dendritic cell functions. J Interferon Cytokine Res. 2003 Aug;23(8):423-31. doi: 10.1089/107999003322277838.
401 Direct evidence for immunomodulatory properties of ribavirin on T-cell reactivity to hepatitis C virus. Antiviral Res. 2007 Jul;75(1):36-42. doi: 10.1016/j.antiviral.2006.11.008. Epub 2006 Dec 13.
402 Differential effects of three antibiotics on T helper cell cytokine expression. J Antimicrob Chemother. 2005 Sep;56(3):502-6. doi: 10.1093/jac/dki251. Epub 2005 Jul 8.
403 Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes. J Immunol. 2008 May 15;180(10):6988-96. doi: 10.4049/jimmunol.180.10.6988.
404 The flavonoid, quercetin, differentially regulates Th-1 (IFNgamma) and Th-2 (IL4) cytokine gene expression by normal peripheral blood mononuclear cells. Biochim Biophys Acta. 2002 Dec 16;1593(1):29-36. doi: 10.1016/s0167-4889(02)00328-2.
405 [Effects of vitamin A on the differentiation, maturation and functions of dendritic cells from cord blood]. Zhonghua Er Ke Za Zhi. 2004 May;42(5):340-3.
406 Detection of Drug-Responsive T-Lymphocytes in a Case of Fatal Antituberculosis Drug-Related Liver Injury. Chem Res Toxicol. 2016 Nov 21;29(11):1793-1795. doi: 10.1021/acs.chemrestox.6b00393. Epub 2016 Nov 9.
407 Characterization of drug-specific signaling between primary human hepatocytes and immune cells. Toxicol Sci. 2017 Jul 1;158(1):76-89.
408 Cannabidiol enhances cytotoxicity of anti-cancer drugs in human head and neck squamous cell carcinoma. Sci Rep. 2020 Nov 26;10(1):20622. doi: 10.1038/s41598-020-77674-y.
409 An in vitro coculture system of human peripheral blood mononuclear cells with hepatocellular carcinoma-derived cells for predicting drug-induced liver injury. Arch Toxicol. 2021 Jan;95(1):149-168. doi: 10.1007/s00204-020-02882-4. Epub 2020 Aug 20.
410 Cannabidiol Modulates the Immunophenotype and Inhibits the Activation of the Inflammasome in Human Gingival Mesenchymal Stem Cells. Front Physiol. 2016 Nov 24;7:559. doi: 10.3389/fphys.2016.00559. eCollection 2016.
411 ERE-independent ERalpha target genes differentially expressed in human breast tumors. Mol Cell Endocrinol. 2005 Dec 21;245(1-2):53-9. doi: 10.1016/j.mce.2005.10.003. Epub 2005 Nov 17.
412 Reactive metabolite of gefitinib activates inflammasomes: implications for gefitinib-induced idiosyncratic reaction. J Toxicol Sci. 2020;45(11):673-680. doi: 10.2131/jts.45.673.
413 Gypenosides protect retinal pigment epithelium cells from oxidative stress. Food Chem Toxicol. 2018 Feb;112:76-85.
414 (9)-Tetrahydrocannabinol Suppresses Monocyte-Mediated Astrocyte Production of Monocyte Chemoattractant Protein 1 and Interleukin-6 in a Toll-Like Receptor 7-Stimulated Human Coculture. J Pharmacol Exp Ther. 2019 Oct;371(1):191-201. doi: 10.1124/jpet.119.260661. Epub 2019 Aug 5.
415 Changes in gene expression profiles in response to selenium supplementation among individuals with arsenic-induced pre-malignant skin lesions. Toxicol Lett. 2007 Mar 8;169(2):162-76. doi: 10.1016/j.toxlet.2007.01.006. Epub 2007 Jan 19.
416 Profiling the immunotoxicity of chemicals based on in vitro evaluation by a combination of the Multi-ImmunoTox assay and the IL-8 Luc assay. Arch Toxicol. 2018 Jun;92(6):2043-2054. doi: 10.1007/s00204-018-2199-7. Epub 2018 Mar 29.
417 Spironolactone induces apoptosis in human mononuclear cells. Association between apoptosis and cytokine suppression. Apoptosis. 2006 Apr;11(4):573-9. doi: 10.1007/s10495-006-4919-3.
418 Ouabain induces inhibition of the progression phase in human T-cell proliferation. J Cell Physiol. 1995 Nov;165(2):246-53. doi: 10.1002/jcp.1041650205.
419 1,25-Dihydroxyvitamin D3-regulated expression of genes involved in human T-lymphocyte proliferation and differentiation. Cancer Res. 1986 Nov;46(11):5827-31.
420 Pimecrolimus inhibits up-regulation of OX40 and synthesis of inflammatory cytokines upon secondary T cell activation by allogeneic dendritic cells. Clin Exp Immunol. 2002 Oct;130(1):85-92. doi: 10.1046/j.1365-2249.2002.01962.x.
421 Effects of different anaesthetic agents on immune cell function in vitro. Eur J Anaesthesiol. 2005 Aug;22(8):616-23. doi: 10.1017/s0265021505001031.
422 Differential effects of statins on relevant functions of human monocyte-derived dendritic cells. J Leukoc Biol. 2006 Mar;79(3):529-38. doi: 10.1189/jlb.0205064. Epub 2005 Dec 30.
423 Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine. Acta Psychiatr Scand. 1994 May;89(5):346-51. doi: 10.1111/j.1600-0447.1994.tb01527.x.
424 Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations. Pharmacogenomics. 2008 Oct;9(10):1543-6. doi: 10.2217/14622416.9.10.1543.
425 Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese. Pharmacogenomics. 2010 Mar;11(3):349-56. doi: 10.2217/pgs.09.162.
426 HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):4134-9. doi: 10.1073/pnas.0409500102. Epub 2005 Mar 2.
427 Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophen. Clin Pharmacol Ther. 2016 Apr;99(4):432-41.
428 HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese. Epilepsia. 2013 Jul;54(7):1307-14. doi: 10.1111/epi.12217. Epub 2013 May 20.
429 Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis. Chem Res Toxicol. 2015 May 18;28(5):927-34. doi: 10.1021/tx5005248. Epub 2015 Apr 3.
430 Genetic variations in HLA-B region and hypersensitivity reactions to abacavir. Lancet. 2002 Mar 30;359(9312):1121-2. doi: 10.1016/S0140-6736(02)08158-8.
431 HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet. 2009 Jul;41(7):816-9. doi: 10.1038/ng.379. Epub 2009 May 31.
432 HLA alleles influence the clinical signature of amoxicillin-clavulanate hepatotoxicity. PLoS One. 2013 Jul 9;8(7):e68111. doi: 10.1371/journal.pone.0068111. Print 2013.
433 A protein-coated magnetic beads as a tool for the rapid drug-protein binding study. J Pharm Biomed Anal. 2010 Jul 8;52(3):420-4. doi: 10.1016/j.jpba.2009.06.023. Epub 2009 Jun 18.
434 The three recombinant domains of human serum albumin. Structural characterization and ligand binding properties. J Biol Chem. 1999 Oct 8;274(41):29303-10. doi: 10.1074/jbc.274.41.29303.
435 Exploring binding properties of sertraline with human serum albumin: Combination of spectroscopic and molecular modeling studies. Chem Biol Interact. 2015 Dec 5;242:235-46. doi: 10.1016/j.cbi.2015.10.006. Epub 2015 Oct 22.
436 Low-expressional IGF1 mediated methimazole-induced liver developmental toxicity in fetal mice. Toxicology. 2018 Sep 1;408:70-79. doi: 10.1016/j.tox.2018.07.004. Epub 2018 Jul 7.
437 Use of peak decay analysis and affinity microcolumns containing silica monoliths for rapid determination of drug-protein dissociation rates. J Chromatogr A. 2011 Apr 15;1218(15):2072-8. doi: 10.1016/j.chroma.2010.09.070. Epub 2010 Oct 16.
438 [Colchicine in chronic liver disease of alcoholic etiology. Double-blind, randomized study of its effects on blood levels of plasma proteins and clinical course in patients]. Rev Assoc Med Bras (1992). 1995 May-Jun;41(3):207-12.
439 Editor's Highlight: Modeling Compound-Induced Fibrogenesis In Vitro Using Three-Dimensional Bioprinted Human Liver Tissues. Toxicol Sci. 2016 Dec;154(2):354-367. doi: 10.1093/toxsci/kfw169. Epub 2016 Sep 7.
440 Covalent binding of the flavonoid quercetin to human serum albumin. J Agric Food Chem. 2005 May 18;53(10):4194-7. doi: 10.1021/jf050061m.
441 Food derived respiratory complex I inhibitors modify the effect of Leber hereditary optic neuropathy mutations. Food Chem Toxicol. 2018 Oct;120:89-97. doi: 10.1016/j.fct.2018.07.014. Epub 2018 Jul 6.
442 Beneficial effects of resveratrol on respiratory chain defects in patients' fibroblasts involve estrogen receptor and estrogen-related receptor alpha signaling. Hum Mol Genet. 2014 Apr 15;23(8):2106-19.
443 In vitro blood brain barrier exposure to mycotoxins and carotenoids pumpkin extract alters mitochondrial gene expression and oxidative stress. Food Chem Toxicol. 2021 Jul;153:112261. doi: 10.1016/j.fct.2021.112261. Epub 2021 May 17.
444 Transcriptome dynamics of alternative splicing events revealed early phase of apoptosis induced by methylparaben in H1299 human lung carcinoma cells. Arch Toxicol. 2020 Jan;94(1):127-140. doi: 10.1007/s00204-019-02629-w. Epub 2019 Nov 20.
445 CD34+ derived macrophage and dendritic cells display differential responses to paraquat. Toxicol In Vitro. 2021 Sep;75:105198. doi: 10.1016/j.tiv.2021.105198. Epub 2021 Jun 9.
446 [Construction of subtracted cDNA library in human Jurkat T cell line induced by arsenic trioxide in vitro]. Zhonghua Yu Fang Yi Xue Za Zhi. 2003 Nov;37(6):403-7.
447 Inhibition of mitochondrial function in HL60 cells is associated with an increased apoptosis and expression of CD14. Biochem Biophys Res Commun. 1999 Sep 24;263(2):294-300. doi: 10.1006/bbrc.1999.1356.
448 Etoposide induces necrosis through p53-mediated antiapoptosis in human kidney proximal tubule cells. Toxicol Sci. 2015 Nov;148(1):204-19.
449 Aberrant cell proliferation by enhanced mitochondrial biogenesis via mtTFA in arsenical skin cancers. Am J Pathol. 2011 May;178(5):2066-76.
450 Respiration and growth defects in transmitochondrial cell lines carrying the 11778 mutation associated with Leber's hereditary optic neuropathy. J Biol Chem. 1996 May 31;271(22):13155-61. doi: 10.1074/jbc.271.22.13155.
451 Involvement of mitochondrial dysfunction in nefazodone-induced hepatotoxicity. Food Chem Toxicol. 2016 Aug;94:148-58. doi: 10.1016/j.fct.2016.06.001. Epub 2016 Jun 8.
452 Effects of BMS-986094, a Guanosine Nucleotide Analogue, on Mitochondrial DNA Synthesis and Function. Toxicol Sci. 2016 Oct;153(2):396-408. doi: 10.1093/toxsci/kfw135. Epub 2016 Jul 27.
453 Persistent and non-persistent changes in gene expression result from long-term estrogen exposure of MCF-7 breast cancer cells. J Steroid Biochem Mol Biol. 2011 Feb;123(3-5):140-50.
454 Arsenite and cadmium promote the development of mammary tumors. Carcinogenesis. 2020 Jul 14;41(7):1005-1014. doi: 10.1093/carcin/bgz176.
455 Comparative effects of microtubules disruption on glucocorticoid receptor functions in proliferating and quiescent cells. Int J Toxicol. 2010 May-Jun;29(3):326-35. doi: 10.1177/1091581810366486.
456 Induction of CYP3As in HepG2 cells by several drugs. Association between induction of CYP3A4 and expression of glucocorticoid receptor. Biol Pharm Bull. 2003 Apr;26(4):510-7.
457 HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. N Engl J Med. 2011 Mar 24;364(12):1134-43. doi: 10.1056/NEJMoa1013297.
458 Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans. Pharmacogenet Genomics. 2011 May;21(5):303-7. doi: 10.1097/FPC.0b013e32834282b8.
459 A study of HLA class I and class II 4-digit allele level in Stevens-Johnson syndrome and toxic epidermal necrolysis. Int J Immunogenet. 2011 Aug;38(4):303-9. doi: 10.1111/j.1744-313X.2011.01011.x. Epub 2011 May 4.
460 Ticlopidine-induced hepatotoxicity is associated with specific human leukocyte antigen genomic subtypes in Japanese patients: a preliminary case-control study. Pharmacogenomics J. 2008 Feb;8(1):29-33. doi: 10.1038/sj.tpj.6500442. Epub 2007 Mar 6.
461 Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2015 Jan;143(1):97-106. doi: 10.1093/toxsci/kfu210. Epub 2014 Oct 10.
462 Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. Toxicol Appl Pharmacol. 2022 Aug 15;449:116110. doi: 10.1016/j.taap.2022.116110. Epub 2022 Jun 7.
463 Sertraline induces endoplasmic reticulum stress in hepatic cells. Toxicology. 2014 Aug 1;322:78-88. doi: 10.1016/j.tox.2014.05.007. Epub 2014 May 24.
464 Comparative gene expression profiling reveals partially overlapping but distinct genomic actions of different antiestrogens in human breast cancer cells. J Cell Biochem. 2006 Aug 1;98(5):1163-84.
465 Arsenite stress down-regulates phosphorylation and 14-3-3 binding of leucine-rich repeat kinase 2 (LRRK2), promoting self-association and cellular redistribution. J Biol Chem. 2014 Aug 1;289(31):21386-400. doi: 10.1074/jbc.M113.528463. Epub 2014 Jun 18.
466 Troglitazone suppresses cell growth of KU812 cells independently of PPARgamma. Eur J Pharmacol. 2002 Feb 1;436(1-2):7-13. doi: 10.1016/s0014-2999(01)01577-1.
467 D-Penicillamine targets metastatic melanoma cells with induction of the unfolded protein response (UPR) and Noxa (PMAIP1)-dependent mitochondrial apoptosis. Apoptosis. 2012 Oct;17(10):1079-94.
468 Pyrazinamide-induced hepatotoxicity is alleviated by 4-PBA via inhibition of the PERK-eIF2-ATF4-CHOP pathway. Toxicology. 2017 Mar 1;378:65-75. doi: 10.1016/j.tox.2017.01.002. Epub 2017 Jan 4.
469 Glucosamine-induced endoplasmic reticulum stress attenuates apolipoprotein B100 synthesis via PERK signaling. J Lipid Res. 2009 Sep;50(9):1814-23. doi: 10.1194/jlr.M800343-JLR200. Epub 2009 Apr 21.
470 Bupropion, an atypical antidepressant, induces endoplasmic reticulum stress and caspase-dependent cytotoxicity in SH-SY5Y cells. Toxicology. 2011 Jul 11;285(1-2):1-7. doi: 10.1016/j.tox.2011.02.006. Epub 2011 Feb 24.
471 Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regeneration. Arthritis Res Ther. 2009;11(1):R15.
472 Mechanisms of dexamethasone-induced disturbed sleep and fatigue in paediatric patients receiving treatment for ALL. Eur J Cancer. 2010 Jul;46(10):1848-55. doi: 10.1016/j.ejca.2010.03.026. Epub 2010 Apr 17.
473 Calcium pantothenate modulates gene expression in proliferating human dermal fibroblasts. Exp Dermatol. 2009 Nov;18(11):969-78. doi: 10.1111/j.1600-0625.2009.00884.x. Epub 2009 Apr 8.
474 Blood cell oxidative stress precedes hemolysis in whole blood-liver slice co-cultures of rat, dog, and human tissues. Toxicol Appl Pharmacol. 2010 May 1;244(3):354-65. doi: 10.1016/j.taap.2010.01.017. Epub 2010 Feb 6.
475 ?-adrenoceptors and muscarinic receptors mediate opposing effects on endothelin-1 expression in human lung fibroblasts. Eur J Pharmacol. 2012 Sep 15;691(1-3):218-24. doi: 10.1016/j.ejphar.2012.07.002. Epub 2012 Jul 13.
476 Induction of endothelin-1 expression by oxidative stress in vascular smooth muscle cells. Cardiovasc Pathol. 2001 Nov-Dec;10(6):311-5. doi: 10.1016/s1054-8807(01)00095-3.
477 Functional gene expression profile underlying methotrexate-induced senescence in human colon cancer cells. Tumour Biol. 2011 Oct;32(5):965-76.
478 [Effect of simvastatin on endothelin-1 expression in endothelial cell cultured hypoxically]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2008 Jan;39(1):72-5.
479 Effects of dietary polyphenols on gene expression in human vascular endothelial cells. Proc Nutr Soc. 2008 Feb;67(1):42-7.
480 Cardiac toxicity of high-dose cyclophosphamide in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation. Int J Hematol. 2007 Jun;85(5):408-14. doi: 10.1532/IJH97.E0620.
481 Different effects of angiotensin converting enzyme inhibitors on endothelin-1 and nitric oxide balance in human vascular endothelial cells: evidence of an oxidant-sensitive pathway. Mediators Inflamm. 2008;2008:305087. doi: 10.1155/2008/305087. Epub 2008 Dec 1.
482 Effect of troglitazone on plasma lipid metabolism and lipoprotein lipase. Br J Clin Pharmacol. 1999 Apr;47(4):433-9. doi: 10.1046/j.1365-2125.1999.00920.x.
483 Global effects of inorganic arsenic on gene expression profile in human macrophages. Mol Immunol. 2009 Feb;46(4):649-56.
484 Effects of nevirapine and efavirenz on human adipocyte differentiation, gene expression, and release of adipokines and cytokines. Antiviral Res. 2011 Aug;91(2):112-9. doi: 10.1016/j.antiviral.2011.04.018. Epub 2011 May 17.
485 Genomic and proteomic analysis of the effects of cannabinoids on normal human astrocytes. Brain Res. 2008 Jan 29;1191:1-11.
486 Activating effect of benzbromarone, a uricosuric drug, on peroxisome proliferator-activated receptors. PPAR Res. 2007;2007:36092. doi: 10.1155/2007/36092.
487 Quantitative proteomics and transcriptomics addressing the estrogen receptor subtype-mediated effects in T47D breast cancer cells exposed to the phytoestrogen genistein. Mol Cell Proteomics. 2011 Jan;10(1):M110.002170.
488 Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells. J Biol Chem. 2012 Dec 14;287(51):43137-55.
489 Transcriptome-based functional classifiers for direct immunotoxicity. Arch Toxicol. 2014 Mar;88(3):673-89.
490 Transcriptome and DNA methylome dynamics during triclosan-induced cardiomyocyte differentiation toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
491 Endoplasmic reticulum stress contributes to arsenic trioxide-induced intrinsic apoptosis in human umbilical and bone marrow mesenchymal stem cells. Environ Toxicol. 2016 Mar;31(3):314-28.
492 Transcriptional profiling in the human prefrontal cortex: evidence for two activational states associated with cocaine abuse. Pharmacogenomics J. 2003;3(1):27-40.
493 4.8% sevoflurane induces activation of autophagy in human neuroblastoma SH-SY5Y cells by the AMPK/mTOR signaling pathway. Neurotoxicology. 2022 May;90:256-264. doi: 10.1016/j.neuro.2022.04.008. Epub 2022 Apr 23.
494 Enhanced chemotherapeutic efficacy of docetaxel in human lung cancer cell line via GLUT1 inhibitor. J Biochem Mol Toxicol. 2023 Jun;37(6):e23348. doi: 10.1002/jbt.23348. Epub 2023 Mar 31.
495 Breast cancer cells response to the antineoplastic agents cisplatin, carboplatin, and doxorubicin at the mRNA expression levels of distinct apoptosis-related genes, including the new member, BCL2L12. Ann N Y Acad Sci. 2007 Jan;1095:35-44. doi: 10.1196/annals.1397.005.
496 Extracellular signal-regulated kinase activation and Bcl-2 downregulation mediate apoptosis after gemcitabine treatment partly via a p53-independent pathway. Eur J Pharmacol. 2004 Oct 19;502(3):169-83. doi: 10.1016/j.ejphar.2004.09.006.
497 Verapamil potentiates anti-glioblastoma efficacy of temozolomide by modulating apoptotic signaling. Toxicol In Vitro. 2018 Oct;52:306-313. doi: 10.1016/j.tiv.2018.07.001. Epub 2018 Jul 9.
498 Inhibition of caspase-dependent mitochondrial permeability transition protects airway epithelial cells against mustard-induced apoptosis. Apoptosis. 2006 Sep;11(9):1545-59. doi: 10.1007/s10495-006-8764-1.
499 -Carotene Induces Apoptosis in Human Esophageal Squamous Cell Carcinoma Cell Lines via the Cav-1/AKT/NF-B Signaling Pathway. J Biochem Mol Toxicol. 2016 Mar;30(3):148-57. doi: 10.1002/jbt.21773. Epub 2016 Jan 6.
500 Synergistic effect of trichostatin A and 5-aza-2'-deoxycytidine on growth inhibition of pancreatic endocrine tumour cell lines: a proteomic study. Proteomics. 2009 Apr;9(7):1952-66. doi: 10.1002/pmic.200701089.
501 Proteomic analysis of liver cancer cells treated with suberonylanilide hydroxamic acid. Cancer Chemother Pharmacol. 2008 Apr;61(5):791-802.
502 Copper chelator ATN-224 inhibits endothelial function by multiple mechanisms. Microvasc Res. 2009 May;77(3):314-26.
503 Consequences of the natural retinoid/retinoid X receptor ligands action in human breast cancer MDA-MB-231 cell line: Focus on functional proteomics. Toxicol Lett. 2017 Nov 5;281:26-34. doi: 10.1016/j.toxlet.2017.09.001. Epub 2017 Sep 5.
504 Identification of biomarkers for the initiation of apoptosis in human preneoplastic colonocytes by proteome analysis. Int J Cancer. 2004 Mar 20;109(2):220-9. doi: 10.1002/ijc.11692.
505 Comparison of the gene expression profiles of monocytic versus granulocytic lineages of HL-60 leukemia cell differentiation by DNA microarray analysis. Life Sci. 2003 Aug 15;73(13):1705-19. doi: 10.1016/s0024-3205(03)00515-0.
506 Darinaparsin induces a unique cellular response and is active in an arsenic trioxide-resistant myeloma cell line. Mol Cancer Ther. 2009 May;8(5):1197-206.
507 Multifaceted preventive effects of single agent quercetin on a human prostate adenocarcinoma cell line (PC-3): implications for nutritional transcriptomics and multi-target therapy. Med Oncol. 2011 Dec;28(4):1395-404. doi: 10.1007/s12032-010-9603-3. Epub 2010 Jul 2.
508 Insulin regulation of hexose transport in mouse 3T3-L1 cells expressing the human HepG2 glucose transporter. J Biol Chem. 1990 Nov 25;265(33):20106-16.
509 Effects of troglitazone on cellular differentiation, insulin signaling, and glucose metabolism in cultured human skeletal muscle cells. Biochem Biophys Res Commun. 2001 Jan 26;280(3):664-74. doi: 10.1006/bbrc.2000.4216.
510 Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13. Front Mol Neurosci. 2021 May 28;14:673144. doi: 10.3389/fnmol.2021.673144. eCollection 2021.
511 Disturbance of cellular glucose transport by two prevalently used fluoroquinolone antibiotics ciprofloxacin and levofloxacin involves glucose transporter type 1. Toxicol Lett. 2009 Jan 30;184(2):81-4. doi: 10.1016/j.toxlet.2008.10.017. Epub 2008 Oct 28.
512 Aluminum toxicity triggers the nuclear translocation of HIF-1alpha and promotes anaerobiosis in hepatocytes. Toxicol In Vitro. 2007 Feb;21(1):16-24. doi: 10.1016/j.tiv.2006.07.013. Epub 2006 Aug 5.
513 Kinetic analysis of the liver-type (GLUT2) and brain-type (GLUT3) glucose transporters in Xenopus oocytes: substrate specificities and effects of transport inhibitors. Biochem J. 1993 Mar 15;290 ( Pt 3)(Pt 3):701-6. doi: 10.1042/bj2900701.
514 A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system. Toxicol Sci. 2005 Feb;83(2):282-92.
515 In vitro detection of drug-induced phospholipidosis using gene expression and fluorescent phospholipid based methodologies. Toxicol Sci. 2007 Sep;99(1):162-73.
516 Retinoic acid represses a cassette of candidate pluripotency chromosome 12p genes during induced loss of human embryonal carcinoma tumorigenicity. Biochim Biophys Acta. 2005 Oct 15;1731(1):48-56. doi: 10.1016/j.bbaexp.2005.08.006. Epub 2005 Sep 1.
517 Crosstalk between alveolar macrophages and alveolar epithelial cells/fibroblasts contributes to the pulmonary toxicity of gefitinib. Toxicol Lett. 2021 Mar 1;338:1-9. doi: 10.1016/j.toxlet.2020.11.011. Epub 2020 Nov 25.
518 Cannabidiol selectively modulates interleukin (IL)-1 and IL-6 production in toll-like receptor activated human peripheral blood monocytes. Toxicology. 2021 Dec;464:153016. doi: 10.1016/j.tox.2021.153016. Epub 2021 Nov 2.
519 Monitoring of deiodinase deficiency based on transcriptomic responses in SH-SY5Y cells. Arch Toxicol. 2013 Jun;87(6):1103-13. doi: 10.1007/s00204-013-1018-4. Epub 2013 Feb 10.
520 Dimethyl Fumarate Inhibits the Nuclear Factor B Pathway in Breast Cancer Cells by Covalent Modification of p65 Protein. J Biol Chem. 2016 Feb 12;291(7):3639-47. doi: 10.1074/jbc.M115.679704. Epub 2015 Dec 18.
521 Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients. Arterioscler Thromb Vasc Biol. 2002 Jul 1;22(7):1194-9. doi: 10.1161/01.atv.0000022694.16328.cc.
522 Plant polyphenols differentially modulate inflammatory responses of human keratinocytes by interfering with activation of transcription factors NFB and AhR and EGFR-ERK pathway. Toxicol Appl Pharmacol. 2011 Sep 1;255(2):138-49.
523 Pharmacogenomic analysis of acute promyelocytic leukemia cells highlights CYP26 cytochrome metabolism in differential all-trans retinoic acid sensitivity. Blood. 2007 May 15;109(10):4450-60.
524 Comparative gene expression analysis of a chronic myelogenous leukemia cell line resistant to cyclophosphamide using oligonucleotide arrays and response to tyrosine kinase inhibitors. Leuk Res. 2007 Nov;31(11):1511-20.
525 Anti-diabetic effect of oligosaccharides from seaweed Sargassum confusum via JNK-IRS1/PI3K signalling pathways and regulation of gut microbiota. Food Chem Toxicol. 2019 Sep;131:110562. doi: 10.1016/j.fct.2019.110562. Epub 2019 Jun 7.
526 Glucosamine-induced endoplasmic reticulum stress affects GLUT4 expression via activating transcription factor 6 in rat and human skeletal muscle cells. Diabetologia. 2010 May;53(5):955-65. doi: 10.1007/s00125-010-1676-1. Epub 2010 Feb 18.
527 Effects of different antipsychotics and the antidepressant mirtazapine on glucose transporter mRNA levels in human blood cells. J Psychiatr Res. 2006 Jun;40(4):374-9. doi: 10.1016/j.jpsychires.2005.04.016. Epub 2005 Jul 5.
528 Valproic acid promotes mitochondrial dysfunction in primary human hepatocytes in vitro; impact of C/EBP-controlled gene expression. Arch Toxicol. 2020 Oct;94(10):3463-3473. doi: 10.1007/s00204-020-02835-x. Epub 2020 Jul 4.
529 Enhanced insulin-stimulated glycogen synthesis in response to insulin, metformin or rosiglitazone is associated with increased mRNA expression of GLUT4 and peroxisomal proliferator activator receptor gamma co-activator 1. Diabetologia. 2005 Jun;48(6):1173-9. doi: 10.1007/s00125-005-1741-3. Epub 2005 Apr 30.
530 Rofecoxib modulates multiple gene expression pathways in a clinical model of acute inflammatory pain. Pain. 2007 Mar;128(1-2):136-47.
531 Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma. Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3951-6. doi: 10.1073/pnas.96.7.3951.
532 Ursodeoxycholic acid but not tauroursodeoxycholic acid inhibits proliferation and differentiation of human subcutaneous adipocytes. PLoS One. 2013 Dec 3;8(12):e82086. doi: 10.1371/journal.pone.0082086. eCollection 2013.
533 Differential effects of peroxisome proliferator-activated receptor activators on the mRNA levels of genes involved in lipid metabolism in primary human monocyte-derived macrophages. Metabolism. 2003 May;52(5):652-7. doi: 10.1053/meta.2003.50100.
534 Induction of the endoplasmic reticulum stress protein GADD153/CHOP by capsaicin in prostate PC-3 cells: a microarray study. Biochem Biophys Res Commun. 2008 Aug 8;372(4):785-91.
535 Human adipocyte fatty acid-binding protein (aP2) gene promoter-driven reporter assay discriminates nonlipogenic peroxisome proliferator-activated receptor gamma ligands. J Pharmacol Exp Ther. 2004 Nov;311(2):467-75. doi: 10.1124/jpet.104.068254. Epub 2004 Jul 23.
536 Cytosine arabinoside induces ectoderm and inhibits mesoderm expression in human embryonic stem cells during multilineage differentiation. Br J Pharmacol. 2011 Apr;162(8):1743-56.
537 Lipid Rafts Disruption Increases Ochratoxin A Cytotoxicity to Hepatocytes. J Biochem Mol Toxicol. 2016 Feb;30(2):71-9. doi: 10.1002/jbt.21738. Epub 2015 Aug 25.
538 ST1926, a novel and orally active retinoid-related molecule inducing apoptosis in myeloid leukemia cells: modulation of intracellular calcium homeostasis. Blood. 2004 Jan 1;103(1):194-207.
539 In vitro dual effect of arsenic trioxide on hemopoiesis: inhibition of erythropoiesis and stimulation of megakaryocytic maturation. Blood Cells Mol Dis. 2006 Jan-Feb;36(1):59-76. doi: 10.1016/j.bcmd.2005.10.005. Epub 2005 Dec 15.
540 Phenolic metabolites of benzene inhibited the erythroid differentiation of K562 cells. Toxicol Lett. 2011 Jun 24;203(3):190-9. doi: 10.1016/j.toxlet.2011.03.012. Epub 2011 Mar 23.
541 Oxidative stress involvement in chemically induced differentiation of K562 cells. Free Radic Biol Med. 2000 Jan 1;28(1):18-27.
542 Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis. Blood. 2005 May 15;105(10):3833-40. doi: 10.1182/blood-2004-03-0828. Epub 2004 Aug 3.
543 Accumulation of gamma-globin mRNA and induction of irreversible erythroid differentiation after treatment of CML cell line K562 with new doxorubicin derivatives. Biochem Pharmacol. 2007 Jan 15;73(2):175-84. doi: 10.1016/j.bcp.2006.09.028. Epub 2006 Oct 4.
544 Effects of arsenic disulfide on apoptosis, histone acetylation, toll like receptor 2 activation, and erythropoiesis in bone marrow mononuclear cells of myelodysplastic syndromes patients in vitro. Leuk Res. 2017 Nov;62:4-11. doi: 10.1016/j.leukres.2017.09.010. Epub 2017 Sep 19.
545 Expression of glutathione S-transferase P1-1 in differentiating K562: role of GATA-1. Biochem Biophys Res Commun. 2003 Nov 28;311(4):815-21.
546 The BET bromodomain inhibitor JQ1 suppresses growth of pancreatic ductal adenocarcinoma in patient-derived xenograft models. Oncogene. 2016 Feb 18;35(7):833-45.
547 Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration. Oncotarget. 2016 Nov 22;7(47):77543-77557. doi: 10.18632/oncotarget.12721.
548 Hsa-let-7g miRNA regulates the anti-tumor effects of gastric cancer cells under oxidative stress through the expression of DDR genes. J Toxicol Sci. 2015 Jun;40(3):329-38. doi: 10.2131/jts.40.329.
549 Inhibition of cardiomyocyte differentiation of human induced pluripotent stem cells by Ribavirin: Implication for its cardiac developmental toxicity. Toxicology. 2020 Apr 15;435:152422. doi: 10.1016/j.tox.2020.152422. Epub 2020 Feb 26.
550 Synthesis and structure-activity relationships of new antiproliferative and proapoptotic retinoid-related biphenyl-4-yl-acrylic acids. Bioorg Med Chem. 2007 Jul 15;15(14):4863-75. doi: 10.1016/j.bmc.2007.04.057. Epub 2007 May 3.
551 Methotrexate induces apoptosis through p53/p21-dependent pathway and increases E-cadherin expression through downregulation of HDAC/EZH2. Biochem Pharmacol. 2011 Feb 15;81(4):510-7. doi: 10.1016/j.bcp.2010.11.014. Epub 2010 Nov 27.
552 Actinomycin D inhibits the expression of the cystine/glutamate transporter xCT via attenuation of CD133 synthesis in CD133(+) HCC. Chem Biol Interact. 2019 Aug 25;309:108713. doi: 10.1016/j.cbi.2019.06.026. Epub 2019 Jun 19.
553 Simvastatin and purine analogs have a synergic effect on apoptosis of chronic lymphocytic leukemia cells. Ann Hematol. 2010 Nov;89(11):1115-24. doi: 10.1007/s00277-010-0988-z. Epub 2010 May 25.
554 The involvement of hepatic cytochrome P450s in the cytotoxicity of lapatinib. Toxicol Sci. 2023 Dec 21;197(1):69-78. doi: 10.1093/toxsci/kfad099.
555 The isoflavonoids genistein and quercetin activate different stress signaling pathways as shown by analysis of site-specific phosphorylation of ATM, p53 and histone H2AX. DNA Repair (Amst). 2004 Mar 4;3(3):235-44. doi: 10.1016/j.dnarep.2003.10.014.
556 Oxidative stress modulates theophylline effects on steroid responsiveness. Biochem Biophys Res Commun. 2008 Dec 19;377(3):797-802.
557 Troglitazone and 15-deoxy-delta(12,14)-prostaglandin J2 inhibit shear-induced coupling factor 6 release in endothelial cells. Cardiovasc Res. 2005 Jul 1;67(1):134-41. doi: 10.1016/j.cardiores.2005.02.022. Epub 2005 Mar 29.
558 Troglitazone acts on cellular pH and DNA synthesis through a peroxisome proliferator-activated receptor gamma-independent mechanism in breast cancer-derived cell lines. Clin Cancer Res. 2004 Oct 15;10(20):7022-30. doi: 10.1158/1078-0432.CCR-04-0879.
559 Paclitaxel induces apoptosis via protein kinase A- and p38 mitogen-activated protein-dependent inhibition of the Na+/H+ exchanger (NHE) NHE isoform 1 in human breast cancer cells. Clin Cancer Res. 2003 Jun;9(6):2366-73.
560 Cannabidiol and Oxygen-Ozone Combination Induce Cytotoxicity in Human Pancreatic Ductal Adenocarcinoma Cell Lines. Cancers (Basel). 2020 Sep 27;12(10):2774. doi: 10.3390/cancers12102774.
561 G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently. J Biol Chem. 1993 Apr 15;268(11):8298-308.
562 Ribavirin inhibits colorectal cancer growth by downregulating PRMT5 expression and H3R8me2s and H4R3me2s accumulation. Toxicol Appl Pharmacol. 2021 Mar 15;415:115450. doi: 10.1016/j.taap.2021.115450. Epub 2021 Feb 9.
563 Sulindac induces specific degradation of the HPV oncoprotein E7 and causes growth arrest and apoptosis in cervical carcinoma cells. Cancer Lett. 2007 Jan 8;245(1-2):103-11. doi: 10.1016/j.canlet.2005.12.034. Epub 2006 Feb 20.
564 Methotrexate modulates folate phenotype and inflammatory profile in EA.hy 926 cells. Eur J Pharmacol. 2014 Jun 5;732:60-7.
565 Simvastatin inactivates beta1-integrin and extracellular signal-related kinase signaling and inhibits cell proliferation in head and neck squamous cell carcinoma cells. Cancer Sci. 2007 Jun;98(6):890-9.
566 CDK4/6 inhibition provides a potent adjunct to Her2-targeted therapies in preclinical breast cancer models. Genes Cancer. 2014 Jul;5(7-8):261-72. doi: 10.18632/genesandcancer.24.
567 A comparative proteomic analysis for capsaicin-induced apoptosis between human hepatocarcinoma (HepG2) and human neuroblastoma (SK-N-SH) cells. Proteomics. 2008 Nov;8(22):4748-67. doi: 10.1002/pmic.200800094.
568 Arsenic exposure, diabetes-related genes and diabetes prevalence in a general population from Spain. Environ Pollut. 2018 Apr;235:948-955. doi: 10.1016/j.envpol.2018.01.008. Epub 2018 Feb 21.
569 Low-dose Bisphenol A exposure alters the functionality and cellular environment in a human cardiomyocyte model. Environ Pollut. 2023 Oct 15;335:122359. doi: 10.1016/j.envpol.2023.122359. Epub 2023 Aug 9.
570 Proteomics-based identification of differentially abundant proteins from human keratinocytes exposed to arsenic trioxide. J Proteomics Bioinform. 2014 Jul;7(7):166-178.
571 Linalool is a PPARalpha ligand that reduces plasma TG levels and rewires the hepatic transcriptome and plasma metabolome. J Lipid Res. 2014 Jun;55(6):1098-110.
572 Stop codon read-through of a methylmalonic aciduria mutation. Mol Genet Metab. 2009 Aug;97(4):244-9. doi: 10.1016/j.ymgme.2009.04.004. Epub 2009 Apr 12.
573 Gene induction for the treatment of methylmalonic aciduria. J Gene Med. 2009 Apr;11(4):361-9. doi: 10.1002/jgm.1297.
574 Regulation of the human norepinephrine transporter by cocaine and amphetamine. J Pharmacol Exp Ther. 2000 Dec;295(3):951-9.
575 Familial orthostatic tachycardia due to norepinephrine transporter deficiency. Ann N Y Acad Sci. 2001 Jun;940:527-43. doi: 10.1111/j.1749-6632.2001.tb03703.x.
576 Pharmacological characterization of the aminorex analogs 4-MAR, 4,4'-DMAR, and 3,4-DMAR. Neurotoxicology. 2019 May;72:95-100. doi: 10.1016/j.neuro.2019.02.011. Epub 2019 Feb 15.
577 Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression. JAMA. 2006 Oct 4;296(13):1609-18. doi: 10.1001/jama.296.13.1609.
578 The NRF2-mediated oxidative stress response pathway is associated with tumor cell resistance to arsenic trioxide across the NCI-60 panel. BMC Med Genomics. 2010 Aug 13;3:37. doi: 10.1186/1755-8794-3-37.
579 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
580 Coordinate up-regulation of TMEM97 and cholesterol biosynthesis genes in normal ovarian surface epithelial cells treated with progesterone: implications for pathogenesis of ovarian cancer. BMC Cancer. 2007 Dec 11;7:223.
581 The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling. Oncogene. 2001 Feb 1;20(5):645-53. doi: 10.1038/sj.onc.1204123.
582 Novel mechanism of cannabidiol-induced apoptosis in breast cancer cell lines. Breast. 2018 Oct;41:34-41. doi: 10.1016/j.breast.2018.06.009. Epub 2018 Jun 22.
583 Cross-talk between non-genomic and genomic signalling pathways--distinct effect profiles of environmental estrogens. Toxicol Appl Pharmacol. 2010 Jun 1;245(2):160-70. doi: 10.1016/j.taap.2010.02.015. Epub 2010 Mar 4.
584 Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival. Cancer Res. 2006 Jun 1;66(11):5542-8. doi: 10.1158/0008-5472.CAN-05-4620.
585 Resveratrol attenuates senescence of adipose-derived mesenchymal stem cells and restores their paracrine effects on promoting insulin secretion of INS-1 cells through Pim-1. Eur Rev Med Pharmacol Sci. 2016;20(6):1203-13.
586 Ribavirin augments doxorubicin's efficacy in human hepatocellular carcinoma through inhibiting doxorubicin-induced eIF4E activation. J Biochem Mol Toxicol. 2018 Jan;32(1). doi: 10.1002/jbt.22007. Epub 2017 Nov 7.
587 Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells. J Pharmacol Exp Ther. 2001 Sep;298(3):976-85.
588 1,25-Dihydroxyvitamin D3 suppresses gene expression of eukaryotic translation initiation factor 2 in human promyelocytic leukemia HL-60 cells. Cell Struct Funct. 2005;30(1):1-6. doi: 10.1247/csf.30.1.
589 Comparison of quantitation methods in proteomics to define relevant toxicological information on AhR activation of HepG2 cells by BaP. Toxicology. 2021 Jan 30;448:152652. doi: 10.1016/j.tox.2020.152652. Epub 2020 Dec 2.
590 Identification of genes linked to gefitinib treatment in prostate cancer cell lines with or without resistance to androgen: a clue to application of gefitinib to hormone-resistant prostate cancer. Oncol Rep. 2006 Jun;15(6):1453-60.
591 Microarray analysis of H2O2-, HNE-, or tBH-treated ARPE-19 cells. Free Radic Biol Med. 2002 Nov 15;33(10):1419-32.
592 Protein expression profiling identifies molecular targets of quercetin as a major dietary flavonoid in human colon cancer cells. Proteomics. 2004 Jul;4(7):2160-74.
593 Comparative study of the neurotoxicological effects of tramadol and tapentadol in SH-SY5Y cells. Toxicology. 2016 Jun 1;359-360:1-10. doi: 10.1016/j.tox.2016.06.010. Epub 2016 Jun 15.
594 Retinoic acid and its 4-oxo metabolites are functionally active in human skin cells in vitro. J Invest Dermatol. 2005 Jul;125(1):143-53.
595 Role of calcitriol and cortisol on human adipocyte proliferation and oxidative and inflammatory stress: a microarray study. J Nutrigenet Nutrigenomics. 2008;1(1-2):30-48. doi: 10.1159/000109873. Epub 2007 Oct 16.
596 Protective effects of S-carvedilol on doxorubicin-induced damages to human umbilical vein endothelial cells and rats. J Appl Toxicol. 2019 Aug;39(8):1233-1244. doi: 10.1002/jat.3809. Epub 2019 May 7.
597 Oxidative stress in kidney transplant patients with calcineurin inhibitor-induced hypertension: effect of ramipril. J Cardiovasc Pharmacol. 2002 Oct;40(4):625-31.
598 Hydrogen peroxide decreases endothelial nitric oxide synthase promoter activity through the inhibition of Sp1 activity. DNA Cell Biol. 2009 Mar;28(3):119-29.
599 Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs. Am J Respir Crit Care Med. 2005 Oct 15;172(8):987-93. doi: 10.1164/rccm.200501-041OC. Epub 2005 Jul 7.
600 A blend of polyphenolic compounds explains the stimulatory effect of red wine on human endothelial NO synthase. Nitric Oxide. 2005 Mar;12(2):97-104.
601 The thiazolidinedione drug troglitazone up-regulates nitric oxide synthase expression in vascular endothelial cells. J Diabetes Complications. 2006 Sep-Oct;20(5):336-42.
602 Fructose induces the inflammatory molecule ICAM-1 in endothelial cells. J Am Soc Nephrol. 2008 Sep;19(9):1712-20.
603 Upregulation of nitric oxide production in vascular endothelial cells by all-trans retinoic acid through the phosphoinositide 3-kinase/Akt pathway. Circulation. 2005 Aug 2;112(5):727-36. doi: 10.1161/CIRCULATIONAHA.104.500959. Epub 2005 Jul 25.
604 Identification of novel gene targets and putative regulators of arsenic-associated DNA methylation in human urothelial cells and bladder cancer. Chem Res Toxicol. 2015 Jun 15;28(6):1144-55. doi: 10.1021/tx500393y. Epub 2015 Jun 3.
605 Differential protein expression of peroxiredoxin I and II by benzo(a)pyrene and quercetin treatment in 22Rv1 and PrEC prostate cell lines. Toxicol Appl Pharmacol. 2007 Apr 15;220(2):197-210. doi: 10.1016/j.taap.2006.12.030. Epub 2007 Jan 9.
606 Selenite and selenomethionine promote HL-60 cell cycle progression. J Nutr. 2002 Apr;132(4):674-9. doi: 10.1093/jn/132.4.674.
607 Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cells. J Pharmacol Exp Ther. 2003 Jun;305(3):932-42. doi: 10.1124/jpet.103.049098. Epub 2003 Mar 20.
608 Retinoid targeting of different D-type cyclins through distinct chemopreventive mechanisms. Cancer Res. 2005 Jul 15;65(14):6476-83. doi: 10.1158/0008-5472.CAN-05-0370.
609 miR-497 and miR-302b regulate ethanol-induced neuronal cell death through BCL2 protein and cyclin D2. J Biol Chem. 2011 Oct 28;286(43):37347-57. doi: 10.1074/jbc.M111.235531. Epub 2011 Aug 30.
610 Gene expression profiling of human primary astrocytes exposed to manganese chloride indicates selective effects on several functions of the cells. Neurotoxicology. 2007 May;28(3):478-89.
611 Characterization of multidrug transporter-mediated efflux of avermectins in human and mouse neuroblastoma cell lines. Toxicol Lett. 2015 Jun 15;235(3):189-98. doi: 10.1016/j.toxlet.2015.04.005. Epub 2015 Apr 9.
612 Folate concentration dependent transport activity of the Multidrug Resistance Protein 1 (ABCC1). Biochem Pharmacol. 2004 Apr 15;67(8):1541-8.
613 Influence of redox-active compounds and PXR-activators on human MRP1 and MRP2 gene expression. Toxicology. 2002 Feb 28;171(2-3):137-46.
614 Enhanced in vitro invasiveness and drug resistance with altered gene expression patterns in a human lung carcinoma cell line after pulse selection with anticancer drugs. Int J Cancer. 2004 Sep 10;111(4):484-93. doi: 10.1002/ijc.20230.
615 Clinical determinants of response to irinotecan-based therapy derived from cell line models. Clin Cancer Res. 2008 Oct 15;14(20):6647-55.
616 Co-encapsulation of chrysophsin-1 and epirubicin in PEGylated liposomes circumvents multidrug resistance in HeLa cells. Chem Biol Interact. 2015 Dec 5;242:13-23. doi: 10.1016/j.cbi.2015.08.023. Epub 2015 Sep 1.
617 Upregulation of multi drug resistance genes in doxorubicin resistant human acute myelogeneous leukemia cells and reversal of the resistance. Hematology. 2007 Dec;12(6):511-7. doi: 10.1080/10245330701562535.
618 Functional analysis of MRP1 cloned from bovine. FEBS Lett. 2002 Jun 19;521(1-3):211-3. doi: 10.1016/s0014-5793(02)02816-8.
619 Alternatives for the worse: Molecular insights into adverse effects of bisphenol a and substitutes during human adipocyte differentiation. Environ Int. 2021 Nov;156:106730. doi: 10.1016/j.envint.2021.106730. Epub 2021 Jun 27.
620 Inhibiting Heat Shock Proteins Can Potentiate the Cytotoxic Effect of Cannabidiol in Human Glioma Cells. Anticancer Res. 2015 Nov;35(11):5827-37.
621 Induction of CCAAT/enhancer-binding protein-homologous protein by cigarette smoke through the superoxide anion-triggered PERK-eIF2 pathway. Toxicology. 2011 Sep 5;287(1-3):105-12. doi: 10.1016/j.tox.2011.06.005. Epub 2011 Jun 15.
622 Amiodarone sensitizes human glioma cells but not astrocytes to TRAIL-induced apoptosis via CHOP-mediated DR5 upregulation. Neuro Oncol. 2011 Mar;13(3):267-79. doi: 10.1093/neuonc/noq195. Epub 2011 Feb 3.
623 Drug-induced hepatic steatosis in absence of severe mitochondrial dysfunction in HepaRG cells: proof of multiple mechanism-based toxicity. Cell Biol Toxicol. 2021 Apr;37(2):151-175. doi: 10.1007/s10565-020-09537-1. Epub 2020 Jun 14.
624 High-content imaging-based BAC-GFP toxicity pathway reporters to assess chemical adversity liabilities. Arch Toxicol. 2017 Mar;91(3):1367-1383. doi: 10.1007/s00204-016-1781-0. Epub 2016 Jun 29.
625 Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury. Toxicol Sci. 2014 Jan;137(1):234-48. doi: 10.1093/toxsci/kft232. Epub 2013 Oct 17.
626 Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma. Cancer Res. 2023 Jan 18;83(2):181-194. doi: 10.1158/0008-5472.CAN-22-1029.
627 Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine. Clin Pharmacol Ther. 2006 Nov;80(5):440-456.
628 Application of a nonradioactive assay for high throughput screening for inhibition of thyroid hormone uptake via the transmembrane transporter MCT8. Toxicol In Vitro. 2017 Apr;40:234-242. doi: 10.1016/j.tiv.2017.01.014. Epub 2017 Jan 21.
629 Lon protease: a novel mitochondrial matrix protein in the interconnection between drug-induced mitochondrial dysfunction and endoplasmic reticulum stress. Br J Pharmacol. 2017 Dec;174(23):4409-4429. doi: 10.1111/bph.14045. Epub 2017 Nov 7.
630 Antihypertrophic Effects of Small Molecules that Maintain Mitochondrial ATP Levels Under Hypoxia. EBioMedicine. 2017 Oct;24:147-158. doi: 10.1016/j.ebiom.2017.09.022. Epub 2017 Sep 19.
631 Acute regulation of the SLC26A3 congenital chloride diarrhoea anion exchanger (DRA) expressed in Xenopus oocytes. J Physiol. 2003 May 15;549(Pt 1):3-19. doi: 10.1113/jphysiol.2003.039818. Epub 2003 Mar 21.
632 Gene expression responses reflecting 5-FU-induced toxicity: Comparison between patient colon tissue and 3D human colon organoids. Toxicol Lett. 2022 Dec 1;371:17-24. doi: 10.1016/j.toxlet.2022.09.013. Epub 2022 Sep 29.
633 Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs. Int J Cardiol. 2010 Apr 1;140(1):73-81. doi: 10.1016/j.ijcard.2008.11.017. Epub 2008 Dec 6.
634 [Quercetin affects leptin and its receptor in human gastric cancer MGC-803 cells and JAK-STAT pathway]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012 Jan;28(1):12-6.
635 Leptin production in adipocytes from morbidly obese subjects: stimulation by dexamethasone, inhibition with troglitazone, and influence of gender. J Clin Endocrinol Metab. 2000 Aug;85(8):2678-84. doi: 10.1210/jcem.85.8.6733.
636 The psychoactive compound of Cannabis sativa, (9)-tetrahydrocannabinol (THC) inhibits the human trophoblast cell turnover. Toxicology. 2015 Aug 6;334:94-103. doi: 10.1016/j.tox.2015.06.005. Epub 2015 Jun 9.
637 Amlodipine improves endothelial function and metabolic parameters in patients with hypertension. Int J Cardiol. 2009 Mar 20;133(1):23-31. doi: 10.1016/j.ijcard.2007.11.058. Epub 2008 Jan 15.
638 Different apoptosis ratios and gene expressions in two human cell lines after sevoflurane anaesthesia. Acta Anaesthesiol Scand. 2009 Oct;53(9):1192-9. doi: 10.1111/j.1399-6576.2009.02036.x. Epub 2009 Jun 30.
639 [Mechanisms underlying the effect of arsenic trioxide on proliferation inhibition and apoptosis induction in myeloma cell line u266]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Oct;15(5):982-5.
640 Lovastatin lactone elicits human lung cancer cell apoptosis via a COX-2/PPAR-dependent pathway. Oncotarget. 2016 Mar 1;7(9):10345-62. doi: 10.18632/oncotarget.7213.
641 Comparison of burst of reactive oxygen species and activation of caspase-3 in apoptosis of K562 and HL-60 cells induced by docetaxel. Cancer Lett. 2004 Oct 8;214(1):103-13. doi: 10.1016/j.canlet.2004.03.047.
642 Induction of mitochondrial manganese superoxide dismutase confers resistance to apoptosis in acute myeloblastic leukaemia cells exposed to etoposide. Br J Haematol. 2000 Mar;108(3):574-81. doi: 10.1046/j.1365-2141.2000.01852.x.
643 Cisplatin-enhanced sensitivity of glioblastoma multiforme U251 cells to adenovirus-delivered TRAIL in vitro. Tumour Biol. 2010 Dec;31(6):613-22. doi: 10.1007/s13277-010-0077-x. Epub 2010 Jul 11.
644 Insulin-like growth factor I is the key growth factor in serum that protects neuroblastoma cells from hyperosmotic-induced apoptosis. J Cell Physiol. 2000 Jan;182(1):24-32. doi: 10.1002/(SICI)1097-4652(200001)182:1<24::AID-JCP3>3.0.CO;2-6.
645 mRNA expression analysis of a variety of apoptosis-related genes, including the novel gene of the BCL2-family, BCL2L12, in HL-60 leukemia cells after treatment with carboplatin and doxorubicin. Biol Chem. 2004 Nov;385(11):1099-103. doi: 10.1515/BC.2004.143.
646 Neurokinin-1 receptor (NK1R) inhibition sensitizes APL cells to anti-tumor effect of arsenic trioxide via restriction of NF-B axis: Shedding new light on resistance to Aprepitant. Int J Biochem Cell Biol. 2018 Oct;103:105-114. doi: 10.1016/j.biocel.2018.08.010. Epub 2018 Aug 23.
647 A gene signature-based approach identifies thioridazine as an inhibitor of phosphatidylinositol-3'-kinase (PI3K)/AKT pathway in ovarian cancer cells. Gynecol Oncol. 2011 Jan;120(1):121-7. doi: 10.1016/j.ygyno.2010.10.003. Epub 2010 Oct 29.
648 Expression of the helix-loop-helix protein inhibitor of DNA binding-1 (ID-1) is activated by all-trans retinoic acid in normal human keratinocytes. Toxicol Appl Pharmacol. 2006 Aug 1;214(3):219-29. doi: 10.1016/j.taap.2005.12.015. Epub 2006 Feb 21.
649 [Re-expression of p16 gene in myeloma cell line U266 by arsenic trioxide]. Ai Zheng. 2004 Jun;23(6):626-30.
650 p16 loss facilitate hydroquinone-induced malignant transformation of TK6 cells through promoting cell proliferation and accelerating the cell cycle progression. Environ Toxicol. 2021 Aug;36(8):1591-1599. doi: 10.1002/tox.23155. Epub 2021 May 1.
651 Delta 9-tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells. Acta Oncol. 2008;47(6):1062-70.
652 Gene expression profiling of human peri-implantation endometria between natural and stimulated cycles. Fertil Steril. 2008 Dec;90(6):2152-64.
653 Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis. Hum Reprod. 2011 Jul;26(7):1813-25.
654 Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts. Mol Cancer. 2010 Jun 27;9:168.
655 Cisplatin induces autophagy to enhance hepatitis B virus replication via activation of ROS/JNK and inhibition of the Akt/mTOR pathway. Free Radic Biol Med. 2019 Feb 1;131:225-236. doi: 10.1016/j.freeradbiomed.2018.12.008. Epub 2018 Dec 11.
656 Inhibition of autophagic flux differently modulates cannabidiol-induced death in 2D and 3D glioblastoma cell cultures. Sci Rep. 2020 Feb 14;10(1):2687. doi: 10.1038/s41598-020-59468-4.
657 Neuroprotective effects of glucomoringin-isothiocyanate against H(2)O(2)-Induced cytotoxicity in neuroblastoma (SH-SY5Y) cells. Neurotoxicology. 2019 Dec;75:89-104. doi: 10.1016/j.neuro.2019.09.008. Epub 2019 Sep 12.
658 Nocodazole-induced p53-dependent c-Jun N-terminal kinase activation reduces apoptosis in human colon carcinoma HCT116 cells. J Biol Chem. 2002 Nov 15;277(46):43648-58. doi: 10.1074/jbc.M203214200. Epub 2002 Sep 6.
659 Disease-modifying effects of glucosamine HCl involving regulation of metalloproteinases and chemokines activated by interleukin-1beta in human primary synovial fibroblasts. J Cell Biochem. 2008 May 1;104(1):38-50. doi: 10.1002/jcb.21597.
660 Characterization of cell death induced by ethacrynic acid in a human colon cancer cell line DLD-1 and suppression by N-acetyl-L-cysteine. Cancer Sci. 2003 Oct;94(10):886-93.
661 Apoptosis induced by arsenic trioxide in leukemia U937 cells is dependent on activation of p38, inactivation of ERK and the Ca2+-dependent production of superoxide. Int J Cancer. 2001 May 15;92(4):518-26. doi: 10.1002/ijc.1220.
662 The anti-cancer drug gefitinib accelerates Fas-mediated apoptosis by enhancing caspase-8 activation in cancer cells. J Toxicol Sci. 2019;44(6):435-440. doi: 10.2131/jts.44.435.
663 NF-B potentiates caspase independent hydrogen peroxide induced cell death. PLoS One. 2011 Feb 15;6(2):e16815. doi: 10.1371/journal.pone.0016815.
664 Carvedilol prevents epinephrine-induced apoptosis in human coronary artery endothelial cells: modulation of Fas/Fas ligand and caspase-3 pathway. Cardiovasc Res. 2000 Feb;45(3):788-94. doi: 10.1016/s0008-6363(99)00369-7.
665 Quercetin induces FasL-related apoptosis, in part, through promotion of histone H3 acetylation in human leukemia HL-60 cells. Oncol Rep. 2011 Feb;25(2):583-91. doi: 10.3892/or.2010.1097. Epub 2010 Dec 10.
666 Influence of antitumor drugs on the expression of Fas system in SW480 colon cancer cells. Eur J Gastroenterol Hepatol. 2006 Oct;18(10):1071-7. doi: 10.1097/01.meg.0000231750.68513.6c.
667 Rifampicin inhibits CD95-mediated apoptosis of Jurkat T cells via glucocorticoid receptors by modifying the expression of molecules regulating apoptosis. J Clin Immunol. 2002 Jan;22(1):37-47. doi: 10.1023/a:1014256603539.
668 Inhibition of drug-induced Fas ligand transcription and apoptosis by Bcl-XL. Mol Cell Biochem. 2001 Sep;225(1-):7-20. doi: 10.1023/a:1012203110027.
669 Mitochondrial reactive oxygen species contribute to high NaCl-induced activation of the transcription factor TonEBP/OREBP. Am J Physiol Renal Physiol. 2006 May;290(5):F1169-76. doi: 10.1152/ajprenal.00378.2005. Epub 2005 Nov 22.
670 Effect of ovarian steroids on gene expression profile in human uterine microvascular endothelial cells. Fertil Steril. 2009 Aug;92(2):709-21.
671 Mechanisms of GABA release from human astrocytes. Glia. 2011 Nov;59(11):1600-11. doi: 10.1002/glia.21202. Epub 2011 Jul 11.
672 Organochloride pesticides induced hepatic ABCG5/G8 expression and lipogenesis in Chinese patients with gallstone disease. Oncotarget. 2016 Jun 7;7(23):33689-702. doi: 10.18632/oncotarget.9399.
673 Effect of atorvastatin, simvastatin, and lovastatin on the metabolism of cholesterol and triacylglycerides in HepG2 cells. Biochem Pharmacol. 2001 Dec 1;62(11):1545-55. doi: 10.1016/s0006-2952(01)00790-0.
674 Hypoxia-inducible factor-1 (HIF-1) pathway activation by quercetin in human lens epithelial cells. Exp Eye Res. 2009 Dec;89(6):995-1002. doi: 10.1016/j.exer.2009.08.011. Epub 2009 Sep 1.
675 Species-specific toxicity of diclofenac and troglitazone in primary human and rat hepatocytes. Chem Biol Interact. 2009 Apr 15;179(1):17-24.
676 Multi-parameter in vitro toxicity testing of crizotinib, sunitinib, erlotinib, and nilotinib in human cardiomyocytes. Toxicol Appl Pharmacol. 2013 Oct 1;272(1):245-55.
677 Effects of paclitaxel on proliferation and apoptosis in human acute myeloid leukemia HL-60 cells. Acta Pharmacol Sin. 2004 Mar;25(3):378-84.
678 Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia. Proc Natl Acad Sci U S A. 2005 May 24;102(21):7653-8.
679 Cardiac toxicity from ethanol exposure in human-induced pluripotent stem cell-derived cardiomyocytes. Toxicol Sci. 2019 May 1;169(1):280-292.
680 Identification by automated screening of a small molecule that selectively eliminates neural stem cells derived from hESCs but not dopamine neurons. PLoS One. 2009 Sep 23;4(9):e7155.
681 Modulation of butyrate transport in Caco-2 cells. Naunyn Schmiedebergs Arch Pharmacol. 2009 Apr;379(4):325-36. doi: 10.1007/s00210-008-0372-x. Epub 2008 Nov 21.
682 Transcriptome and DNA methylation changes modulated by sulforaphane induce cell cycle arrest, apoptosis, DNA damage, and suppression of proliferation in human liver cancer cells. Food Chem Toxicol. 2020 Feb;136:111047. doi: 10.1016/j.fct.2019.111047. Epub 2019 Dec 12.
683 3-Nitrobenzanthrone promotes malignant transformation in human lung epithelial cells through the epiregulin-signaling pathway. Cell Biol Toxicol. 2022 Oct;38(5):865-887. doi: 10.1007/s10565-021-09612-1. Epub 2021 May 25.
684 Identification and characterization of 3-iodothyronamine intracellular transport. Endocrinology. 2009 Apr;150(4):1991-9.
685 Delphinidin modulates the DNA-damaging properties of topoisomerase II poisons. Chem Res Toxicol. 2009 Mar 16;22(3):554-64. doi: 10.1021/tx800293v.
686 MS4A3-HSP27 target pathway reveals potential for haematopoietic disorder treatment in alimentary toxic aleukia. Cell Biol Toxicol. 2023 Feb;39(1):201-216. doi: 10.1007/s10565-021-09639-4. Epub 2021 Sep 28.
687 Changes in DNA methylation of erythroid-specific genes in K562 cells exposed to phenol and hydroquinone. Toxicology. 2013 Oct 4;312:108-14. doi: 10.1016/j.tox.2013.08.007. Epub 2013 Aug 20.
688 Voxelotor for the treatment of sickle cell disease. Expert Rev Hematol. 2021 Mar;14(3):253-262. doi: 10.1080/17474086.2021.1893688. Epub 2021 Mar 4.
689 Label-Free Bottom-Up Proteomic Workflow for Simultaneously Assessing the Target Specificity of Covalent Drug Candidates and Their Off-Target Reactivity to Selected Proteins. Chem Res Toxicol. 2016 Jan 19;29(1):109-16. doi: 10.1021/acs.chemrestox.5b00460. Epub 2015 Dec 29.
690 Identification of flucloxacillin-modified hepatocellular proteins: implications in flucloxacillin-induced liver injury. Toxicol Sci. 2023 Mar 20;192(1):106-116. doi: 10.1093/toxsci/kfad015.
691 Incorporation of 5-fluorouracil into U2 snRNA blocks pseudouridylation and pre-mRNA splicing in vivo. Nucleic Acids Res. 2007;35(2):550-8. doi: 10.1093/nar/gkl1084. Epub 2006 Dec 14.
692 Progesterone regulation of implantation-related genes: new insights into the role of oestrogen. Cell Mol Life Sci. 2007 Apr;64(7-8):1009-32.
693 Comparison of Drug Metabolism and Its Related Hepatotoxic Effects in HepaRG, Cryopreserved Human Hepatocytes, and HepG2 Cell Cultures. Biol Pharm Bull. 2018 May 1;41(5):722-732. doi: 10.1248/bpb.b17-00913. Epub 2018 Feb 14.
694 Effects of chlorpromazine with and without UV irradiation on gene expression of HepG2 cells. Mutat Res. 2005 Aug 4;575(1-2):47-60. doi: 10.1016/j.mrfmmm.2005.03.002. Epub 2005 Apr 26.
695 Identification of a transcriptomic signature of food-relevant genotoxins in human HepaRG hepatocarcinoma cells. Food Chem Toxicol. 2020 Jun;140:111297. doi: 10.1016/j.fct.2020.111297. Epub 2020 Mar 28.
696 In vitro antioxidant and antigenotoxic potentials of 3,5-O-di-galloylquinic acid extracted from Myrtus communis leaves and modulation of cell gene expression by H2O2. J Appl Toxicol. 2012 May;32(5):333-41.
697 HMG-CoA reductase inhibitors, statins, induce phosphorylation of Mdm2 and attenuate the p53 response to DNA damage. FASEB J. 2005 Mar;19(3):476-8. doi: 10.1096/fj.04-2745fje. Epub 2004 Dec 29.
698 Amifostine impairs p53-mediated apoptosis of human myeloid leukemia cells. Mol Cancer Ther. 2003 Sep;2(9):893-900.
699 Moving toward integrating gene expression profiling into high-throughput testing: a gene expression biomarker accurately predicts estrogen receptor alpha modulation in a microarray compendium. Toxicol Sci. 2016 May;151(1):88-103.
700 Comparison of base-line and chemical-induced transcriptomic responses in HepaRG and RPTEC/TERT1 cells using TempO-Seq. Arch Toxicol. 2018 Aug;92(8):2517-2531.
701 Hormone-sensitive lipase in human adipose tissue, isolated adipocytes, and cultured adipocytes. Pediatr Res. 1982 Dec;16(12):982-8. doi: 10.1203/00006450-198212000-00002.
702 In Vitro and In Vivo Characterizations of Chiglitazar, a Newly Identified PPAR Pan-Agonist. PPAR Res. 2012;2012:546548. doi: 10.1155/2012/546548. Epub 2012 Oct 22.
703 Effects of extended-release niacin on lipid profile and adipocyte biology in patients with impaired glucose tolerance. Atherosclerosis. 2009 Jul;205(1):207-13. doi: 10.1016/j.atherosclerosis.2008.11.026. Epub 2008 Dec 3.
704 High expression of the Pi-transporter SLC20A1/Pit1 in calcific aortic valve disease promotes mineralization through regulation of Akt-1. PLoS One. 2013;8(1):e53393. doi: 10.1371/journal.pone.0053393. Epub 2013 Jan 4.
705 Antidepressant drug sertraline modulates AMPK-MTOR signaling-mediated autophagy via targeting mitochondrial VDAC1 protein. Autophagy. 2021 Oct;17(10):2783-2799. doi: 10.1080/15548627.2020.1841953. Epub 2020 Nov 9.
706 Comparative effects of fructose and glucose on lipogenic gene expression and intermediary metabolism in HepG2 liver cells. PLoS One. 2011;6(11):e26583. doi: 10.1371/journal.pone.0026583. Epub 2011 Nov 11.
707 Aspirin regulates hepatocellular lipid metabolism by activating AMPK signaling pathway. J Toxicol Sci. 2015 Feb;40(1):127-36. doi: 10.2131/jts.40.127.
708 Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells. Carcinogenesis. 2005 May;26(5):883-91. doi: 10.1093/carcin/bgi036. Epub 2005 Feb 10.
709 Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis. Br J Cancer. 2011 Apr 12;104(8):1278-87. doi: 10.1038/bjc.2011.84.
710 Essential role of caspase-8 in p53/p73-dependent apoptosis induced by etoposide in head and neck carcinoma cells. Mol Cancer. 2011 Jul 31;10:95. doi: 10.1186/1476-4598-10-95.
711 Melatonin enhances hydrogen peroxide-induced apoptosis in human promyelocytic leukaemia HL-60 cells. Mol Cell Biochem. 2011 Jul;353(1-2):167-76. doi: 10.1007/s11010-011-0783-8. Epub 2011 Mar 23.
712 Apoptotic signaling pathways induced by nitric oxide in human lymphoblastoid cells expressing wild-type or mutant p53. Cancer Res. 2004 May 1;64(9):3022-9. doi: 10.1158/0008-5472.can-03-1880.
713 Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells. Br J Cancer. 2002 Feb 1;86(3):443-8. doi: 10.1038/sj.bjc.6600079.
714 Delta9-tetrahydrocannabinol inhibits cytotrophoblast cell proliferation and modulates gene transcription. Mol Hum Reprod. 2006 May;12(5):321-33. doi: 10.1093/molehr/gal036. Epub 2006 Apr 5.
715 Cellular zinc homeostasis is a regulator in monocyte differentiation of HL-60 cells by 1 alpha,25-dihydroxyvitamin D3. J Leukoc Biol. 2010 May;87(5):833-44. doi: 10.1189/jlb.0409241. Epub 2010 Jan 20.
716 Additive beneficial cardiovascular and metabolic effects of combination therapy with ramipril and candesartan in hypertensive patients. Eur Heart J. 2007 Jun;28(12):1440-7. doi: 10.1093/eurheartj/ehm101. Epub 2007 May 5.
717 Adipogenic Effects and Gene Expression Profiling of Firemaster? 550 Components in Human Primary Preadipocytes. Environ Health Perspect. 2017 Sep 14;125(9):097013. doi: 10.1289/EHP1318.
718 Combination of an ACE inhibitor and indapamide improves blood pressure control, but attenuates the beneficial effects of ACE inhibition on plasma adiponectin in patients with essential hypertension. Circ J. 2009 Dec;73(12):2282-7. doi: 10.1253/circj.cj-09-0387. Epub 2009 Sep 29.
719 Role of PML SUMOylation in arsenic trioxide-induced fibrosis in HSCs. Life Sci. 2020 Jun 15;251:117607. doi: 10.1016/j.lfs.2020.117607. Epub 2020 Mar 30.
720 (9)-Tetrahydrocannabinol upregulates fatty acid 2-hydroxylase (FA2H) via PPAR induction: A possible evidence for the cancellation of PPAR/-mediated inhibition of PPAR in MDA-MB-231?cells. Arch Biochem Biophys. 2019 Feb 15;662:219-225. doi: 10.1016/j.abb.2018.12.011. Epub 2018 Dec 13.
721 Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men. Eur J Endocrinol. 2006 Jul;155(1):167-76. doi: 10.1530/eje.1.02175.
722 Identification of novel low-dose bisphenol a targets in human foreskin fibroblast cells derived from hypospadias patients. PLoS One. 2012;7(5):e36711. doi: 10.1371/journal.pone.0036711. Epub 2012 May 4.
723 Cannabidiol promotes apoptosis via regulation of XIAP/Smac in gastric cancer. Cell Death Dis. 2019 Nov 7;10(11):846. doi: 10.1038/s41419-019-2001-7.
724 Expression Profiling of Human Pluripotent Stem Cell-Derived Cardiomyocytes Exposed to Doxorubicin-Integration and Visualization of Multi-Omics Data. Toxicol Sci. 2018 May 1;163(1):182-195. doi: 10.1093/toxsci/kfy012.
725 Anti-cancer analogues ME-143 and ME-344 exert toxicity by directly inhibiting mitochondrial NADH: ubiquinone oxidoreductase (Complex I). Am J Cancer Res. 2015 Jan 15;5(2):689-701. eCollection 2015.
726 Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma. Oncotarget. 2014 May 15;5(9):2355-71.
727 Genomic structure, gene expression, and promoter analysis of human multidrug resistance-associated protein 7. J Biomed Sci. 2003 Jan-Feb;10(1):98-110. doi: 10.1007/BF02256002.
728 Targeting MYCN in neuroblastoma by BET bromodomain inhibition. Cancer Discov. 2013 Mar;3(3):308-23.
729 Influence of common and rare genetic variation on warfarin dose among African-Americans and European-Americans using the exome array. Pharmacogenomics. 2017 Jul;18(11):1059-1073. doi: 10.2217/pgs-2017-0046. Epub 2017 Jul 7.
730 CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer. J Clin Invest. 2016 Feb;126(2):639-52.
731 Validation of a genotoxicity test based on p53R2 gene expression in human lymphoblastoid cells. Mutat Res. 2011 Sep 18;724(1-2):76-85. doi: 10.1016/j.mrgentox.2011.06.003. Epub 2011 Jun 17.
732 Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia. J Exp Med. 2010 Apr 12;207(4):731-50. doi: 10.1084/jem.20091488. Epub 2010 Apr 5.
733 SLC13A5 is a novel transcriptional target of the pregnane X receptor and sensitizes drug-induced steatosis in human liver. Mol Pharmacol. 2015 Apr;87(4):674-82. doi: 10.1124/mol.114.097287. Epub 2015 Jan 27.
734 Identification of transcriptome signatures and biomarkers specific for potential developmental toxicants inhibiting human neural crest cell migration. Arch Toxicol. 2016 Jan;90(1):159-80.
735 LSD1 activates a lethal prostate cancer gene network independently of its demethylase function. Proc Natl Acad Sci U S A. 2018 May 1;115(18):E4179-E4188.
736 Intracellular zinc stores protect the intestinal epithelium from Ochratoxin A toxicity. Toxicol In Vitro. 2009 Dec;23(8):1516-21.
737 ZD6474 inhibits tumor growth and intraperitoneal dissemination in a highly metastatic orthotopic gastric cancer model. Int J Cancer. 2006 Jan 15;118(2):483-9. doi: 10.1002/ijc.21340.
738 Gene expression profiling of breast cancer cells in response to gemcitabine: NF-kappaB pathway activation as a potential mechanism of resistance. Breast Cancer Res Treat. 2007 Apr;102(2):157-72.
739 Characterizing the genetic basis for nicotine induced cancer development: a transcriptome sequencing study. PLoS One. 2013 Jun 18;8(6):e67252.
740 Dose- and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells. Toxicol Appl Pharmacol. 2009 Feb 1;234(3):345-60.
741 The molecular basis of genistein-induced mitotic arrest and exit of self-renewal in embryonal carcinoma and primary cancer cell lines. BMC Med Genomics. 2008 Oct 10;1:49.
742 Evidence for a role of claudin 2 as a proximal tubular stress responsive paracellular water channel. Toxicol Appl Pharmacol. 2014 Sep 1;279(2):163-72.
743 CXCL14 downregulation in human keratinocytes is a potential biomarker for a novel in vitro skin sensitization test. Toxicol Appl Pharmacol. 2020 Jan 1;386:114828. doi: 10.1016/j.taap.2019.114828. Epub 2019 Nov 14.
744 BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell. 2011 Sep 16;146(6):904-17.
745 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.
746 Design principles of concentration-dependent transcriptome deviations in drug-exposed differentiating stem cells. Chem Res Toxicol. 2014 Mar 17;27(3):408-20.
747 The renal Na(+)-dependent dicarboxylate transporter, NaDC-3, translocates dimethyl- and disulfhydryl-compounds and contributes to renal heavy metal detoxification. J Am Soc Nephrol. 2002 Nov;13(11):2628-38. doi: 10.1097/01.asn.0000033463.58641.f9.
748 Arsenic alters transcriptional responses to Pseudomonas aeruginosa infection and decreases antimicrobial defense of human airway epithelial cells. Toxicol Appl Pharmacol. 2017 Sep 15;331:154-163.
749 Novel ATP-competitive Akt inhibitor afuresertib suppresses the proliferation of malignant pleural mesothelioma cells. Cancer Med. 2017 Nov;6(11):2646-2659. doi: 10.1002/cam4.1179. Epub 2017 Sep 27.
750 Influence of cyclooxygenase inhibitors on the function of the prostaglandin transporter organic anion-transporting polypeptide 2A1 expressed in human gastroduodenal mucosa. J Pharmacol Exp Ther. 2010 Feb;332(2):345-51. doi: 10.1124/jpet.109.154518. Epub 2009 Oct 20.
751 Transporter gene expression in human head and neck squamous cell carcinoma and associated epigenetic regulatory mechanisms. Am J Pathol. 2013 Jan;182(1):234-43. doi: 10.1016/j.ajpath.2012.09.008. Epub 2012 Nov 6.
752 Inorganic arsenic exposure promotes malignant progression by HDAC6-mediated down-regulation of HTRA1. J Appl Toxicol. 2023 Aug;43(8):1214-1224. doi: 10.1002/jat.4457. Epub 2023 Mar 11.
753 Multi-level gene expression profiles affected by thymidylate synthase and 5-fluorouracil in colon cancer. BMC Genomics. 2006 Apr 3;7:68. doi: 10.1186/1471-2164-7-68.
754 Genomic profiling uncovers a molecular pattern for toxicological characterization of mutagens and promutagens in vitro. Toxicol Sci. 2011 Jul;122(1):185-97.
755 Effects of progesterone treatment on expression of genes involved in uterine quiescence. Reprod Sci. 2011 Aug;18(8):781-97.
756 Comparative Analysis of Transcriptomic Changes including mRNA and microRNA Expression Induced by the Xenoestrogens Zearalenone and Bisphenol A in Human Ovarian Cells. Toxins (Basel). 2023 Feb 9;15(2):140. doi: 10.3390/toxins15020140.
757 Exposure to Insecticides Modifies Gene Expression and DNA Methylation in Hematopoietic Tissues In Vitro. Int J Mol Sci. 2023 Mar 26;24(7):6259. doi: 10.3390/ijms24076259.
758 Changes in gene expression profiles of multiple myeloma cells induced by arsenic trioxide (ATO): possible mechanisms to explain ATO resistance in vivo. Br J Haematol. 2005 Mar;128(5):636-44.
759 Effect of aflatoxin B(1), benzo[a]pyrene, and methapyrilene on transcriptomic and epigenetic alterations in human liver HepaRG cells. Food Chem Toxicol. 2018 Nov;121:214-223. doi: 10.1016/j.fct.2018.08.034. Epub 2018 Aug 26.
760 ABCC11 expression is regulated by estrogen in MCF7 cells, correlated with estrogen receptor alpha expression in postmenopausal breast tumors and overexpressed in tamoxifen-resistant breast cancer cells. Endocr Relat Cancer. 2008 Mar;15(1):125-38. doi: 10.1677/ERC-07-0189.
761 ABCC11/MRP8 confers pemetrexed resistance in lung cancer. Cancer Sci. 2010 Nov;101(11):2404-10.
762 Screening autism-associated environmental factors in differentiating human neural progenitors with fractional factorial design-based transcriptomics. Sci Rep. 2023 Jun 29;13(1):10519. doi: 10.1038/s41598-023-37488-0.
763 Propofol suppresses proliferation, migration, invasion, and tumor growth of liver cancer cells via suppressing cancer susceptibility candidate 9/phosphatase and tensin homolog/AKT serine/threonine kinase/mechanistic target of rapamycin kinase axis. Hum Exp Toxicol. 2022 Jan-Dec;41:9603271211065972. doi: 10.1177/09603271211065972.
764 Synergistic effect of JQ1 and rapamycin for treatment of human osteosarcoma. Int J Cancer. 2015 May 1;136(9):2055-64.
765 Transcriptome profile analysis of saturated aliphatic aldehydes reveals carbon number-specific molecules involved in pulmonary toxicity. Chem Res Toxicol. 2014 Aug 18;27(8):1362-70.
766 Cyclosporine A--induced oxidative stress in human renal mesangial cells: a role for ERK 1/2 MAPK signaling. Toxicol Sci. 2012 Mar;126(1):101-13.
767 Alleviation of the drug-resistant phenotype in idarubicin and cytosine arabinoside double-resistant acute myeloid leukemia cells by indomethacin. Int J Oncol. 2008 Apr;32(4):931-6.
768 Schedule-dependent therapeutic effects of gemcitabine combined with uracil-tegafur in a human pancreatic cancer xenograft model. Pancreas. 2006 Aug;33(2):142-7. doi: 10.1097/01.mpa.0000226882.48204.26.
769 Two distinct molecular mechanisms underlying cytarabine resistance in human leukemic cells. Cancer Res. 2008 Apr 1;68(7):2349-57. doi: 10.1158/0008-5472.CAN-07-5528.
770 Functional role of the polymorphic 647 T/C variant of ENT1 (SLC29A1) and its association with alcohol withdrawal seizures. PLoS One. 2011 Jan 24;6(1):e16331. doi: 10.1371/journal.pone.0016331.
771 Bisphenolic compounds alter gene expression in MCF-7 cells through interaction with estrogen receptor . Toxicol Appl Pharmacol. 2020 Jul 15;399:115030. doi: 10.1016/j.taap.2020.115030. Epub 2020 May 6.
772 A highly conserved hydrophobic motif in the exofacial vestibule of fructose transporting SLC2A proteins acts as a critical determinant of their substrate selectivity. Mol Membr Biol. 2007 Sep-Dec;24(5-6):455-63. doi: 10.1080/09687680701298143.
773 Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3. Am J Physiol Gastrointest Liver Physiol. 2009 Apr;296(4):G910-22. doi: 10.1152/ajpgi.90672.2008. Epub 2009 Jan 22.
774 Gene expression signatures after ethanol exposure in differentiating embryoid bodies. Toxicol In Vitro. 2018 Feb;46:66-76.
775 Transcellular movement of hydroxyurea is mediated by specific solute carrier transporters. Exp Hematol. 2011 Apr;39(4):446-56.
776 Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity. Br J Clin Pharmacol. 2016 Sep;82(3):683-95. doi: 10.1111/bcp.13008. Epub 2016 Jun 30.
777 Human Mincle Binds to Cholesterol Crystals and Triggers Innate Immune Responses. J Biol Chem. 2015 Oct 16;290(42):25322-32. doi: 10.1074/jbc.M115.645234. Epub 2015 Aug 20.
778 Transcriptional signature of human macrophages exposed to the environmental contaminant benzo(a)pyrene. Toxicol Sci. 2010 Apr;114(2):247-59.
779 High folic acid increases cell turnover and lowers differentiation and iron content in human HT29 colon cancer cells. Br J Nutr. 2008 Apr;99(4):703-8.
780 Role of oxidative stress in the induction of metallothionein-2A and heme oxygenase-1 gene expression by the antineoplastic agent gallium nitrate in human lymphoma cells. Free Radic Biol Med. 2008 Sep 15;45(6):763-72.
781 Anti-proliferative and gene expression actions of resveratrol in breast cancer cells in vitro. Oncotarget. 2014 Dec 30;5(24):12891-907.
782 SIRT3 Mediates the Antioxidant Effect of Hydrogen Sulfide in Endothelial Cells. Antioxid Redox Signal. 2016 Feb 20;24(6):329-43. doi: 10.1089/ars.2015.6331. Epub 2015 Nov 10.
783 Effects of SIDT2 on the miR-25/NOX4/HuR axis and SIRT3 mRNA stability lead to ROS-mediated TNF- expression in hydroquinone-treated leukemia cells. Cell Biol Toxicol. 2023 Oct;39(5):2207-2225. doi: 10.1007/s10565-022-09705-5. Epub 2022 Mar 18.
784 Various concentrations of hesperetin induce different types of programmed cell death in human breast cancerous and normal cell lines in a ROS-dependent manner. Chem Biol Interact. 2023 Sep 1;382:110642. doi: 10.1016/j.cbi.2023.110642. Epub 2023 Jul 23.
785 Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer. Cancer. 2011 Apr 15;117(8):1670-8. doi: 10.1002/cncr.25676. Epub 2010 Nov 29.
786 Novel mechanism of endocrine disruption by fungicides through binding to the membrane androgen receptor, ZIP9 (SLC39A9), and antagonizing rapid testosterone induction of the intrinsic apoptotic pathway. Steroids. 2019 Sep;149:108415. doi: 10.1016/j.steroids.2019.05.007. Epub 2019 May 30.
787 Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies. J Biol Chem. 2019 Oct 18;294(42):15218-15234. doi: 10.1074/jbc.RA119.009147. Epub 2019 Jul 8.
788 Role of vitamin C transporters and biliverdin reductase in the dual pro-oxidant and anti-oxidant effect of biliary compounds on the placental-fetal unit in cholestasis during pregnancy. Toxicol Appl Pharmacol. 2008 Oct 15;232(2):327-36.
789 Integrated transcriptomic and metabolomic analyses to characterize the anti-cancer effects of (-)-epigallocatechin-3-gallate in human colon cancer cells. Toxicol Appl Pharmacol. 2020 Aug 15;401:115100. doi: 10.1016/j.taap.2020.115100. Epub 2020 Jun 6.
790 Arsenic exposure from drinking water is associated with decreased gene expression and increased DNA methylation in peripheral blood. Toxicol Appl Pharmacol. 2017 Apr 15;321:57-66. doi: 10.1016/j.taap.2017.02.019. Epub 2017 Feb 24.
791 Gene induction and apoptosis in human hepatocellular carci-noma cells SMMC-7721 exposed to 5-aza-2'-deoxycytidine. Chin Med J (Engl). 2007 Sep 20;120(18):1626-31.
792 Changes in gene expressions elicited by physiological concentrations of genistein on human endometrial cancer cells. Mol Carcinog. 2006 Oct;45(10):752-63.
793 Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells. Nat Commun. 2018 Aug 9;9(1):3069. doi: 10.1038/s41467-018-05402-2.
794 Alcohol and Cannabinoids Differentially Affect HIV Infection and Function of Human Monocyte-Derived Dendritic Cells (MDDC). Front Microbiol. 2015 Dec 22;6:1452. doi: 10.3389/fmicb.2015.01452. eCollection 2015.
795 Repurposing L-menthol for systems medicine and cancer therapeutics? L-menthol induces apoptosis through caspase 10 and by suppressing HSP90. OMICS. 2016 Jan;20(1):53-64.
796 Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system. (Comparison with steroids). Int Immunopharmacol. 2001 Jun;1(6):1219-26. doi: 10.1016/s1567-5769(01)00059-5.
797 Effects of theophylline, dexamethasone and salbutamol on cytokine gene expression in human peripheral blood CD4+ T-cells. Eur Respir J. 1999 Nov;14(5):1106-12. doi: 10.1183/09031936.99.14511069.
798 Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid. Liver Int. 2008 Aug;28(7):997-1010. doi: 10.1111/j.1478-3231.2008.01744.x. Epub 2008 Apr 15.
799 Proteomic analysis of the cellular response to a potent sensitiser unveils the dynamics of haptenation in living cells. Toxicology. 2020 Dec 1;445:152603. doi: 10.1016/j.tox.2020.152603. Epub 2020 Sep 28.
800 Global expression profiling of theophylline response genes in macrophages: evidence of airway anti-inflammatory regulation. Respir Res. 2005 Aug 8;6(1):89. doi: 10.1186/1465-9921-6-89.
801 Assessment of mitochondrial toxicity by analysis of mitochondrial protein expression in mononuclear cells. Cytometry B Clin Cytom. 2009 May;76(3):181-90. doi: 10.1002/cyto.b.20458.
802 Examining the impact of skin lighteners in vitro. Oxid Med Cell Longev. 2013;2013:702120. doi: 10.1155/2013/702120. Epub 2013 Apr 28.
803 White-to-brown metabolic conversion of human adipocytes by JAK inhibition. Nat Cell Biol. 2015 Jan;17(1):57-67. doi: 10.1038/ncb3075. Epub 2014 Dec 8.
804 Chloramphenicol-induced mitochondrial stress increases p21 expression and prevents cell apoptosis through a p21-dependent pathway. J Biol Chem. 2005 Jul 15;280(28):26193-9. doi: 10.1074/jbc.M501371200. Epub 2005 May 19.
805 PPARgama activation rescues mitochondrial function from inhibition of complex I and loss of PINK1. Exp Neurol. 2014 Mar;253:16-27.
806 Trans-Resveratrol in Gnetum gnemon protects against oxidative-stress-induced endothelial senescence. J Nat Prod. 2013 Jul 26;76(7):1242-7.
807 AMPK activator acadesine fails to alleviate isoniazid-caused mitochondrial instability in HepG2 cells. J Appl Toxicol. 2017 Oct;37(10):1219-1224. doi: 10.1002/jat.3483. Epub 2017 May 29.
808 Analysis of the transcriptional regulation of cancer-related genes by aberrant DNA methylation of the cis-regulation sites in the promoter region during hepatocyte carcinogenesis caused by arsenic. Oncotarget. 2015 Aug 28;6(25):21493-506. doi: 10.18632/oncotarget.4085.
809 Plasmatic concentration of organochlorine lindane acts as metabolic disruptors in HepG2 liver cell line by inducing mitochondrial disorder. Toxicol Appl Pharmacol. 2013 Oct 15;272(2):325-34.
810 Estrogen receptor alpha 46 is reduced in tamoxifen resistant breast cancer cells and re-expression inhibits cell proliferation and estrogen receptor alpha 66-regulated target gene transcription. Mol Cell Endocrinol. 2010 Jul 29;323(2):268-76. doi: 10.1016/j.mce.2010.03.013. Epub 2010 Mar 17.
811 HIF and reactive oxygen species regulate oxidative phosphorylation in cancer. Carcinogenesis. 2008 Aug;29(8):1528-37. doi: 10.1093/carcin/bgn125. Epub 2008 May 29.
812 Altered redox mitochondrial biology in the neurodegenerative disorder fragile X-tremor/ataxia syndrome: use of antioxidants in precision medicine. Mol Med. 2016 Oct;22:548-559. doi: 10.2119/molmed.2016.00122. Epub 2016 Jun 30.
813 Acquisition of temozolomide chemoresistance in gliomas leads to remodeling of mitochondrial electron transport chain. J Biol Chem. 2010 Dec 17;285(51):39759-67. doi: 10.1074/jbc.M110.147504. Epub 2010 Sep 24.
814 Mitotane alters mitochondrial respiratory chain activity by inducing cytochrome c oxidase defect in human adrenocortical cells. Endocr Relat Cancer. 2013 May 21;20(3):371-81.
815 Erythropoietin activates SIRT1 to protect human cardiomyocytes against doxorubicin-induced mitochondrial dysfunction and toxicity. Toxicol Lett. 2017 Jun 5;275:28-38. doi: 10.1016/j.toxlet.2017.04.018. Epub 2017 Apr 27.
816 Differential transport of cytosine-containing nucleosides by recombinant human concentrative nucleoside transporter protein hCNT1. Nucleosides Nucleotides Nucleic Acids. 2000 Jan-Feb;19(1-2):415-34. doi: 10.1080/15257770008033018.
817 Molecular cloning and functional expression of cDNAs encoding a human Na+-nucleoside cotransporter (hCNT1). Am J Physiol. 1997 Feb;272(2 Pt 1):C707-14. doi: 10.1152/ajpcell.1997.272.2.C707.
818 Human concentrative nucleoside transporter 1-mediated uptake of 5-azacytidine enhances DNA demethylation. Mol Cancer Ther. 2009 Jan;8(1):225-31. doi: 10.1158/1535-7163.MCT-08-0743.